Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 1c,Condition 2a,Condition 2b,Condition 2c,Condition 3a,Condition 3b,Condition 4 61,"Pravenec M, et al., J Hypertens 2001 Jun;19(6):1061-4.",body mass,,RS:0000715,SHR/OlaIpcv,male,100 days,12,,CMO:0000012,body weight,,,,268.4,g,8.1,28.0592,MMO:0000016,body weighing method,,,,,,,control condition,11283,control condition,,,,,,,, 61,"Pravenec M, et al., J Hypertens 2001 Jun;19(6):1061-4.",body mass,,RS:0000717,SHR.BN-(D2Rat171-D2Arb24)/Ipcv,male,100 days,8,,CMO:0000012,body weight,,,,314.2,g,4.8,13.5765,MMO:0000016,body weighing method,,0.0,,,,,control condition,11284,control condition,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0000021,ACI/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,309,g,4.0,13.8564,MMO:0000016,body weighing method,,,,,,,control condition,11285,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000134,BN/Crl,male,84 days,26,,CMO:0000012,body weight,,,,237,g,5.0,25.4951,MMO:0000016,body weighing method,,,,,,,control condition,11289,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000119,BN.GK-(D8Rat29-D8Got130)/Ox,male,84 days,11,,CMO:0000012,body weight,,,,234,g,5.0,16.5831,MMO:0000016,body weighing method,,,,,,,control condition,11290,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000117,BN.GK-(D8Got302-D8Got130)/Ox,male,84 days,17,,CMO:0000012,body weight,,,,244,g,5.0,20.6155,MMO:0000016,body weighing method,,,,,,,control condition,11291,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000134,BN/Crl,male,168 days,15,,CMO:0000012,body weight,,,,313,g,4.0,15.4919,MMO:0000016,body weighing method,,,,,,,control condition,11292,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000119,BN.GK-(D8Rat29-D8Got130)/Ox,male,168 days,13,,CMO:0000012,body weight,,,,309,g,6.0,21.6333,MMO:0000016,body weighing method,,,,,,,control condition,11293,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000117,BN.GK-(D8Got302-D8Got130)/Ox,male,168 days,12,,CMO:0000012,body weight,,,,345,g,11.0,38.1051,MMO:0000016,body weighing method,,,,,,,control condition,11294,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000134,BN/Crl,female,84 days,33,,CMO:0000012,body weight,,,,160,g,2.0,11.4891,MMO:0000016,body weighing method,,,,,,,control condition,11295,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000119,BN.GK-(D8Rat29-D8Got130)/Ox,female,84 days,15,,CMO:0000012,body weight,,,,164,g,4.0,15.4919,MMO:0000016,body weighing method,,,,,,,control condition,11296,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000117,BN.GK-(D8Got302-D8Got130)/Ox,female,84 days,24,,CMO:0000012,body weight,,,,168,g,3.0,14.6969,MMO:0000016,body weighing method,,,,,,,control condition,11297,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0000134,BN/Crl,male,90 days,28,,CMO:0000012,body weight,,,,236,g,5.0,26.4575,MMO:0000016,body weighing method,,,,,,,control condition,11298,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0002463,BN.GK-(D2Wox49-D2Rat70)/Ox,male,90 days,27,,CMO:0000012,body weight,,,,247,g,4.0,20.7846,MMO:0000016,body weighing method,,,,,,,control condition,11299,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0002464,BN.GK-(D2Wox30-D2Wox68)/Ox,male,90 days,16,,CMO:0000012,body weight,,,,250,g,6.0,24.0,MMO:0000016,body weighing method,,,,,,,control condition,11300,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0002465,BN.GK-(D2Rat40-D2Wox35)/Ox,male,90 days,11,,CMO:0000012,body weight,,,,238,g,10.0,33.1662,MMO:0000016,body weighing method,,,,,,,control condition,11301,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0001459,BN.GK-(D2Rat40-D2Got149)/Ox,male,90 days,15,,CMO:0000012,body weight,,,,248,g,4.0,15.4919,MMO:0000016,body weighing method,,,,,,,control condition,11302,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0000134,BN/Crl,female,90 days,36,,CMO:0000012,body weight,,,,159,g,2.0,12.0,MMO:0000016,body weighing method,,,,,,,control condition,11303,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0002463,BN.GK-(D2Wox49-D2Rat70)/Ox,female,90 days,46,,CMO:0000012,body weight,,,,170,g,2.0,13.5647,MMO:0000016,body weighing method,,,,,,,control condition,11304,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0002464,BN.GK-(D2Wox30-D2Wox68)/Ox,female,90 days,17,,CMO:0000012,body weight,,,,174,g,4.0,16.4924,MMO:0000016,body weighing method,,,,,,,control condition,11305,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0002465,BN.GK-(D2Rat40-D2Wox35)/Ox,female,90 days,6,,CMO:0000012,body weight,,,,178,g,8.0,19.5959,MMO:0000016,body weighing method,,,,,,,control condition,11306,control condition,,,,,,,, 69,"Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20.",body mass,,RS:0001459,BN.GK-(D2Rat40-D2Got149)/Ox,female,90 days,8,,CMO:0000012,body weight,,,,158,g,5.0,14.1421,MMO:0000016,body weighing method,,,,,,,control condition,11307,control condition,,,,,,,, 82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",body mass,,RS:0000118,GK/KyoSwe,not specified,80 days,8,,CMO:0000012,body weight,,,,228,g,19.0,53.7401,MMO:0000016,body weighing method,,0.0,,,,,control condition,11392,control condition,,,,,,,, 82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",body mass,,RS:0000179,F344/DuCrl,not specified,80 days,10,,CMO:0000012,body weight,,,,168,g,16.0,50.5964,MMO:0000016,body weighing method,,0,,,,,control condition,11401,control condition,,,,,,,, 83,Ogino Genom 2000 Nov 15;70(1):19-25.,body mass,,RS:0000625,OLETF/Got,male,252 days to 245 days,14,,CMO:0000012,body weight,,,,650.6,g,8.6058,32.2,MMO:0000016,body weighing method,,,,,,,control condition,11406,control condition,,,,,,,, 83,Ogino Genom 2000 Nov 15;70(1):19-25.,body mass,,RS:0000305,F344/DuCrlCrlj,male,252 days to 245 days,15,,CMO:0000012,body weight,,,,404.4,g,5.164,20.0,MMO:0000016,body weighing method,,,,,,,control condition,11411,control condition,,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,95 days,11,,CMO:0000012,body weight,,,,27,g,6.0,19.8997,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 95 days),11443,control condition (for 95 days),,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000305,F344/DuCrlCrlj,male,95 days,15,,CMO:0000012,body weight,,,,279,g,4.0,15.4919,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 95 days),11444,control condition (for 95 days),,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,95 days,11,,CMO:0000012,body weight,,,,305,g,5.0,16.5831,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 95 days),11445,control condition (for 95 days),,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,65 days,11,,CMO:0000012,body weight,,,,197,g,5.0,16.5831,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 65 days),11464,control condition (for 65 days),,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000305,F344/DuCrlCrlj,male,65 days,15,,CMO:0000012,body weight,,,,207,g,3.0,11.619,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 65 days),11465,control condition (for 65 days),,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,65 days,11,,CMO:0000012,body weight,,,,228,g,4.0,13.2665,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 65 days),11466,control condition (for 65 days),,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,185 days,10,,CMO:0000012,body weight,,,,35,g,6.0,18.9737,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 185 days),11485,control condition (for 185 days),,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000305,F344/DuCrlCrlj,male,185 days,9,,CMO:0000012,body weight,,,,365,g,9.0,27.0,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 185 days),11486,control condition (for 185 days),,,,,,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",body mass,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,185 days,10,,CMO:0000012,body weight,,,,386,g,4.0,12.6491,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 185 days),11487,control condition (for 185 days),,,,,,,, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",body mass,,RS:0000374,GH/Omr,male,146 days to 132 days,21,,CMO:0000012,body weight,,,,365.4,g,3.7097,17.0,MMO:0000016,body weighing method,,,,,,,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours),11527,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours),,,norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours),,,phenylephrine (4 ug/kg) (between 0 and 0 hours),, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",body mass,,RS:0001668,BN.GH-(D2Rat22-D2Mgh11)/Mcwi,male,146 days to 132 days,19,,CMO:0000012,body weight,,,,330.6,g,5.9648,26.0,MMO:0000016,body weighing method,,,,,,,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours),11534,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours),,,norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours),,,phenylephrine (4 ug/kg) (between 0 and 0 hours),, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",body mass,,RS:0001667,BN.GH-(D6Mit12-D6Rat15)/Mcwi,male,146 days to 132 days,16,,CMO:0000012,body weight,,,,299.9,g,6.0,24.0,MMO:0000016,body weighing method,,,,,,,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours),11541,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours),,,norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours),,,phenylephrine (4 ug/kg) (between 0 and 0 hours),, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",body mass,,RS:0001665,BN.GH-(D18Rat41-D18Mgh4)/Mcwi,male,146 days to 132 days,21,,CMO:0000012,body weight,,,,315.2,g,5.2372,24.0,MMO:0000016,body weighing method,,,,,,,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours),11548,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours),,,norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours),,,phenylephrine (4 ug/kg) (between 0 and 0 hours),, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",body mass,,RS:0000137,BN/Elh,male,146 days to 132 days,21,,CMO:0000012,body weight,,,,310.3,g,7.6376,35.0,MMO:0000016,body weighing method,,,,,,,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours),11555,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours),,,norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours),,,phenylephrine (4 ug/kg) (between 0 and 0 hours),, 102,"Zhao L et al., 2001, Circulation, 103(3), 442-7",body mass,,RS:0000363,F344/NHsd,male,105 days,12,,CMO:0000012,body weight,,,median,290,g,,,MMO:0000016,body weighing method,,,,,,,control condition,11562,control condition,,,,,,,, 102,"Zhao L et al., 2001, Circulation, 103(3), 442-7",body mass,,RS:0001072,WKY/NCruk,male,105 days,12,,CMO:0000012,body weight,,,median,250,g,,,MMO:0000016,body weighing method,,,,,,,control condition,11570,control condition,,,,,,,, 102,"Zhao L et al., 2001, Circulation, 103(3), 442-7",body mass,,RS:0001072,WKY/NCruk,male,105 days,28,,CMO:0000012,body weight,,,median,270,g,,,MMO:0000016,body weighing method,,,,,,,air oxygen content (10 %) (for 21 days),11574,air oxygen content (10 %) (for 21 days),,,,,,,, 103,"Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7",body mass,,RS:0000510,LEW/CrlCrlj,male,168 days,5,,CMO:0000012,body weight,,,,417,g,8.4971,19.0,MMO:0000016,body weighing method,,,,,,,control condition,11578,control condition,,,,,,,, 103,"Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7",body mass,,RS:0000746,SHR/Izm,male,168 days,6,,CMO:0000012,body weight,,,,348,g,3.6742,9.0,MMO:0000016,body weighing method,,,,,,,control condition,11579,control condition,,,,,,,, 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",body mass,,RS:0000709,SDT/Jcl,male,420 days,5,,CMO:0000012,body weight,,,,334.2,g,7.6,16.9941,MMO:0000016,body weighing method,,0.0,,,,,specific pathogen-free condition then fasting (for 16 hours),11605,specific pathogen-free condition,,,fasting (for 16 hours),,,,, 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",body mass,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000012,body weight,,,,470.3,g,9.59,25.3728,MMO:0000016,body weighing method,,0,,,,,specific pathogen-free condition then fasting (for 16 hours),11607,specific pathogen-free condition,,,fasting (for 16 hours),,,,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",body mass,,RS:0000916,WKY/NHsd,male,119 days,10,,CMO:0000012,body weight,,,,352,g,4.5,14.2302,MMO:0000016,body weighing method,,0,,,,,fasting (for 16 hours),11608,fasting (for 16 hours),,,,,,,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",body mass,,RS:0000363,F344/NHsd,male,119 days,10,,CMO:0000012,body weight,,,,345,g,5.4,17.0763,MMO:0000016,body weighing method,,0,,,,,fasting (for 16 hours),11609,fasting (for 16 hours),,,,,,,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",body mass,,RS:0000916,WKY/NHsd,female,119 days,10,,CMO:0000012,body weight,,,,230,g,3.2,10.1193,MMO:0000016,body weighing method,,0,,,,,fasting (for 16 hours),11610,fasting (for 16 hours),,,,,,,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",body mass,,RS:0000363,F344/NHsd,female,119 days,10,,CMO:0000012,body weight,,,,221,g,3.8,12.0167,MMO:0000016,body weighing method,,0,,,,,fasting (for 16 hours),11611,fasting (for 16 hours),,,,,,,, 110,"Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7",body mass,,RS:0001072,WKY/NCruk,male,175 days,19,,CMO:0000012,body weight,,,,329.3,g,5.6207,24.5,MMO:0000016,body weighing method,,,,,,,control condition,11641,control condition,,,,,,,, 110,"Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7",body mass,,RS:0001039,WKY.SHR-(D1Wox19-D1Mit2)/Njs,male,175 days,20,,CMO:0000012,body weight,,,,343.1,g,6.015,26.9,MMO:0000016,body weighing method,,,,,,,control condition,11642,control condition,,,,,,,, 113,"Innes BA, et al., Hypertension 1998 Mar;31(3):741-6",body mass,,RS:0000729,SHR/N,male,140 days,34,,CMO:0000012,body weight,,,,355,g,3.43,20.0,MMO:0000016,body weighing method,,,,,,,control condition,11663,control condition,,,,,,,, 113,"Innes BA, et al., Hypertension 1998 Mar;31(3):741-6",body mass,,RS:0000250,DRY,male,140 days,35,,CMO:0000012,body weight,,,,346,g,3.8877,23.0,MMO:0000016,body weighing method,,,,,,,control condition,11666,control condition,,,,,,,, 145,"Cicila GT, et al., Mamm Genome 1999 Feb;10(2):112-6.",body mass,,RS:0000817,SS/Jr,male,65 days,20,,CMO:0000012,body weight,,,,306.8,g,4.6,20.5718,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 28 days),11779,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 145,"Cicila GT, et al., Mamm Genome 1999 Feb;10(2):112-6.",body mass,,RS:0001562,SS.SR-(D3Mco19-D3Mco5)/Jr,male,65 days,19,,CMO:0000012,body weight,,,,307.3,g,2.4,10.4614,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 28 days),11780,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",body mass,,RS:0000817,SS/Jr,male,100 days,21,,CMO:0000012,body weight,,,,350,g,7.3,33.4528,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (1 %) (for 30 days) then controlled sodium content diet (0.2 %) (for 40 days),11785,controlled sodium content diet (1 %) (for 30 days),,,controlled sodium content diet (0.2 %) (for 40 days),,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",body mass,,RS:0000909,SS.SR-(Cyp11b1)/Jr,male,100 days,16,,CMO:0000012,body weight,,,,336.7,g,6.7,26.8,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (1 %) (for 30 days) then controlled sodium content diet (0.2 %) (for 40 days),11786,controlled sodium content diet (1 %) (for 30 days),,,controlled sodium content diet (0.2 %) (for 40 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,298.2,g,4.2,18.783,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11799,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0002420,SS.SR-(D7Rat16-D7Mgh5)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,292.1,g,2.2,9.8387,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11800,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,289.4,g,2.0,8.9443,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11805,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0002421,SS.SR-(D7Rat16-D7Rat189)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,296.3,g,3.0,13.4164,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11806,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,297.1,g,2.3,10.2859,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11811,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0002422,SS.SR-(D7Mco7-D7Rat81)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,302.4,g,2.3,10.2859,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11812,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,289.8,g,3.2,14.3108,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11817,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0000912,SS.SR-(D7Uia1-D7Mco7)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,300.2,g,2.6,11.6276,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11818,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,297.7,g,2.5,11.1803,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11823,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0000911,SS.SR-(D7Mco7-D7Wox19)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,299.4,g,2.8,12.522,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11824,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,19,,CMO:0000012,body weight,,,,302.3,g,3.5,15.2561,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11829,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",body mass,,RS:0002423,SS.SR-(D7Rat16-D7Rat176)/Jr,male,70 days to 68 days,19,,CMO:0000012,body weight,,,,306.4,g,1.7,7.4101,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11830,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,, 223,"Aitman TJ, et al., Nat Genet 1997 Jun;16(2):197-201",body mass,,RS:0000753,SHR/NCruk,not specified,115 days,23,,CMO:0000012,body weight,,,,308,g,1.5847,7.6,MMO:0000016,body weighing method,,0.0,,,,,control condition,11921,control condition,,,,,,,, 223,"Aitman TJ, et al., Nat Genet 1997 Jun;16(2):197-201",body mass,,RS:0001072,WKY/NCruk,not specified,107 days,23,,CMO:0000012,body weight,,,,314,g,2.8775,13.8,MMO:0000016,body weighing method,,0.0,,,,,control condition,11922,control condition,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001164,ACI.FHH-(D1Rat298-D1Rat90)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,333,g,7.0,24.2487,MMO:0000016,body weighing method,,0.0,,,,,control condition,11924,control condition,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001168,ACI.FHH-(D3Wox2-D3Rat59)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,314,g,3.0,10.3923,MMO:0000016,body weighing method,,0.0,,,,,control condition,11926,control condition,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0000021,ACI/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,315,g,3.0,10.3923,MMO:0000016,body weighing method,,,,,,,right nephrectomy,11930,right nephrectomy,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001167,ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,311,g,3.0,10.3923,MMO:0000016,body weighing method,,,,,,,control condition,11944,control condition,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001168,ACI.FHH-(D3Wox2-D3Rat59)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,311,g,4.0,13.8564,MMO:0000016,body weighing method,,0.0,,,,,right nephrectomy,11948,right nephrectomy,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001164,ACI.FHH-(D1Rat298-D1Rat90)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,330,g,6.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,right nephrectomy,11951,right nephrectomy,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001167,ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,304,g,5.0,17.3205,MMO:0000016,body weighing method,,,,,,,right nephrectomy,11953,right nephrectomy,,,,,,,, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",body mass,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000012,body weight,,,,650,g,7.7,24.3495,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),11961,fasting (for 16 hours),,,,,,,, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",body mass,,RS:0000305,F344/DuCrlCrlj,male,210 days,10,,CMO:0000012,body weight,,,,374.1,g,8.0,25.2982,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),11968,fasting (for 16 hours),,,,,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0000817,SS/Jr,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,337,g,2.36,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11973,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0000817,SS/Jr,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,302,g,5.58,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11974,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0000817,SS/Jr,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,331,g,2.08,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11975,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0000817,SS/Jr,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,310,g,2.38,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11976,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0001520,SS.LEW-(D10Mco113-D10Got93)/Mco,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,337,g,2.09,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11977,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0001526,SS.LEW-(D10Mco84-D10Mco134)/Mco,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,306,g,2.34,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11978,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0001527,SS.LEW-(D10Mco84-D10Mco143)/Mco,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,335,g,3.0,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11979,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0001528,SS.LEW-(D10Mco84-D10Rat58)/Mco,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,311,g,4.21,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11980,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 205,"Saad Y, et al., Hypertension. 2007",body mass,,RS:0001525,SS.LEW-(D10Mco84-D10Mco129)/Mco,male,66 days to 64 days,N/A,,CMO:0000012,body weight,,,,308,g,5.3,,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11981,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000012,body weight,,,,386.4,g,6.5,30.4877,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),11983,fasting (for 16 hours),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000012,body weight,,,,366.8,g,4.2,16.8,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),11985,fasting (for 16 hours),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000012,body weight,,,,384,g,3.4,13.1681,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),11991,fasting (for 16 hours),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000012,body weight,,,,398.6,g,4.9,21.3586,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),11997,fasting (for 16 hours),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000012,body weight,,,,411.2,g,4.2,15.1433,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12000,fasting (for 16 hours),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001535,SS.LEW-(D2Rat18-D2Chm277)/Ayd,male,98 days,6,,CMO:0000012,body weight,,,,311,g,20.0,48.9898,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12014,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000876,SS.LEW-(D2Rat199-D2Mco17)/Ayd,male,98 days,8,,CMO:0000012,body weight,,,,321,g,5.0,14.1421,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12017,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000012,body weight,,,,368.4,g,3.8,14.7173,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12019,fasting (for 16 hours),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,15,,CMO:0000012,body weight,,,,382.8,g,4.8,18.5903,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12027,fasting (for 16 hours),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000904,SS.MNS-(D2Rat183-D2Chm113)/Ayd,male,98 days,8,,CMO:0000012,body weight,,,,415,g,6.0,16.9706,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12029,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000899,SS.MNS-(D2Chm25-D2Rat131)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,394,g,0.8,1.7889,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12031,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000905,SS.MNS-(D2Wox27-Adh1)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,352,g,15.0,33.541,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12032,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000902,SS.MNS-(D2Chm51-D2Rat341)/Ayd,male,98 days,8,,CMO:0000012,body weight,,,,368,g,10.0,28.2843,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12033,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000012,body weight,,,,352.5,g,4.4,13.914,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12034,fasting (for 16 hours),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000900,SS.MNS-(D2Chm25-Fgg)/Ayd,male,98 days,9,,CMO:0000012,body weight,,,,396,g,5.0,15.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12035,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000882,SS.LEW-(D3Rat52-D3Rat130)/Ayd,male,98 days,7,,CMO:0000012,body weight,,,,390,g,6.0,15.8745,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12037,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000880,SS.LEW-(D3Mco21-D3Rat17)/Ayd,male,98 days,4,,CMO:0000012,body weight,,,,401,g,9.0,18.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12041,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001645,SS.LEW-(D3Got33-D3Chm68)/Ayd,male,98 days,10,,CMO:0000012,body weight,,,,389,g,6.0,18.9737,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12042,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001643,SS.LEW-(D3Rat61-D3Wox1)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,399,g,1.0,2.2361,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12046,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000841,SS.LEW-(D8Chm14-D8Rat16)/Ayd,male,98 days,7,,CMO:0000012,body weight,,,,399,g,5.0,13.2288,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12049,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000012,body weight,,,,365.5,g,7.0,19.799,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12052,fasting (for 16 hours),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000840,SS.LEW-(D8Rat56-D8Rat51)/Ayd,male,98 days,9,,CMO:0000012,body weight,,,,280,g,9.0,27.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12057,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000853,SS.LEW-(D10Rat27-Igfbp4)/Ayd,male,98 days,7,,CMO:0000012,body weight,,,,388,g,6.0,15.8745,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12058,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000852,SS.LEW-(D10Rat24-Igfbp4)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,374,g,14.0,31.305,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12059,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001510,SS.LEW-(D10Chm128-D10Chm121)/Ayd,male,98 days,9,,CMO:0000012,body weight,,,,379,g,11.0,33.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12060,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001507,SS.LEW-(D10Chm10-D10Rat11)/Ayd,male,98 days,7,,CMO:0000012,body weight,,,,375,g,5.0,13.2288,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12061,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001509,SS.LEW-(D10Chm128-D10Chm169)/Ayd,male,98 days,8,,CMO:0000012,body weight,,,,369,g,6.0,16.9706,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12063,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000860,SS.LEW-(D16Rat38-D16Chm66)/Ayd,male,98 days,8,,CMO:0000012,body weight,,,,360,g,15.0,42.4264,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12064,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000012,body weight,,,,367.2,g,5.2,18.7489,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12065,fasting (for 16 hours),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000859,SS.LEW-(D16Rat12-D16Chm23)/Ayd,male,98 days,10,,CMO:0000012,body weight,,,,374,g,12.0,37.9473,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12066,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001644,SS.LEW-(D16Got3-D16Rat112)/Ayd,male,98 days,9,,CMO:0000012,body weight,,,,389,g,7.0,21.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12068,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001491,SS.LEW-(D17Chm14-D17Rat181)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,377,g,9.0,20.1246,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12069,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001494,SS.LEW-(D17Rat65-D17Chm2)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,387,g,9.0,20.1246,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12070,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001493,SS.LEW-(D17Chm9-D17Rat97)/Ayd,male,98 days,10,,CMO:0000012,body weight,,,,367,g,15.0,47.4342,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12071,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001659,SS.LEW-(D18Rat61-D18Rat45)/Ayd,male,98 days,6,,CMO:0000012,body weight,,,,379,g,8.0,19.5959,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12073,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000012,body weight,,,,392.2,g,5.2,19.4566,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12074,fasting (for 16 hours),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001654,SS.LEW-(D18Chm41-D18Rat92)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,386,g,5.0,11.1803,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12076,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001655,SS.LEW-(D18Chm91-D18Rat67)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,389,g,8.0,17.8885,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12077,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001661,SS.LEW-(D18Chm56-D18Rat55)/Ayd,male,98 days,5,,CMO:0000012,body weight,,,,351,g,14.0,31.305,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12078,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000817,SS/Jr,male,98 days,16,,CMO:0000012,body weight,,,,348,g,9.0,36.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12079,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0000121,LEW,male,98 days,6,,CMO:0000012,body weight,,,,372,g,9.0,22.0454,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12080,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000012,body weight,,,,378.4,g,6.5,20.5548,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12081,fasting (for 16 hours),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001513,SS.LEW-(D10Chm224-D10Chm6)/Ayd,male,98 days,11,,CMO:0000012,body weight,,,,382,g,6.0,19.8997,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),12082,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000012,body weight,,,,345.3,g,2.8,7.4081,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),12083,fasting (for 16 hours),,,,,,,, 233,"Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53.",body mass,,RS:0000363,F344/NHsd,not specified,84 days,23,,CMO:0000012,body weight,,,,262.8,g,4.4831,21.5,MMO:0000016,body weighing method,,0.0,,,,,control condition,12133,control condition,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,340,g,5.26,23.5234,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12141,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,308,g,1.28,5.7243,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12142,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,312,g,3.22,14.4003,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12143,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,306,g,3.09,13.8189,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12144,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,307,g,2.02,9.0337,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12145,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0001551,SS.MNS-(D10Mco62-D10Mco30)/Mco,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,345,g,7.09,31.7074,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12146,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0001550,SS.MNS-(D10Mco62-D10Got99)/Mco,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,304,g,2.1,9.3915,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12147,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0001545,SS.MNS-(D10Mco30-D10Got112)/Mco,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,299,g,2.78,12.4325,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12148,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0001544,SS.MNS-(D10Mco30-D10Got101)/Mco,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,297,g,1.47,6.574,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12149,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0001546,SS.MNS-(D10Mco30-D10Got91)/1Mco,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,306,g,2.31,10.3306,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12150,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0001547,SS.MNS-(D10Mco30-D10Got91)/2Mco,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,296,g,3.6,16.0997,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12151,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",body mass,,RS:0001548,SS.MNS-(D10Mco30-D10Got91)/3Mco,male,68 days to 64 days,20,,CMO:0000012,body weight,,,,300,g,3.15,14.0872,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),12152,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000786,SR/Jr,male,63 days,10,,CMO:0000012,body weight,,,,238,g,4.7,14.8627,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 28 days),12180,controlled sodium content diet (0.2 %) (for 28 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000786,SR/Jr,male,91 days,10,,CMO:0000012,body weight,,,,313,g,4.8,15.1789,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 56 days),12181,controlled sodium content diet (0.2 %) (for 56 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000786,SR/Jr,male,147 days,10,,CMO:0000012,body weight,,,,379,g,5.7,18.025,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 112 days),12182,controlled sodium content diet (0.2 %) (for 112 days),,,,,,,, 233,"Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53.",body mass,,RS:0001072,WKY/NCruk,not specified,84 days,22,,CMO:0000012,body weight,,,,273.4,g,4.4346,20.8,MMO:0000016,body weighing method,,0.0,,,,,control condition,12183,control condition,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000786,SR/Jr,male,63 days,10,,CMO:0000012,body weight,,,,243,g,5.5,17.3925,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 28 days),12184,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 28 days),,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000786,SR/Jr,male,91 days,10,,CMO:0000012,body weight,,,,309,g,6.3,19.9223,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 56 days),12186,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 56 days),,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000786,SR/Jr,male,147 days,10,,CMO:0000012,body weight,,,,365,g,6.4,20.2386,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 112 days),12187,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 112 days),,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000786,SR/Jr,male,203 days,10,,CMO:0000012,body weight,,,,407,g,5.7,18.025,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 168 days),12189,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 168 days),,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000520,LEW/NCrl,male,91 days,8,,CMO:0000012,body weight,,,,375,g,7.1,20.0818,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 56 days),12190,controlled sodium content diet (0.2 %) (for 56 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000520,LEW/NCrl,male,147 days,8,,CMO:0000012,body weight,,,,455,g,9.1,25.7387,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 112 days),12191,controlled sodium content diet (0.2 %) (for 112 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000520,LEW/NCrl,male,203 days,8,,CMO:0000012,body weight,,,,506,g,12.4,35.0725,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 168 days),12192,controlled sodium content diet (0.2 %) (for 168 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000520,LEW/NCrl,male,63 days,8,,CMO:0000012,body weight,,,,286,g,4.4,12.4451,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 28 days),12194,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 28 days),,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000520,LEW/NCrl,male,63 days,8,,CMO:0000012,body weight,,,,284,g,6.2,17.5362,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 28 days),12198,controlled sodium content diet (0.2 %) (for 28 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000520,LEW/NCrl,male,147 days,8,,CMO:0000012,body weight,,,,409,g,5.1,14.425,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 112 days),12199,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 112 days),,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000520,LEW/NCrl,male,203 days,8,,CMO:0000012,body weight,,,,452,g,5.2,14.7078,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 168 days),12200,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 168 days),,,,, 234,"Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50.",body mass,,RS:0000284,OLETF,male,245 days,7,,CMO:0000012,body weight,,,,650.2,g,11.7925,31.2,MMO:0000016,body weighing method,,,,,,,control condition,12201,control condition,,,,,,,, 234,"Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50.",body mass,,RS:0000313,F344/NRrrc,male,245 days,7,,CMO:0000012,body weight,,,,375.6,g,7.5593,20.0,MMO:0000016,body weighing method,,,,,,,control condition,12202,control condition,,,,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0001566,SS.SR-(D3Mco36-D3Mco46)/Jr,male,72 days to 70 days,40,,CMO:0000012,body weight,,,,313.7,g,2.6,16.4438,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12281,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0000817,SS/Jr,male,72 days to 70 days,40,,CMO:0000012,body weight,,,,318.6,g,2.6,16.4438,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12282,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0001565,SS.SR-(D3Mco36-D3Got166)/Jr,male,72 days to 70 days,40,,CMO:0000012,body weight,,,,303.9,g,2.0,12.6491,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12283,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0000817,SS/Jr,male,72 days to 70 days,40,,CMO:0000012,body weight,,,,298.6,g,2.0,12.6491,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12285,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0001564,SS.SR-(D3Mco36-D3Got159)/Jr,male,72 days to 70 days,20,,CMO:0000012,body weight,,,,300.5,g,2.0,8.9443,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12286,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0000817,SS/Jr,male,72 days to 70 days,20,,CMO:0000012,body weight,,,,288.1,g,2.8,12.522,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12287,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0001568,SS.SR-(D3Mco78-D3Got130)/Jr,male,72 days to 70 days,20,,CMO:0000012,body weight,,,,296.3,g,3.0,13.4164,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12288,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0000817,SS/Jr,male,72 days to 70 days,20,,CMO:0000012,body weight,,,,301.8,g,2.4,10.7331,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12296,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0001563,SS.SR-(D3Mco24-D3Got130)/Jr,male,72 days to 70 days,19,,CMO:0000012,body weight,,,,307.7,g,1.9,8.2819,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12297,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0000817,SS/Jr,male,72 days to 70 days,20,,CMO:0000012,body weight,,,,304.7,g,2.1,9.3915,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12299,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0001567,SS.SR-(D3Mco39-D3Got130)/Jr,male,72 days to 70 days,39,,CMO:0000012,body weight,,,,319.1,g,1.8,11.241,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12302,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",body mass,,RS:0000817,SS/Jr,male,72 days to 70 days,41,,CMO:0000012,body weight,,,,326.2,g,2.1,13.4466,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12305,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,, 246,"Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28.",body mass,,RS:0000817,SS/Jr,male,84 days,12,,CMO:0000012,body weight,,,,375,g,6.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) ,12331,controlled sodium content diet (0.3 %) ,,,,,,,, 246,"Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28.",body mass,,RS:0002200,SS.SHR-(D8Uia1-D8Rat90)/Mco,male,84 days,12,,CMO:0000012,body weight,,,,366,g,4.3,14.8956,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) ,12332,controlled sodium content diet (0.3 %) ,,,,,,,, 246,"Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28.",body mass,,RS:0001556,SS.SHR-(D13Rat63-D13Mit1)/Mco,male,84 days,12,,CMO:0000012,body weight,,,,397,g,3.4,11.7779,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) ,12333,controlled sodium content diet (0.3 %) ,,,,,,,, 246,"Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28.",body mass,,RS:0000754,SHR/NHsd,male,84 days,12,,CMO:0000012,body weight,,,,292,g,3.6,12.4708,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) ,12334,controlled sodium content diet (0.3 %) ,,,,,,,, 246,"Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28.",body mass,,RS:0002163,SHR.SS-(D8Uia1-D8Rat90)/Mco,male,84 days,12,,CMO:0000012,body weight,,,,306,g,3.6,12.4708,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) ,12336,controlled sodium content diet (0.3 %) ,,,,,,,, 246,"Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28.",body mass,,RS:0002162,SHR.SS-(D13Rat1-D13Mgh6)/Mco,male,84 days,12,,CMO:0000012,body weight,,,,298,g,3.6,12.4708,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) ,12337,controlled sodium content diet (0.3 %) ,,,,,,,, 248,"Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44.",body mass,,RS:0000284,OLETF,male,246 days,23,,CMO:0000012,body weight,,,,641,g,6.9248,33.21,MMO:0000016,body weighing method,,,,,,,fasting (for 18 hours),12363,fasting (for 18 hours),,,,,,,, 248,"Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44.",body mass,,RS:0000313,F344/NRrrc,male,246 days,21,,CMO:0000012,body weight,,,,641,g,7.247,33.21,MMO:0000016,body weighing method,,,,,,,fasting (for 18 hours),12378,fasting (for 18 hours),,,,,,,, 251,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6.",body mass,,RS:0000065,WOKW,female,210 days,12,,CMO:0000012,body weight,,,,255,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,12398,control condition,,,,,,,, 251,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6.",body mass,,RS:0000243,DA/K,female,210 days,12,,CMO:0000012,body weight,,,,199,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,12429,control condition,,,,,,,, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",body mass,,RS:0000771,WKY/Izm,male,98 days to 91 days,10,,CMO:0000012,body weight,,,,318,g,3.7631,11.9,MMO:0000016,body weighing method,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days),12430,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),,,,,,, 262,"Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6.",body mass,,RS:0000305,F344/DuCrlCrlj,male,245 days,12,,CMO:0000012,body weight,,,,393.6,g,5.3116,18.4,MMO:0000016,body weighing method,,,,,,,control condition,12431,control condition,,,,,,,, 262,"Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6.",body mass,,RS:0000625,OLETF/Got,male,245 days,12,,CMO:0000012,body weight,,,,605.2,g,7.3612,25.5,MMO:0000016,body weighing method,,,,,,,control condition,12437,control condition,,,,,,,, 262,"Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6.",body mass,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,245 days,9,,CMO:0000012,body weight,,,,483.1,g,6.8,20.4,MMO:0000016,body weighing method,,,,,,,control condition,12442,control condition,,,,,,,, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",body mass,,RS:0000746,SHR/Izm,male,119 days,10,,CMO:0000012,body weight,,,,288,g,1.423,4.5,MMO:0000016,body weighing method,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days),12449,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),,controlled fat content diet (26 %) (for 14 days),controlled potassium content diet (0.44 %) (for 14 days),,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,294,g,4.02,17.978,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12483,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,318,g,3.57,15.9655,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12484,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,309,g,3.43,15.3394,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12485,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,314,g,1.72,7.6921,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12486,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",body mass,,RS:0000746,SHR/Izm,male,98 days to 91 days,10,,CMO:0000012,body weight,,,,285.7,g,3.4469,10.9,MMO:0000016,body weighing method,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days),12487,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),,,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,304,g,2.95,13.1928,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12488,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,308,g,1.68,7.5132,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12489,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,302,g,3.24,14.4897,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12490,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",body mass,,RS:0000771,WKY/Izm,male,119 days,10,,CMO:0000012,body weight,,,,325,g,5.3442,16.9,MMO:0000016,body weighing method,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days),12491,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),,controlled fat content diet (26 %) (for 14 days),controlled potassium content diet (0.44 %) (for 14 days),,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,305,g,4.02,17.978,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12492,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000863,SS.LEW-(D1Mco2-D1Rat49)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,294,g,2.63,11.7617,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12493,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000829,SS.LEW-(D1Mco87-D1Rat71)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,329,g,2.27,10.1517,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12494,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000831,SS.LEW-(D1Rat35-D1Rat49)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,304,g,2.97,13.2822,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12496,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000830,SS.LEW-(D1Mco36-D1Rat49)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,307,g,3.23,14.445,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12497,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000827,SS.LEW-(D1Mco38-D1Rat49)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,295,g,4.32,19.3196,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12498,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000828,SS.LEW-(D1Uia2-D1Rat49)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,307,g,5.02,22.4501,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12500,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000825,SS.LEW-(D1Rat196-D1Mgh7)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,294,g,3.72,16.6363,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12501,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000824,SS.LEW-(D1Rat196-D1Mco36)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,303,g,2.91,13.0139,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12502,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000871,SS.LEW-(D1Uia8-D1Mco38)/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,296,g,2.14,9.5704,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12503,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000865,SS.LEW-(D1Uia8-D1Rat18)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,308,g,1.72,7.6921,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12505,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0002424,SS.LEW-(D1Uia8-D1Rat124)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,298,g,2.53,11.3145,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12506,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0002425,SS.LEW-(D1Uia8-D1Rat213)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,277,g,5.53,24.7309,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12507,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 267,"de Wolf ID, et al., Exp Biol Med (Maywood) 2002 Jul;227(7):529-34.",body mass,,RS:0000082,BC/CpbU,male,77 days,4,,CMO:0000012,body weight,,,,220,g,10.5,21.0,MMO:0000016,body weighing method,,,,,,,controlled olive oil content diet (5 %) (for 30 days) and controlled cholesterol content diet (2 %) (for 30 days),12509,controlled olive oil content diet (5 %) (for 30 days),controlled cholesterol content diet (2 %) (for 30 days),,,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,304,g,2.6,11.6276,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days),12510,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,,, 267,"de Wolf ID, et al., Exp Biol Med (Maywood) 2002 Jul;227(7):529-34.",body mass,,RS:0000082,BC/CpbU,female,77 days,4,,CMO:0000012,body weight,,,,177,g,2.5,5.0,MMO:0000016,body weighing method,,,,,,,controlled olive oil content diet (5 %) (for 30 days) and controlled cholesterol content diet (2 %) (for 30 days),12512,controlled olive oil content diet (5 %) (for 30 days),controlled cholesterol content diet (2 %) (for 30 days),,,,,,, 267,"de Wolf ID, et al., Exp Biol Med (Maywood) 2002 Jul;227(7):529-34.",body mass,,RS:0000525,LEW/OlaHsd,male,77 days,4,,CMO:0000012,body weight,,,,352,g,17.0,34.0,MMO:0000016,body weighing method,,,,,,,controlled olive oil content diet (5 %) (for 30 days) and controlled cholesterol content diet (2 %) (for 30 days),12514,controlled olive oil content diet (5 %) (for 30 days),controlled cholesterol content diet (2 %) (for 30 days),,,,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",body mass,,RS:0000759,SHRSP,male,360 days,4,,CMO:0000012,body weight,,,,245.2,g,6.5,13.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days),12532,controlled sodium content diet (0.4 %) (for 122 days),,,controlled sodium content diet (1.4 %) (for 210 days),,,,, 267,"de Wolf ID, et al., Exp Biol Med (Maywood) 2002 Jul;227(7):529-34.",body mass,,RS:0000525,LEW/OlaHsd,female,77 days,4,,CMO:0000012,body weight,,,,224,g,6.0,12.0,MMO:0000016,body weighing method,,,,,,,controlled olive oil content diet (5 %) (for 30 days) and controlled cholesterol content diet (2 %) (for 30 days),12538,controlled olive oil content diet (5 %) (for 30 days),controlled cholesterol content diet (2 %) (for 30 days),,,,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",body mass,,RS:0000759,SHRSP,female,360 days,4,,CMO:0000012,body weight,,,,160.4,g,4.05,8.1,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days),12539,controlled sodium content diet (0.4 %) (for 122 days),,,controlled sodium content diet (1.4 %) (for 210 days),,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",body mass,,RS:0000015,SHR,male,360 days,4,,CMO:0000012,body weight,,,,254,g,6.15,12.3,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days),12574,controlled sodium content diet (0.4 %) (for 122 days),,,controlled sodium content diet (1.4 %) (for 210 days),,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",body mass,,RS:0000015,SHR,female,360 days,4,,CMO:0000012,body weight,,,,173.5,g,2.3,4.6,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days),12575,controlled sodium content diet (0.4 %) (for 122 days),,,controlled sodium content diet (1.4 %) (for 210 days),,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",body mass,,RS:0000742,WKY,male,360 days,4,,CMO:0000012,body weight,,,,318,g,6.65,13.3,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days),12588,controlled sodium content diet (0.4 %) (for 122 days),,,controlled sodium content diet (1.4 %) (for 210 days),,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",body mass,,RS:0000742,WKY,female,360 days,4,,CMO:0000012,body weight,,,,200.8,g,3.45,6.9,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days),12589,controlled sodium content diet (0.4 %) (for 122 days),,,controlled sodium content diet (1.4 %) (for 210 days),,,,, 271,"Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9.",body mass,,RS:0000082,BC/CpbU,male,49 days,6,,CMO:0000012,body weight,,,,109,g,5.3072,13.0,MMO:0000016,body weighing method,,,,,,,control condition,12598,control condition,,,,,,,, 271,"Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9.",body mass,,RS:0000082,BC/CpbU,male,77 days,6,,CMO:0000012,body weight,,,,223,g,6.9402,17.0,MMO:0000016,body weighing method,,,,,,,controlled olive oil content diet (5 %) (for 28 days) and controlled cholesterol content diet (2 %) (for 28 days),12602,controlled olive oil content diet (5 %) (for 28 days),controlled cholesterol content diet (2 %) (for 28 days),,,,,,, 271,"Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9.",body mass,,RS:0000082,BC/CpbU,female,49 days,6,,CMO:0000012,body weight,,,,106,g,2.0412,5.0,MMO:0000016,body weighing method,,,,,,,control condition,12604,control condition,,,,,,,, 271,"Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9.",body mass,,RS:0000082,BC/CpbU,female,77 days,6,,CMO:0000012,body weight,,,,177,g,1.633,4.0,MMO:0000016,body weighing method,,,,,,,controlled olive oil content diet (5 %) (for 28 days) and controlled cholesterol content diet (2 %) (for 28 days),12606,controlled olive oil content diet (5 %) (for 28 days),controlled cholesterol content diet (2 %) (for 28 days),,,,,,, 271,"Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9.",body mass,,RS:0000525,LEW/OlaHsd,male,49 days,6,,CMO:0000012,body weight,,,,217,g,5.3072,13.0,MMO:0000016,body weighing method,,,,,,,control condition,12609,control condition,,,,,,,, 271,"Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9.",body mass,,RS:0000525,LEW/OlaHsd,male,77 days,6,,CMO:0000012,body weight,,,,341,g,14.2887,35.0,MMO:0000016,body weighing method,,,,,,,controlled olive oil content diet (5 %) (for 28 days) and controlled cholesterol content diet (2 %) (for 28 days),12610,controlled olive oil content diet (5 %) (for 28 days),controlled cholesterol content diet (2 %) (for 28 days),,,,,,, 271,"Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9.",body mass,,RS:0000525,LEW/OlaHsd,female,49 days,6,,CMO:0000012,body weight,,,,160,g,3.266,8.0,MMO:0000016,body weighing method,,,,,,,control condition,12611,control condition,,,,,,,, 271,"Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9.",body mass,,RS:0000525,LEW/OlaHsd,female,77 days,6,,CMO:0000012,body weight,,,,219,g,4.899,12.0,MMO:0000016,body weighing method,,,,,,,controlled olive oil content diet (5 %) (for 28 days) and controlled cholesterol content diet (2 %) (for 28 days),12612,controlled olive oil content diet (5 %) (for 28 days),controlled cholesterol content diet (2 %) (for 28 days),,,,,,, 308,"Alam I, et al., J Bone Miner Res. 2010 Jan 8.",body mass,,RS:0001375,NP/Iusm,male,180 days,8,,CMO:0000012,body weight,,,,639,g,10.253,29.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12754,control condition,,,,,,,, 308,"Alam I, et al., J Bone Miner Res. 2010 Jan 8.",body mass,,RS:0001377,P/Iusm,male,180 days,8,,CMO:0000012,body weight,,,,543,g,10.253,29.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12755,control condition,,,,,,,, 308,"Alam I, et al., J Bone Miner Res. 2010 Jan 8.",body mass,,RS:0001376,NP.P-(D4Rat119-D4Rat55)/Iusm,male,180 days,8,,CMO:0000012,body weight,,,,609,g,11.6673,33.0,MMO:0000016,body weighing method,,,,,,,control condition,12756,control condition,,,,,,,, 308,"Alam I, et al., J Bone Miner Res. 2010 Jan 8.",body mass,,RS:0001380,P.NP-(D4Rat119-D4Rat55)/Iusm,male,180 days,8,,CMO:0000012,body weight,,,,597,g,10.253,29.0,MMO:0000016,body weighing method,,,,,,,control condition,12757,control condition,,,,,,,, 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",body mass,,RS:0000744,SHR/FubRkb,female,168 days,10,,CMO:0000012,body weight,,,,208,g,5.5,17.3925,MMO:0000016,body weighing method,,0.0,,,,,control condition,12758,control condition,,,,,,,, 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",body mass,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000012,body weight,,,,214.4,g,5.2,23.2551,MMO:0000016,body weighing method,,0.0,,,,,control condition,12759,control condition,,,,,,,, 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",body mass,,RS:0000596,MWF/FubRkb,female,168 days,18,,CMO:0000012,body weight,,,,207.2,g,1.2,5.0912,MMO:0000016,body weighing method,,0.0,,,,,control condition,12760,control condition,,,,,,,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000012,body weight,,,,393.6,g,6.2,16.4037,MMO:0000016,body weighing method,,,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12785,specific pathogen-free condition (for 210 days),,,fasting (for 1 days),,,"glucose solution, 2.8M (2 g/kg) ",, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000012,body weight,,,,368.7,g,8.7,23.018,MMO:0000016,body weighing method,,,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12791,specific pathogen-free condition (for 210 days),,,fasting (for 1 days),,,"glucose solution, 2.8M (2 g/kg) ",, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000012,body weight,,,,425.3,g,5.3,17.5781,MMO:0000016,body weighing method,,0.0,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12797,specific pathogen-free condition (for 210 days),,,fasting (for 1 days),,,"glucose solution, 2.8M (2 g/kg) ",, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000012,body weight,,,,423.2,g,7.3,24.2114,MMO:0000016,body weighing method,,0.0,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12803,specific pathogen-free condition (for 210 days),,,fasting (for 1 days),,,"glucose solution, 2.8M (2 g/kg) ",, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0000817,SS/Jr,male,66 days to 64 days,20,,CMO:0000012,body weight,,,,314,g,2.23,9.9729,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12863,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0000817,SS/Jr,male,66 days to 64 days,20,,CMO:0000012,body weight,,,,309,g,2.53,11.3145,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12864,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0000817,SS/Jr,male,66 days to 64 days,20,,CMO:0000012,body weight,,,,345,g,1.65,7.379,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12865,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0000817,SS/Jr,male,66 days to 64 days,30,,CMO:0000012,body weight,,,,328,g,2.61,14.2956,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12866,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0001498,SS.LEW-(D1Mco36-D1Rat131)/1Mco,male,66 days to 64 days,20,,CMO:0000012,body weight,,,,305,g,2.4,10.7331,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12873,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0001499,SS.LEW-(D1Mco36-D1Rat131)/2Mco,male,66 days to 64 days,20,,CMO:0000012,body weight,,,,306,g,1.91,8.5418,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12874,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0001496,SS.LEW-(D1Mco36-D1Mco77)/Mco,male,66 days to 64 days,20,,CMO:0000012,body weight,,,,334,g,2.4,10.7331,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12875,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0001497,SS.LEW-(D1Mco36-D1Rat106)/Mco,male,66 days to 64 days,30,,CMO:0000012,body weight,,,,335,g,2.61,14.2956,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12876,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0001534,SS.LEW-(D1Mco36-D1Mco101)/Mco,male,66 days to 64 days,30,,CMO:0000012,body weight,,,,323,g,2.25,12.3238,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12877,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0001500,SS.LEW-(D1Mco85-D1Rat49)/Mco,male,66 days to 64 days,20,,CMO:0000012,body weight,,,,316,g,2.87,12.835,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12878,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",body mass,,RS:0001501,SS.LEW-(D1Mco99-D1Rat49)/Mco,male,66 days to 64 days,20,,CMO:0000012,body weight,,,,302,g,1.89,8.4523,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12879,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",body mass,,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000012,body weight,,,,332.7,g,6.1,13.64,MMO:0000016,body weighing method,,,,,,,controlled protein content diet,12906,controlled protein content diet,,,,,,,, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",body mass,,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000012,body weight,,,,248,g,4.3,9.6151,MMO:0000016,body weighing method,,,,,,,controlled protein content diet,12913,controlled protein content diet,,,,,,,, 322,"Kovacs P, et al., Mamm Genome 1998 Apr;9(4):294-6.",body mass,,RS:0000067,BB/OK,male,98 days,16,,CMO:0000012,body weight,,,,342,g,7.75,31.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12914,control condition,,,,,,,, 322,"Kovacs P, et al., Mamm Genome 1998 Apr;9(4):294-6.",body mass,,RS:0000067,BB/OK,female,98 days,21,,CMO:0000012,body weight,,,,214,g,5.2372,24.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12916,control condition,,,,,,,, 322,"Kovacs P, et al., Mamm Genome 1998 Apr;9(4):294-6.",body mass,,RS:0000749,SHR/Mol,male,98 days,12,,CMO:0000012,body weight,,,,293,g,3.4641,12.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12917,control condition,,,,,,,, 322,"Kovacs P, et al., Mamm Genome 1998 Apr;9(4):294-6.",body mass,,RS:0000749,SHR/Mol,female,98 days,12,,CMO:0000012,body weight,,,,188,g,1.7321,6.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12918,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,male,21 days,12,,CMO:0000012,body weight,,,,28,g,1.1547,4.0,MMO:0000016,body weighing method,,0.0,Kent Scientific Corp,,,,control condition,12927,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,male,56 days,12,,CMO:0000012,body weight,,,,221,g,2.5981,9.0,MMO:0000016,body weighing method,,,,,,,control condition,12928,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,male,70 days,12,,CMO:0000012,body weight,,,,265,g,2.8868,10.0,MMO:0000016,body weighing method,,,,,,,control condition,12929,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,male,84 days,12,,CMO:0000012,body weight,,,,293,g,3.4641,12.0,MMO:0000016,body weighing method,,,,,,,control condition,12930,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,male,98 days,12,,CMO:0000012,body weight,,,,314,g,3.4641,12.0,MMO:0000016,body weighing method,,,,,,,control condition,12931,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,female,21 days,12,,CMO:0000012,body weight,,,,30,g,1.4434,5.0,MMO:0000016,body weighing method,,,Kent Scientific Corp,,,,control condition,12937,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,female,56 days,12,,CMO:0000012,body weight,,,,144,g,1.7321,6.0,MMO:0000016,body weighing method,,,,,,,control condition,12938,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,female,70 days,12,,CMO:0000012,body weight,,,,171,g,2.0207,7.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12939,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,female,84 days,12,,CMO:0000012,body weight,,,,188,g,1.7321,6.0,MMO:0000016,body weighing method,,,,,,,control condition,12940,control condition,,,,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",body mass,,RS:0000749,SHR/Mol,female,98 days,12,,CMO:0000012,body weight,,,,201,g,2.3094,8.0,MMO:0000016,body weighing method,,,,,,,control condition,12941,control condition,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,316,g,3.93,17.5755,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12942,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0001561,SS.SHR-(D9Wox16-D9Rat64)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,311,g,3.93,17.5755,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12943,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,311,g,1.63,7.2896,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12944,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,339,g,3.0,13.4164,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12945,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,318,g,2.09,9.3468,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12947,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,343,g,5.2,23.2551,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12948,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,316,g,2.83,12.6561,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12950,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0002205,SS.SHR-(D9Wox16-D9Mco77)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,301,g,5.65,25.2676,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12951,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0002204,SS.SHR-(D9Wox16-D9Mco73)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,328,g,7.67,34.3013,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12952,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0002207,SS.SHR-(D9Wox16-D9Rat76)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,366,g,3.96,17.7097,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12953,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0002206,SS.SHR-(D9Wox16-D9Mco85)/Mco,male,70 days to 68 days,14,,CMO:0000012,body weight,,,,295,g,3.95,14.7795,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12954,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0002202,SS.SHR-(D9Mco74-D9Rat64)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,321,g,6.99,31.2602,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12955,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0002201,SS.SHR-(D9Mco72-D9Mco93)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,329,g,5.81,25.9831,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12956,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",body mass,,RS:0002203,SS.SHR-(D9Rat7-D9Mco93)/Mco,male,70 days to 68 days,20,,CMO:0000012,body weight,,,,314,g,2.76,12.3431,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (2 %) (for 28 days),12957,controlled sodium content diet (2 %) (for 28 days),,,,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",body mass,,RS:0000372,BB.SHR-(D6Rat184-D6Rat3)/K,male,84 days,22,,CMO:0000012,body weight,,,,302,g,4.9036,23.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12975,control condition,,,,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",body mass,,RS:0000372,BB.SHR-(D6Rat184-D6Rat3)/K,female,84 days,24,,CMO:0000012,body weight,,,,200,g,3.0619,15.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,12976,control condition,,,,,,,, 325,"Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9.",body mass,,RS:0000595,MWF/Fub,male,126 days,8,,CMO:0000012,body weight,,,,333.1,g,6.9296,19.6,MMO:0000016,body weighing method,,,,,,,control condition,13002,control condition,,,,,,,, 325,"Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9.",body mass,,RS:0000743,SHR/Fub,male,126 days,8,,CMO:0000012,body weight,,,,391.3,g,8.3792,23.7,MMO:0000016,body weighing method,,,,,,,control condition,13007,control condition,,,,,,,, 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",body mass,,RS:0000729,SHR/N,male,84 days,14,,CMO:0000012,body weight,,,,441,g,26.0,97.2831,MMO:0000016,body weighing method,,,,,,,control condition,13046,control condition,,,,,,,, 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",body mass,,RS:0000729,SHR/N,female,84 days,16,,CMO:0000012,body weight,,,,331,g,24.0,96.0,MMO:0000016,body weighing method,,,,,,,control condition,13054,control condition,,,,,,,, 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",body mass,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000012,body weight,,,,399,g,16.0,61.9677,MMO:0000016,body weighing method,,,,,,,control condition,13062,control condition,,,,,,,, 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",body mass,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000012,body weight,,,,353,g,19.0,89.1179,MMO:0000016,body weighing method,,,,,,,control condition,13070,control condition,,,,,,,, 330,"Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1.",body mass,,RS:0000306,F344/NCrl,male,95 days,24,,CMO:0000012,body weight,,,,289,g,3.0,14.6969,MMO:0000016,body weighing method,,0,,,,,fasting (for 6 hours),13076,fasting (for 6 hours),,,,,,,, 330,"Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1.",body mass,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,95 days,24,,CMO:0000012,body weight,,,,286,g,3.0,14.6969,MMO:0000016,body weighing method,,0,,,,,fasting (for 6 hours),13088,fasting (for 6 hours),,,,,,,, 330,"Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1.",body mass,,RS:0001300,F344.GK-(D1Rat175-D1Rat90)/Swe,male,95 days,24,,CMO:0000012,body weight,,,,307,g,2.0,9.798,MMO:0000016,body weighing method,,0,,,,,fasting (for 6 hours),13094,fasting (for 6 hours),,,,,,,, 330,"Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1.",body mass,,RS:0001290,F344.GK-(D1Got250-D1Rat90)/Swe,male,95 days,24,,CMO:0000012,body weight,,,,303,g,3.0,14.6969,MMO:0000016,body weighing method,,0,,,,,fasting (for 6 hours),13098,fasting (for 6 hours),,,,,,,, 330,"Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1.",body mass,,RS:0001298,F344.GK-(D1Mgh14-D1Rat90)/Swe,male,95 days,24,,CMO:0000012,body weight,,,,286,g,4.0,19.5959,MMO:0000016,body weighing method,,0,,,,,fasting (for 6 hours),13104,fasting (for 6 hours),,,,,,,, 330,"Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1.",body mass,,RS:0001301,F344.GK-(D1Rat83-D1Rat376)/Swe,male,95 days,24,,CMO:0000012,body weight,,,,290,g,5.0,24.4949,MMO:0000016,body weighing method,,0,,,,,fasting (for 6 hours),13108,fasting (for 6 hours),,,,,,,, 330,"Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1.",body mass,,RS:0001302,F344.GK-(D1Swe4-D1Rat85)/Swe,male,95 days,24,,CMO:0000012,body weight,,,,279,g,1.0,4.899,MMO:0000016,body weighing method,,0,,,,,fasting (for 6 hours),13112,fasting (for 6 hours),,,,,,,, 120,"Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47.",body mass,,RS:0000397,HTG,male,180 days to 150 days,10,,CMO:0000012,body weight,,,,309.3,g,15.9,50.2802,MMO:0000016,body weighing method,,,,,,,control condition,13151,control condition,,,,,,,, 120,"Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47.",body mass,,RS:0000397,HTG,female,180 days to 150 days,10,,CMO:0000012,body weight,,,,238.2,g,6.5,20.5548,MMO:0000016,body weighing method,,,,,,,control condition,13152,control condition,,,,,,,, 120,"Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47.",body mass,,RS:0000121,LEW,male,180 days to 150 days,10,,CMO:0000012,body weight,,,,300.2,g,8.0,25.2982,MMO:0000016,body weighing method,,,,,,,control condition,13153,control condition,,,,,,,, 120,"Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47.",body mass,,RS:0000121,LEW,female,180 days to 150 days,10,,CMO:0000012,body weight,,,,212.7,g,3.8,12.0167,MMO:0000016,body weighing method,,0,,,,,control condition,13154,control condition,,,,,,,, 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",body mass,,RS:0000032,ACI/SegHsd,male,900 days,12,,CMO:0000012,body weight,,,,419.6,g,,,MMO:0000016,body weighing method,,,"method not specified, assumed to be digital scale",,,,control condition,13301,control condition,,,,,,,, 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",body mass,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000012,body weight,,,,350.7,g,,,MMO:0000016,body weighing method,,,"method not specified, assumed to be digital scale",,,,control condition,13302,control condition,,,,,,,, 344,"Huang BS, et al., Hypertension. 2007 Apr 9;.",body mass,,RS:0000816,LEW/Crlc,male,52 days to 43 days,8,,CMO:0000420,body weight gain,,,,54,g,3.0,8.4853,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (8 %) (between 8 and 10 days),13315,controlled sodium content diet (8 %) (between 8 and 10 days),,,,,,,, 344,"Huang BS, et al., Hypertension. 2007 Apr 9;.",body mass,,RS:0001507,SS.LEW-(D10Chm10-D10Rat11)/Ayd,male,52 days to 43 days,10,,CMO:0000420,body weight gain,,,,53,g,3.0,9.4868,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (8 %) (between 8 and 10 days),13316,controlled sodium content diet (8 %) (between 8 and 10 days),,,,,,,, 344,"Huang BS, et al., Hypertension. 2007 Apr 9;.",body mass,,RS:0001491,SS.LEW-(D17Chm14-D17Rat181)/Ayd,male,52 days to 43 days,8,,CMO:0000420,body weight gain,,,,56,g,3.0,8.4853,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (8 %) (between 8 and 10 days),13317,controlled sodium content diet (8 %) (between 8 and 10 days),,,,,,,, 344,"Huang BS, et al., Hypertension. 2007 Apr 9;.",body mass,,RS:0000817,SS/Jr,male,52 days to 43 days,12,,CMO:0000420,body weight gain,,,,51,g,2.0,6.9282,MMO:0000016,body weighing method,,,,,,,controlled sodium content diet (8 %) (between 8 and 10 days),13318,controlled sodium content diet (8 %) (between 8 and 10 days),,,,,,,, 345,"Lee SJ, et al., Physiol Genomics 2005 Jul 20;.",body mass,,RS:0000186,COP/OlaHsd,male,105 days,4,,CMO:0000012,body weight,,,,260.5,g,,,MMO:0000016,body weighing method,,0.0,,,,,running on inclined treadmill (10 m/min) (for 0.1 hours),13335,running on inclined treadmill (10 m/min) (for 0.1 hours),,,,,,,, 345,"Lee SJ, et al., Physiol Genomics 2005 Jul 20;.",body mass,,RS:0000244,DA/OlaHsd,male,105 days,4,,CMO:0000012,body weight,,,,270.1,g,,,MMO:0000016,body weighing method,,0.0,,,,,running on inclined treadmill (10 m/min) (for 0.1 hours),13336,running on inclined treadmill (10 m/min) (for 0.1 hours),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000786,SR/Jr,male,203 days,10,,CMO:0000012,body weight,,,,422,g,5.4,17.0763,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 168 days),64709,controlled sodium content diet (0.2 %) (for 168 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000520,LEW/NCrl,male,91 days,8,,CMO:0000012,body weight,,,,352,g,4.6,13.0108,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 56 days),64710,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 56 days),,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000817,SS/Jr,not specified,71 days to 64 days,46,,CMO:0000012,body weight,,,,302,g,1.8,12.2082,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64713,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000862,SS.LEW-(D1Mco2-D1Mco35)/Jr,not specified,71 days to 64 days,39,,CMO:0000012,body weight,,,,300,g,2.7,16.8615,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64715,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000817,SS/Jr,not specified,71 days to 64 days,40,,CMO:0000012,body weight,,,,304,g,1.6,10.1193,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64716,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000883,SS.LEW-(D5Mit9-D5Mco10)/Jr,not specified,71 days to 64 days,40,,CMO:0000012,body weight,,,,282,g,1.8,11.3842,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64717,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000817,SS/Jr,not specified,71 days to 64 days,20,,CMO:0000012,body weight,,,,290,g,1.9,8.4971,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64718,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000884,SS.LEW-(D10Mit10-D10Mgh1)/Jr,not specified,71 days to 64 days,20,,CMO:0000012,body weight,,,,292,g,2.1,9.3915,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64725,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000817,SS/Jr,not specified,71 days to 64 days,19,,CMO:0000012,body weight,,,,299,g,4.0,17.4356,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64727,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",body mass,"4 rats per cage, 2 SR/Jr 2 LEW/NCrl",RS:0000861,SS.LEW-(D17Mco3-D17Mco10)/Jr,not specified,71 days to 64 days,20,,CMO:0000012,body weight,,,,287,g,2.2,9.8387,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64730,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,, 226,"Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161",body mass,,RS:0001646,SS.LEW-(D18Rat30-D18Chm29)/Ayd,male,98 days,8,,CMO:0000012,body weight,,,,378,g,9.0,25.4558,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (2 %) (between 35 and 98 days),64803,controlled sodium content diet (2 %) (between 35 and 98 days),,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",body mass,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000012,body weight,,,,245.4,g,5.9,13.1928,MMO:0000016,body weighing method,,0,,,,,control condition (0 null) ,64828,control condition (0 null) ,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",body mass,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,male,91 days,5,,CMO:0000012,body weight,,,,226,g,2.81,6.2834,MMO:0000016,body weighing method,,0,,,,,control condition (0 null) ,64829,control condition (0 null) ,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",body mass,,RS:0000771,WKY/Izm,male,91 days,5,,CMO:0000012,body weight,,,,318,g,5.9,13.1928,MMO:0000016,body weighing method,,0,,,,,control condition (0 null) ,64830,control condition (0 null) ,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",body mass,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000012,body weight,,,,160.6,g,3.6,8.0498,MMO:0000016,body weighing method,,0,,,,,control condition (0 null) ,64831,control condition (0 null) ,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",body mass,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,female,91 days,5,,CMO:0000012,body weight,,,,158.48,g,4.8,10.7331,MMO:0000016,body weighing method,,0,,,,,control condition (0 null) ,64832,control condition (0 null) ,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",body mass,,RS:0000771,WKY/Izm,female,91 days,5,,CMO:0000012,body weight,,,,200.8,g,3.1,6.9318,MMO:0000016,body weighing method,,0,,,,,control condition (0 null) ,64833,control condition (0 null) ,,,,,,,, 542,"Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943.",body mass,,RS:0000121,LEW,male,77 days,14,,CMO:0000012,body weight,,,,299.2,g,6.7617,25.3,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days),65004,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 35 days),,,,, 542,"Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943.",body mass,,RS:0000817,SS/Jr,male,77 days,40,,CMO:0000012,body weight,,,,305.6,g,4.3798,27.7,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days),65005,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 35 days),,,,, 542,"Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943.",body mass,,RS:0001658,SS.LEW-(D18Rat29-D18Rat55)/Ayd,male,77 days,11,,CMO:0000012,body weight,,,,324.5,g,3.8895,12.9,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days),65006,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 35 days),,,,, 542,"Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943.",body mass,,RS:0001654,SS.LEW-(D18Chm41-D18Rat92)/Ayd,male,77 days,8,,CMO:0000012,body weight,,,,326.1,g,3.2173,9.1,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days),65007,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 35 days),,,,, 542,"Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943.",body mass,,RS:0002418,SS.LEW-(D16Chm36-D16Mit2)/Ayd,male,77 days,18,,CMO:0000012,body weight,,,,319.8,g,3.5355,15.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days),65008,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 35 days),,,,, 542,"Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943.",body mass,,RS:0002419,SS.LEW-(D16Rat112-D16Chm60)/Ayd,male,77 days,14,,CMO:0000012,body weight,,,,317.8,g,3.314,12.4,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days),65009,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 35 days),,,,, 542,"Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943.",body mass,,RS:0002417,SS.LEW-(D10Got112-Igfbp4)/Ayd,male,77 days,5,,CMO:0000012,body weight,,,,318.8,g,9.0337,20.2,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days),65010,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 35 days),,,,, 542,"Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943.",body mass,,RS:0002416,SS.LEW-(D3Rat52-D3Chm57)/Ayd,male,77 days,5,,CMO:0000012,body weight,,,,291.1,g,3.0858,6.9,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days),65011,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 35 days),,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",body mass,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,42 days to 40 days,20,,CMO:0000012,body weight,,,,150.2,g,3.4,15.2053,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days),65021,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",body mass,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,42 days to 40 days,15,,CMO:0000012,body weight,,,,145.1,g,3.6,13.9427,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days),65022,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",body mass,,RS:0002208,SS.SR-(D7Mco19-D7Mco7)/Jr,male,42 days to 40 days,19,,CMO:0000012,body weight,,,,150.2,g,2.5,10.8972,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days),65023,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",body mass,,RS:0000817,SS/Jr,male,42 days to 40 days,20,,CMO:0000012,body weight,,,,161,g,2.1,9.3915,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days),65024,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",body mass,,RS:0000817,SS/Jr,male,118 days to 114 days,4,,CMO:0000012,body weight,,,,357,g,26.0,52.0,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days),65096,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 46 and 48 days),, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",body mass,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,118 days to 114 days,6,,CMO:0000012,body weight,,,,367.5,g,4.7,11.5126,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days),65097,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 46 and 48 days),, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",body mass,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,118 days to 114 days,6,,CMO:0000012,body weight,,,,384.2,g,7.3,17.8813,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days),65098,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 46 and 48 days),, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",body mass,,RS:0002208,SS.SR-(D7Mco19-D7Mco7)/Jr,male,118 days to 114 days,3,,CMO:0000012,body weight,,,,360.3,g,15.3,26.5004,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days),65099,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 46 and 48 days),, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",body mass,,RS:0000744,SHR/FubRkb,not specified,168 days,10,,CMO:0000012,body weight,,,,377.5,g,4.4,13.914,MMO:0000016,body weighing method,,0.0,,,,,control condition,65358,control condition,,,,,,,, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",body mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000012,body weight,,,,375,g,8.9,38.7942,MMO:0000016,body weighing method,,0.0,,,,,control condition,65359,control condition,,,,,,,, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",body mass,,RS:0000596,MWF/FubRkb,not specified,168 days,18,,CMO:0000012,body weight,,,,363.9,g,11.3,47.9418,MMO:0000016,body weighing method,,0.0,,,,,control condition,65360,control condition,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0000015,SHR,male,87 days,23,,CMO:0000012,body weight,,,,271,g,4.0,19.1833,MMO:0000016,body weighing method,,0,,,,,control condition (for 98 days),65428,control condition (for 98 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0000015,SHR,male,87 days,24,,CMO:0000012,body weight,,,,269,g,6.0,29.3939,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (1 %) (for 14 days),65429,controlled sodium content diet (1 %) (for 14 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0002154,SHR.BN-(D2Rat114-D2Rat123)/Jk,male,87 days,22,,CMO:0000012,body weight,,,,270,g,4.0,18.7617,MMO:0000016,body weighing method,,0,,,,,control condition (for 98 days),65430,control condition (for 98 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0002154,SHR.BN-(D2Rat114-D2Rat123)/Jk,male,87 days,23,,CMO:0000012,body weight,,,,273,g,7.0,33.5708,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (1 %) (for 14 days),65431,controlled sodium content diet (1 %) (for 14 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0002155,SHR.BN-(D2Rat226-D2Rat294)/Jk,male,87 days,22,,CMO:0000012,body weight,,,,292,g,4.0,18.7617,MMO:0000016,body weighing method,,0,,,,,control condition (for 98 days),65432,control condition (for 98 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0002155,SHR.BN-(D2Rat226-D2Rat294)/Jk,male,87 days,22,,CMO:0000012,body weight,,,,281,g,4.0,18.7617,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (1 %) (for 14 days),65433,controlled sodium content diet (1 %) (for 14 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0002156,SHR.BN-(D4Rat33-D4Rat54)/Jk,male,87 days,22,,CMO:0000012,body weight,,,,267,g,3.0,14.0712,MMO:0000016,body weighing method,,0,,,,,control condition (for 98 days),65434,control condition (for 98 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0002156,SHR.BN-(D4Rat33-D4Rat54)/Jk,male,87 days,23,,CMO:0000012,body weight,,,,275,g,4.0,19.1833,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (1 %) (for 14 days),65435,controlled sodium content diet (1 %) (for 14 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0002147,SHR.BN-(D16Rat87-D16Mgh1)/Jk,male,87 days,22,,CMO:0000012,body weight,,,,260,g,7.0,32.8329,MMO:0000016,body weighing method,,0,,,,,control condition (for 98 days),65436,control condition (for 98 days),,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",body mass,,RS:0002147,SHR.BN-(D16Rat87-D16Mgh1)/Jk,male,87 days,23,,CMO:0000012,body weight,,,,271,g,5.0,23.9792,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (1 %) (for 14 days),65437,controlled sodium content diet (1 %) (for 14 days),,,,,,,, 568,"Ueno T, et al., Physiol Res 2003;52(6):689-700.",body mass,,RS:0000397,HTG,not specified,0 days,10,,CMO:0000012,body weight,,,serial mean,309.3,g,,,MMO:0000016,body weighing method,,0,,,,,losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours),65438,losartan (10 mg/kg) (for 0.2 hours),,,pentolinium (5 mg/kg) (for 0.1 hours),,,NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours),, 568,"Ueno T, et al., Physiol Res 2003;52(6):689-700.",body mass,,RS:0000511,LEW/Cub,not specified,0 days,9,,CMO:0000012,body weight,,,serial mean,300.2,g,,,MMO:0000016,body weighing method,,0,,,,,losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours),65439,losartan (10 mg/kg) (for 0.2 hours),,,pentolinium (5 mg/kg) (for 0.1 hours),,,NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours),, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",body mass,,RS:0000817,SS/Jr,male,57 days to 56 days,6,,CMO:0000012,body weight,,,,293,g,9.8,24.005,MMO:0000016,body weighing method,,0,,,,,control condition,65440,control condition,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",body mass,,RS:0000754,SHR/NHsd,male,57 days to 56 days,6,,CMO:0000012,body weight,,,,203,g,6.0,14.6969,MMO:0000016,body weighing method,,0,,,,,control condition,65441,control condition,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",body mass,,RS:0000817,SS/Jr,male,85 days to 84 days,6,,CMO:0000012,body weight,,,,384,g,8.9,21.8005,MMO:0000016,body weighing method,,0,,,,,control condition,65442,control condition,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",body mass,,RS:0000754,SHR/NHsd,male,85 days to 84 days,6,,CMO:0000012,body weight,,,,285,g,6.0,14.6969,MMO:0000016,body weighing method,,0,,,,,control condition,65443,control condition,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",body mass,,RS:0000817,SS/Jr,male,141 days to 140 days,6,,CMO:0000012,body weight,,,,451,g,18.5,45.3156,MMO:0000016,body weighing method,,0,,,,,control condition,65444,control condition,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",body mass,,RS:0000754,SHR/NHsd,male,141 days to 140 days,6,,CMO:0000012,body weight,,,,375,g,13.0,31.8434,MMO:0000016,body weighing method,,0,,,,,control condition,65445,control condition,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",body mass,,RS:0000817,SS/Jr,male,183 days to 182 days,6,,CMO:0000012,body weight,,,,485,g,11.9,29.1489,MMO:0000016,body weighing method,,0,,,,,control condition,65446,control condition,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",body mass,,RS:0000754,SHR/NHsd,male,183 days to 182 days,6,,CMO:0000012,body weight,,,,392,g,7.0,17.1464,MMO:0000016,body weighing method,,0,,,,,control condition,65447,control condition,,,,,,,, 612,"Pravenec M, et al., Physiol Res 2003;52(3):285-9.",body mass,,RS:0000715,SHR/OlaIpcv,male,100 days to 80 days,10,,CMO:0000012,body weight,,,,291.9,g,11.4,36.05,MMO:0000016,body weighing method,,0.0,,,,,control condition,65505,control condition,,,,,,,, 612,"Pravenec M, et al., Physiol Res 2003;52(3):285-9.",body mass,,RS:0000723,SHR.BN-(D5Wox12-D5Wox20)/Ipcv,male,100 days to 80 days,8,,CMO:0000012,body weight,,,,325.5,g,8.8,24.8902,MMO:0000016,body weighing method,,0.0,,,,,control condition,65506,control condition,,,,,,,, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",body mass,,RS:0000770,SHRSP/Izm,male,150 days,17,,CMO:0000012,body weight,,,,315,g,7.2761,30.0,MMO:0000016,body weighing method,,0,,,,,control condition,65509,control condition,,,,,,,, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",body mass,,RS:0001433,SHRSP.WKY-(D1Wox29-D1Arb21)/Izm,male,150 days,15,,CMO:0000012,body weight,,,,390,g,6.7132,26.0,MMO:0000016,body weighing method,,0,,,,,control condition,65510,control condition,,,,,,,, 633,"Rapp JP, et al., Genomics 1998 Jul 15;51(2):191-6",body mass,,RS:0000817,SS/Jr,male,62 days,20,,CMO:0000012,body weight,,,,324,g,2.5,11.1803,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),65831,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 633,"Rapp JP, et al., Genomics 1998 Jul 15;51(2):191-6",body mass,,RS:0000915,SS.SR-Inha/Jr,male,62 days,20,,CMO:0000012,body weight,,,,316,g,2.2,9.8387,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (2 %) (for 24 days),65833,controlled sodium content diet (2 %) (for 24 days),,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0002074,N:HS,both,70 days,220,,CMO:0000012,body weight,,,,234.2,g,3.8497,57.1,MMO:0000016,body weighing method,,0,,,,,control condition,66005,control condition,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0000154,BN/SsN,both,70 days,220,,CMO:0000012,body weight,,,,246.1,g,0.5461,8.1,MMO:0000016,body weighing method,,0,,,,,control condition,66006,control condition,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0000023,ACI/N,both,70 days,220,,CMO:0000012,body weight,,,,202.4,g,0.6809,10.1,MMO:0000016,body weighing method,,0,,,,,control condition,66007,control condition,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0000714,WKY/N,both,70 days,220,,CMO:0000012,body weight,,,,215,g,1.3551,20.1,MMO:0000016,body weighing method,,0,,,,,control condition,66008,control condition,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0000573,M520/N,both,70 days,220,,CMO:0000012,body weight,,,,201,g,0.6,8.9,MMO:0000016,body weighing method,,0,,,,,control condition,66009,control condition,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0000589,MR/N,both,70 days,220,,CMO:0000012,body weight,,,,224,g,0.2629,3.9,MMO:0000016,body weighing method,,0,,,,,control condition,66010,control condition,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0000166,BUF/N,both,70 days,220,,CMO:0000012,body weight,,,,269.3,g,0.4652,6.9,MMO:0000016,body weighing method,,0,,,,,control condition,66011,control condition,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0001082,WN/N,both,70 days,220,,CMO:0000012,body weight,,,,256,g,0.5259,7.8,MMO:0000016,body weighing method,,0,,,,,control condition,66012,control condition,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0000313,F344/NRrrc,both,70 days,220,,CMO:0000012,body weight,,,,233.2,g,0.5528,8.2,MMO:0000016,body weighing method,,0,,,,,control condition,66013,control condition,,,,,,,, 669,"Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102.",body mass,,RS:0000925,SS/JrRkb,male,98 days,14,,CMO:0000012,body weight,,,,371,g,5.0,18.7083,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 56 days),66082,controlled sodium content diet (0.2 %) (for 56 days),,,,,,,, 669,"Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102.",body mass,,RS:0000925,SS/JrRkb,male,98 days,14,,CMO:0000012,body weight,,,,342,g,6.0,22.4499,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (4 %) (for 56 days),66083,controlled sodium content diet (4 %) (for 56 days),,,,,,,, 669,"Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102.",body mass,,RS:0001456,SS-Chr 19SHR/Rkb,male,98 days,20,,CMO:0000012,body weight,,,,355,g,8.0,35.7771,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (0.2 %) (for 56 days),66084,controlled sodium content diet (0.2 %) (for 56 days),,,,,,,, 669,"Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102.",body mass,,RS:0001456,SS-Chr 19SHR/Rkb,male,98 days,20,,CMO:0000012,body weight,,,,355,g,9.0,40.2492,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (4 %) (for 56 days),66085,controlled sodium content diet (4 %) (for 56 days),,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",body mass,,RS:0000817,SS/Jr,male,53 days,10,,CMO:0000012,body weight,,,,222,g,5.1,16.1276,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet,66105,controlled sodium content diet,,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",body mass,,RS:0000754,SHR/NHsd,male,53 days,10,,CMO:0000012,body weight,,,,145,g,3.9,12.3329,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet,66106,controlled sodium content diet,,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",body mass,,RS:0000817,SS/Jr,male,67 days to 53 days,10,,CMO:0000012,body weight,,,,297,g,5.0,15.8114,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (4 %) (for 14 days),66107,controlled sodium content diet (4 %) (for 14 days),,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",body mass,,RS:0000754,SHR/NHsd,male,67 days to 53 days,10,,CMO:0000012,body weight,,,,215,g,4.2,13.2816,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (4 %) (for 14 days),66108,controlled sodium content diet (4 %) (for 14 days),,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",body mass,,RS:0000817,SS/Jr,male,81 days to 53 days,10,,CMO:0000012,body weight,,,,344,g,5.1,16.1276,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (4 %) (for 28 days),66109,controlled sodium content diet (4 %) (for 28 days),,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",body mass,,RS:0000754,SHR/NHsd,male,81 days to 53 days,10,,CMO:0000012,body weight,,,,255,g,4.7,14.8627,MMO:0000016,body weighing method,,0,,,,,controlled sodium content diet (4 %) (for 28 days),66110,controlled sodium content diet (4 %) (for 28 days),,,,,,,, 102,"Zhao L et al., 2001, Circulation, 103(3), 442-7",body mass,,RS:0000363,F344/NHsd,male,105 days,23,,CMO:0000012,body weight,,,median,238,g,,,MMO:0000016,body weighing method,,0,,,,,air oxygen content (10 %) (for 21 days),66124,air oxygen content (10 %) (for 21 days),,,,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",body mass,,RS:0000372,BB.SHR-(D6Rat184-D6Rat3)/K,male,84 days,17,,CMO:0000012,body weight,,,,324,g,6.791,28.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,66144,control condition,,,,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",body mass,,RS:0000372,BB.SHR-(D6Rat184-D6Rat3)/K,female,84 days,15,,CMO:0000012,body weight,,,,214,g,3.3566,13.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,66145,control condition,,,,,,,, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",body mass,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000012,body weight,,,,387.4,g,10.3,30.9,MMO:0000016,body weighing method,,0,,,,,fasting (between 16 and 18 hours),66178,fasting (between 16 and 18 hours),,,,,,,, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",body mass,,RS:0000364,F344/NSlc,male,210 days,20,,CMO:0000012,body weight,,,,409.9,g,5.3,23.7023,MMO:0000016,body weighing method,,0,,,,,fasting (between 16 and 18 hours),66179,fasting (between 16 and 18 hours),,,,,,,, 322,"Kovacs P, et al., Mamm Genome 1998 Apr;9(4):294-6.",body mass,,RS:0003214,BB.SHR-(Acsm3-Igf2)/K,male,98 days,15,,CMO:0000012,body weight,,,,293,g,7.4878,29.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,66200,control condition,,,,,,,, 322,"Kovacs P, et al., Mamm Genome 1998 Apr;9(4):294-6.",body mass,,RS:0003214,BB.SHR-(Acsm3-Igf2)/K,female,98 days,6,,CMO:0000012,body weight,,,,211,g,7.3485,18.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,66201,control condition,,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",body mass,,RS:0002409,SS/JrSeac,not specified,42 days,20,,CMO:0000012,body weight,,,,195,g,3.3541,15.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,67247,control condition,,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",body mass,,RS:0002409,SS/JrSeac,not specified,77 days,5,,CMO:0000012,body weight,,,,247,g,7.6026,17.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 35 days),67253,controlled sodium content diet (0.3 %) (for 35 days),,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",body mass,,RS:0002409,SS/JrSeac,not specified,77 days,5,,CMO:0000012,body weight,,,,236,g,7.1554,16.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (8 %) (for 35 days),67254,controlled sodium content diet (8 %) (for 35 days),,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",body mass,,RS:0002409,SS/JrSeac,not specified,126 days,5,,CMO:0000012,body weight,,,,303,g,14.3108,32.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 35 days),67255,controlled sodium content diet (0.3 %) (for 35 days),,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",body mass,,RS:0002409,SS/JrSeac,not specified,126 days,5,,CMO:0000012,body weight,,,,273,g,6.261,14.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (8 %) (for 35 days),67256,controlled sodium content diet (8 %) (for 35 days),,,,,,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",body mass,,RS:0000145,BN/NHsdMcwi,female,84 days,33,,CMO:0000012,body weight,,,,175,g,3.0,17.2337,MMO:0000016,body weighing method,,0.0,after catheterization and jacket attachment,,,,controlled sodium content diet (0.4 %) ,67293,controlled sodium content diet (0.4 %) ,,,,,,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",body mass,,RS:0000811,SS/JrHsdMcwi,female,84 days,28,,CMO:0000012,body weight,,,,230,g,3.0,15.8745,MMO:0000016,body weighing method,,0.0,after catheterization and jacket attachment,,,,controlled sodium content diet (0.4 %) ,67294,controlled sodium content diet (0.4 %) ,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000134,BN/Crl,female,168 days,23,,CMO:0000012,body weight,,,,200,g,5.0,23.9792,MMO:0000016,body weighing method,,0.0,,,,,control condition,67312,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000119,BN.GK-(D8Rat29-D8Got130)/Ox,female,168 days,8,,CMO:0000012,body weight,,,,192,g,4.0,11.3137,MMO:0000016,body weighing method,,0.0,,,,,control condition,67313,control condition,,,,,,,, 66,"Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26",body mass,,RS:0000117,BN.GK-(D8Got302-D8Got130)/Ox,female,168 days,16,,CMO:0000012,body weight,,,,209,g,3.0,12.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,67314,control condition,,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000021,ACI/Eur,male,180 days to 173 days,8,,CMO:0000012,body weight,,,,315,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,67499,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000016,ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur,male,180 days to 173 days,7,,CMO:0000012,body weight,,,,283,g,8.0,21.166,MMO:0000016,body weighing method,,0.0,,,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,67500,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000020,ACI.FHH-(D1Rat324-D1Rat156)/Eur,male,180 days to 173 days,8,,CMO:0000012,body weight,,,,309,g,3.0,8.4853,MMO:0000016,body weighing method,,0.0,,,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,67501,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0000817,SS/Jr,not specified,0 days,N/A,,CMO:0000012,body weight,,,,307,g,4.93,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67527,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003333,SS.SHR-(D9Mco72-D9Rat55)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,302,g,2.88,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67528,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0000817,SS/Jr,not specified,0 days,N/A,,CMO:0000012,body weight,,,,312,g,2.8,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67529,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003334,SS.SHR-(D9Mco72-D9Mco109)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,307,g,2.84,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67530,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0000817,SS/Jr,not specified,0 days,N/A,,CMO:0000012,body weight,,,,334,g,5.6,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67531,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003335,SS.SHR-(D9Mco72-D9Uia4)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,324,g,2.3,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67532,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0000817,SS/Jr,not specified,0 days,N/A,,CMO:0000012,body weight,,,,296,g,14.72,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67533,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003337,SS.SHR-(D9Mco72-D9Mco105)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,328,g,6.89,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67534,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003336,SS.SHR-(D9Mco72-D9Mco106)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,300,g,4.41,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67536,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0000817,SS/Jr,not specified,0 days,N/A,,CMO:0000012,body weight,,,,353,g,6.24,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67537,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003341,SS.SHR-(D9Rat7-D9Rat84)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,339,g,3.37,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67538,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003338,SS.SHR-(D9Rat7-D9Got111)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,347,g,4.08,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67539,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0000817,SS/Jr,not specified,0 days,N/A,,CMO:0000012,body weight,,,,367,g,6.23,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67540,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003340,SS.SHR-(D9Rat7-D9Mco91)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,367,g,3.77,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67541,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",body mass,,RS:0003339,SS.SHR-(D9Rat7-D9Rat52)/Mco,not specified,0 days,N/A,,CMO:0000012,body weight,,,,365,g,3.84,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67542,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,, 769,"Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14.",body mass,,RS:0000596,MWF/FubRkb,not specified,126 days,8,,CMO:0000012,body weight,,,,333.1,g,6.9296,19.6,MMO:0000016,body weighing method,,0.0,,,,,control condition,67593,control condition,,,,,,,, 769,"Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14.",body mass,,RS:0000529,LEW/Rkb,not specified,126 days,8,,CMO:0000012,body weight,,,,312.3,g,4.9497,14.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,67594,control condition,,,,,,,, 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",body mass,,RS:0002215,SS/HsdMcwiCrl,male,112 days,7,,CMO:0001197,body weight to tibia length ratio,,,,100.21,g/cm,1.76,4.6565,MMO:0000016,body weighing method,,0.0,,,,,controlled carbohydrate content diet (53 %) (for 91 days) and controlled fat content diet (14 %) (for 91 days) and controlled protein content diet (33 %) (for 91 days),67614,controlled carbohydrate content diet (53 %) (for 91 days),controlled fat content diet (14 %) (for 91 days),controlled protein content diet (33 %) (for 91 days),,,,,, 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",body mass,,RS:0002215,SS/HsdMcwiCrl,male,112 days,9,,CMO:0001197,body weight to tibia length ratio,,,,98.04,g/cm,2.35,7.05,MMO:0000016,body weighing method,,0.0,,,,,controlled carbohydrate content diet (53 %) (for 63 days) and controlled fat content diet (14 %) (for 63 days) and controlled protein content diet (33 %) (for 63 days) then controlled carbohydrate content diet (69 %) (for 28 days) and controlled fat content diet (12 %) (for 28 days) and controlled protein content diet (19 %) (for 28 days),67615,controlled carbohydrate content diet (53 %) (for 63 days),controlled fat content diet (14 %) (for 63 days),controlled protein content diet (33 %) (for 63 days),controlled carbohydrate content diet (69 %) (for 28 days),controlled fat content diet (12 %) (for 28 days),controlled protein content diet (19 %) (for 28 days),,, 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",body mass,,RS:0002215,SS/HsdMcwiCrl,male,112 days,6,,CMO:0001197,body weight to tibia length ratio,,,,96.12,g/cm,1.28,3.1353,MMO:0000016,body weighing method,,0.0,,,,,controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days),67616,controlled carbohydrate content diet (69 %) (for 91 days),controlled fat content diet (12 %) (for 91 days),controlled protein content diet (19 %) (for 91 days),,,,,, 735,"Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26.",body mass,,RS:0002215,SS/HsdMcwiCrl,male,112 days,8,,CMO:0001197,body weight to tibia length ratio,,,,97.84,g/cm,0.03,0.0849,MMO:0000016,body weighing method,,0.0,,,,,controlled carbohydrate content diet (69 %) (for 63 days) and controlled fat content diet (12 %) (for 63 days) and controlled protein content diet (19 %) (for 63 days) then controlled carbohydrate content diet (53 %) (for 28 days) and controlled fat content diet (14 %) (for 28 days) and controlled protein content diet (33 %) (for 28 days),67617,controlled carbohydrate content diet (69 %) (for 63 days),controlled fat content diet (12 %) (for 63 days),controlled protein content diet (19 %) (for 63 days),controlled carbohydrate content diet (53 %) (for 28 days),controlled fat content diet (14 %) (for 28 days),controlled protein content diet (33 %) (for 28 days),,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000021,ACI/Eur,male,180 days to 173 days,8,,CMO:0000012,body weight,,,,312,g,2.0,5.6569,MMO:0000016,body weighing method,,0.0,,,,,controlled NG-nitroarginine methyl ester content in acidified drinking water (8-13 mg/kg/d) (for 126 days),67675,controlled NG-nitroarginine methyl ester content in acidified drinking water (8-13 mg/kg/d) (for 126 days),,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000016,ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur,male,180 days to 173 days,9,,CMO:0000012,body weight,,,,296,g,8.0,24.0,MMO:0000016,body weighing method,,0.0,,,,,controlled NG-nitroarginine methyl ester content in acidified drinking water (8-13 mg/kg/d) (for 126 days),67676,controlled NG-nitroarginine methyl ester content in acidified drinking water (8-13 mg/kg/d) (for 126 days),,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000020,ACI.FHH-(D1Rat324-D1Rat156)/Eur,male,180 days to 173 days,7,,CMO:0000012,body weight,,,,293,g,6.0,15.8745,MMO:0000016,body weighing method,,0.0,,,,,controlled NG-nitroarginine methyl ester content in acidified drinking water (8-13 mg/kg/d) (for 126 days),67677,controlled NG-nitroarginine methyl ester content in acidified drinking water (8-13 mg/kg/d) (for 126 days),,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000021,ACI/Eur,male,180 days to 173 days,8,,CMO:0000012,body weight,,,,308,g,5.0,14.1421,MMO:0000016,body weighing method,,0.0,,,,,unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) ,67678,unilateral nephrectomy,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000016,ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur,male,180 days to 173 days,10,,CMO:0000012,body weight,,,,301,g,4.0,12.6491,MMO:0000016,body weighing method,,0.0,,,,,unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) ,67679,unilateral nephrectomy,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000020,ACI.FHH-(D1Rat324-D1Rat156)/Eur,male,180 days to 173 days,8,,CMO:0000012,body weight,,,,284,g,5.0,14.1421,MMO:0000016,body weighing method,,0.0,,,,,unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) ,67680,unilateral nephrectomy,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000021,ACI/Eur,male,180 days to 173 days,11,,CMO:0000012,body weight,,,,292,g,9.0,29.8496,MMO:0000016,body weighing method,,0.0,,,,,unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days),67681,unilateral nephrectomy,,,controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days),,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000016,ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur,male,180 days to 173 days,9,,CMO:0000012,body weight,,,,284,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,,,,unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days),67682,unilateral nephrectomy,,,controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days),,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000020,ACI.FHH-(D1Rat324-D1Rat156)/Eur,male,180 days to 173 days,8,,CMO:0000012,body weight,,,,235,g,9.0,25.4558,MMO:0000016,body weighing method,,0.0,,,,,unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days),67683,unilateral nephrectomy,,,controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days),,,,, 307,"Kose H, et al., Exp Anim. 2009 Apr;58(2):193-8.",body mass,,RS:0000247,DA/Slc,female,64 days,10,,CMO:0000012,body weight,,,,136.8,g,,,MMO:0000016,body weighing method,,0.0,,antibody injection,8,days,anti-glomerular basement membrane antibody (500 ul) ,67689,anti-glomerular basement membrane antibody (500 ul) ,,,,,,,, 307,"Kose H, et al., Exp Anim. 2009 Apr;58(2):193-8.",body mass,,RS:0000731,WKY/NCrl,female,64 days,10,,CMO:0000012,body weight,,,,164.6,g,,,MMO:0000016,body weighing method,,0.0,,antibody injection,8,days,anti-glomerular basement membrane antibody (500 ul) ,67690,anti-glomerular basement membrane antibody (500 ul) ,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0000021,ACI/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,319,g,5.0,17.3205,MMO:0000016,body weighing method,,0.0,,,,,NG-nitroarginine methyl ester (50-150 mg/l) ,67700,NG-nitroarginine methyl ester (50-150 mg/l) ,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001168,ACI.FHH-(D3Wox2-D3Rat59)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,321,g,4.0,13.8564,MMO:0000016,body weighing method,,0.0,,,,,NG-nitroarginine methyl ester (50-150 mg/l) ,67701,NG-nitroarginine methyl ester (50-150 mg/l) ,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001164,ACI.FHH-(D1Rat298-D1Rat90)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,328,g,3.0,10.3923,MMO:0000016,body weighing method,,0.0,,,,,NG-nitroarginine methyl ester (50-150 mg/l) ,67702,NG-nitroarginine methyl ester (50-150 mg/l) ,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001167,ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,296,g,6.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,NG-nitroarginine methyl ester (50-150 mg/l) ,67703,NG-nitroarginine methyl ester (50-150 mg/l) ,,,,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0000021,ACI/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,314,g,6.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) ,67704,right nephrectomy,,,NG-nitroarginine methyl ester (50-150 mg/l) ,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001168,ACI.FHH-(D3Wox2-D3Rat59)/Eur,male,175 days to 168 days,11,,CMO:0000012,body weight,,,,301,g,6.0,19.8997,MMO:0000016,body weighing method,,0.0,,,,,right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) ,67705,right nephrectomy,,,NG-nitroarginine methyl ester (50-150 mg/l) ,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001164,ACI.FHH-(D1Rat298-D1Rat90)/Eur,male,175 days to 168 days,12,,CMO:0000012,body weight,,,,319,g,6.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) ,67706,right nephrectomy,,,NG-nitroarginine methyl ester (50-150 mg/l) ,,,,, 62,"Van Dijk SJ, et al., Kidney Int. 2006",body mass,,RS:0001167,ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur,male,175 days to 168 days,5,,CMO:0000012,body weight,,,,263,g,12.0,26.8328,MMO:0000016,body weighing method,,0.0,,,,,right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) ,67707,right nephrectomy,,,NG-nitroarginine methyl ester (50-150 mg/l) ,,,,, 110,"Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7",body mass,,RS:0001072,WKY/NCruk,male,175 days,20,,CMO:0000012,body weight,,,,347.3,g,7.938,35.5,MMO:0000016,body weighing method,,0.0,,,,,left nephrectomy,67744,left nephrectomy,,,,,,,, 110,"Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7",body mass,,RS:0001039,WKY.SHR-(D1Wox19-D1Mit2)/Njs,male,175 days,19,,CMO:0000012,body weight,,,,341.3,g,6.8136,29.7,MMO:0000016,body weighing method,,0.0,,,,,left nephrectomy,67745,left nephrectomy,,,,,,,, 110,"Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7",body mass,,RS:0001072,WKY/NCruk,male,175 days,17,,CMO:0000012,body weight,,,,335.8,g,7.6156,31.4,MMO:0000016,body weighing method,,0.0,,,,,left nephrectomy and left kidney transplant then right nephrectomy,67746,left nephrectomy,left kidney transplant,,right nephrectomy,,,,, 110,"Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7",body mass,,RS:0001072,WKY/NCruk,male,175 days,20,,CMO:0000012,body weight,,,,338.8,g,5.9479,26.6,MMO:0000016,body weighing method,,0.0,,,,,left nephrectomy and left kidney transplant then right nephrectomy,67747,left nephrectomy,left kidney transplant,,right nephrectomy,,,,, 204,"Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52",body mass,,RS:0000922,SS/Hsd,male,180 days,20,,CMO:0001246,cubic root of body weight to nasoanal length ratio,,,,315.4,g/mm x 10000,1.87,8.3629,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) then fasting (for 16 hours),67893,controlled sodium content diet (0.3 %) ,,,fasting (for 16 hours),,,,, 204,"Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52",body mass,,RS:0000785,SR/Hsd,female,180 days,14,,CMO:0001246,cubic root of body weight to nasoanal length ratio,,,,306,g/mm x 10000,2.0,7.4833,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) then fasting (for 16 hours),67894,controlled sodium content diet (0.3 %) ,,,fasting (for 16 hours),,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0000021,ACI/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,314,g,3.0,10.3923,MMO:0000016,body weighing method,,0.0,,unilateral nephrectomy,126,days,unilateral nephrectomy,67899,unilateral nephrectomy,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001165,ACI.FHH-(D1Rat384-D1Rat156)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,305,g,8.0,27.7128,MMO:0000016,body weighing method,,0.0,,unilateral nephrectomy,126,days,unilateral nephrectomy,67900,unilateral nephrectomy,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001162,ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,304,g,2.0,6.9282,MMO:0000016,body weighing method,,0.0,,unilateral nephrectomy,126,days,unilateral nephrectomy,67901,unilateral nephrectomy,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001166,ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,304,g,4.0,13.8564,MMO:0000016,body weighing method,,0.0,,unilateral nephrectomy,126,days,unilateral nephrectomy,67902,unilateral nephrectomy,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0000021,ACI/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,309,g,4.0,13.8564,MMO:0000016,body weighing method,,0.0,,,,,specific pathogen-free condition,67903,specific pathogen-free condition,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001165,ACI.FHH-(D1Rat384-D1Rat156)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,312,g,6.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,specific pathogen-free condition,67904,specific pathogen-free condition,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001162,ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,305,g,2.0,6.9282,MMO:0000016,body weighing method,,0.0,,,,,specific pathogen-free condition,67905,specific pathogen-free condition,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001166,ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,307,g,5.0,17.3205,MMO:0000016,body weighing method,,0.0,,,,,specific pathogen-free condition,67906,specific pathogen-free condition,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0000021,ACI/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,314,g,5.0,17.3205,MMO:0000016,body weighing method,,0.0,,unilateral nephrectomy,126,days,unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days),67907,unilateral nephrectomy,,,NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days),,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001165,ACI.FHH-(D1Rat384-D1Rat156)/Eur,not specified,175 days to 168 days,11,,CMO:0000012,body weight,,,,267,g,11.0,36.4829,MMO:0000016,body weighing method,,0.0,,unilateral nephrectomy,126,days,unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days),67908,unilateral nephrectomy,,,NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days),,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001162,ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur,not specified,175 days to 168 days,2,,CMO:0000012,body weight,,,,286,g,1.0,1.4142,MMO:0000016,body weighing method,,0.0,,unilateral nephrectomy,126,days,unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days),67909,unilateral nephrectomy,,,NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days),,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001166,ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur,not specified,175 days to 168 days,9,,CMO:0000012,body weight,,,,277,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,unilateral nephrectomy,126,days,unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days),67910,unilateral nephrectomy,,,NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days),,,,, 251,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6.",body mass,,RS:0000065,WOKW,female,224 days,12,,CMO:0000105,body mass index (BMI),,,,0.62,g/cm2,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,67913,control condition,,,,,,,, 251,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6.",body mass,,RS:0000243,DA/K,female,224 days,12,,CMO:0000105,body mass index (BMI),,,,0.51,g/cm2,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,67914,control condition,,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0000021,ACI/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,314,g,6.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days),67935,NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days),,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001165,ACI.FHH-(D1Rat384-D1Rat156)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,292,g,5.0,17.3205,MMO:0000016,body weighing method,,0.0,,,,,NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days),67936,NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days),,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001162,ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,285,g,8.0,27.7128,MMO:0000016,body weighing method,,0.0,,,,,NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days),67937,NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days),,,,,,,, 832,"van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12.",body mass,,RS:0001166,ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur,not specified,175 days to 168 days,12,,CMO:0000012,body weight,,,,296,g,5.0,17.3205,MMO:0000016,body weighing method,,0.0,,,,,NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days),67938,NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days),,,,,,,, 834,"Garrett MR, et al., Physiol Genomics. 2007 May 15;.",body mass,,RS:0000924,SS/JrTol,male,140 days,6,,CMO:0000012,body weight,,,,421,g,11.1,27.1893,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 140 days),67963,control condition (for 140 days),,,,,,,, 834,"Garrett MR, et al., Physiol Genomics. 2007 May 15;.",body mass,,RS:0002406,SHR/NHsdMco,male,140 days,6,,CMO:0000012,body weight,,,,339,g,9.3,22.7803,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 140 days),67973,control condition (for 140 days),,,,,,,, 834,"Garrett MR, et al., Physiol Genomics. 2007 May 15;.",body mass,,RS:0001559,SS.SHR-(D2Rat61-D2Mco18)/Mco,male,140 days,6,,CMO:0000012,body weight,,,,435,g,10.0,24.4949,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 140 days),67974,control condition (for 140 days),,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000021,ACI/Eur,male,98 days,15,,CMO:0000012,body weight,,,,269,g,4.0,15.4919,MMO:0000016,body weighing method,,0.0,,,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,68032,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000016,ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur,male,98 days,15,,CMO:0000012,body weight,,,,248,g,6.0,23.2379,MMO:0000016,body weighing method,,0.0,,,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,68033,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000018,FHH/Eur,male,98 days,15,,CMO:0000012,body weight,,,,308,g,4.0,15.4919,MMO:0000016,body weighing method,,0.0,,,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,68034,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,,,,, 751,"Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66.",body mass,,RS:0000020,ACI.FHH-(D1Rat324-D1Rat156)/Eur,male,98 days,18,,CMO:0000012,body weight,,,,254,g,4.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,68035,controlled hydrogen ion content drinking water (2.4-2.8 pH) ,,,,,,,, 835,"Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64.",body mass,,RS:0000971,WAG/RijKyo,not specified,180 days,9,,CMO:0000012,body weight,,,,310,g,5.0,15.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,68050,control condition,,,,,,,, 835,"Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64.",body mass,,RS:0001334,ISIAH,not specified,180 days,11,,CMO:0000012,body weight,,,,302,g,4.5,14.9248,MMO:0000016,body weighing method,,0.0,,,,,control condition,68062,control condition,,,,,,,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",body mass,,RS:0000113,BN,male,210 days,20,,CMO:0000012,body weight,,,,355.3,g,5.8,25.9384,MMO:0000016,body weighing method,,0.0,,,,,control condition,68066,control condition,,,,,,,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",body mass,,RS:0000313,F344/NRrrc,male,210 days,7,,CMO:0000012,body weight,,,,374.1,g,8.0,21.166,MMO:0000016,body weighing method,,0.0,,,,,control condition,68067,control condition,,,,,,,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",body mass,,RS:0000284,OLETF,male,210 days,14,,CMO:0000012,body weight,,,,653.3,g,6.3,23.5724,MMO:0000016,body weighing method,,0.0,,,,,control condition,68068,control condition,,,,,,,, 837,"Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716.",body mass,,RS:0001858,DA/ZtmKini,female,77 days to 56 days,N/A,,CMO:0000012,body weight,,,,162.9,g,,9.5,MMO:0000016,body weighing method,,0.0,,,,,control condition,68120,control condition,,,,,,,, 837,"Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716.",body mass,,RS:0002506,DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini,female,77 days to 56 days,N/A,,CMO:0000012,body weight,,,,153.5,g,,16.7,MMO:0000016,body weighing method,,0.0,,,,,control condition,68121,control condition,,,,,,,, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0001858,DA/ZtmKini,male,131 days to 103 days,11,,CMO:0001400,maximum body weight loss to initial body weight ratio,,CMO:0001400,,14.4,%,2.4724,8.2,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68134,myelin oligodendrocyte glycoprotein (20 ug) ,,,,,,,, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",body mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000012,body weight,,,,271,g,5.5,21.3014,MMO:0000016,body weighing method,,0.0,,,,,control condition,68485,control condition,,,,,,,, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",body mass,,RS:0000244,DA/OlaHsd,not specified,105 days,12,,CMO:0000012,body weight,,,,257,g,3.5,12.1244,MMO:0000016,body weighing method,,0.0,,,,,control condition,68486,control condition,,,,,,,, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",body mass,,RS:0001215,COP.DA-(D16Rat12-D16Rat90)/Mco,not specified,105 days,8,,CMO:0000012,body weight,,,,275.6,g,4.6,13.0108,MMO:0000016,body weighing method,,0.0,,,,,control condition,68487,control condition,,,,,,,, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",body mass,,RS:0001216,COP.DA-(D3Rat233-D3Mgh14)/Mco,not specified,105 days,18,,CMO:0000012,body weight,,,,252.6,g,4.6,19.5161,MMO:0000016,body weighing method,,0.0,,,,,control condition,68488,control condition,,,,,,,, 971,"Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9.",body mass,,RS:0001054,WKY.SHRSP-(D1Wox29-D1Arb21)/Izm,not specified,112 days,10,,CMO:0000012,body weight,,,,393,g,5.6605,17.9,MMO:0000016,body weighing method,,0.0,,,,,control condition,68692,control condition,,,,,,,, 971,"Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9.",body mass,,RS:0001054,WKY.SHRSP-(D1Wox29-D1Arb21)/Izm,not specified,112 days,10,,CMO:0000012,body weight,,,,406,g,5.0596,16.0,MMO:0000016,body weighing method,,0.0,,,,,cold ambient air exposure (4 degrees C) (for 90 days),68693,cold ambient air exposure (4 degrees C) (for 90 days),,,,,,,, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0001858,DA/ZtmKini,male,131 days to 103 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.5,%,1.4863,4.7,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68708,myelin oligodendrocyte glycoprotein (20 ug) ,,,,,,,, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0001858,DA/ZtmKini,male,131 days to 103 days,12,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,1,%,0.7794,2.7,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68712,myelin oligodendrocyte glycoprotein (20 ug) ,,,,,,,, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0001858,DA/ZtmKini,male,131 days to 103 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,2.8,%,1.2649,4.0,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68716,myelin oligodendrocyte glycoprotein (20 ug) ,,,,,,,, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0000199,DA.ACI-(D10Rat2-D10Rat29)/Kini,male,131 days to 103 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,1.2,%,1.1384,3.6,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68720,myelin oligodendrocyte glycoprotein (20 ug) ,,,,,,,, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0000199,DA.ACI-(D10Rat2-D10Rat29)/Kini,male,131 days to 103 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,0,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68723,myelin oligodendrocyte glycoprotein (20 ug) ,,,,,,,, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0000199,DA.ACI-(D10Rat2-D10Rat29)/Kini,male,131 days to 103 days,8,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,0,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68725,myelin oligodendrocyte glycoprotein (20 ug) ,,,,,,,, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0000199,DA.ACI-(D10Rat2-D10Rat29)/Kini,male,131 days to 103 days,7,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,0,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68728,myelin oligodendrocyte glycoprotein (20 ug) ,,,,,,,, 1012,"Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.",body mass,,RS:0000134,BN/Crl,male,60 days,6,,CMO:0000012,body weight,,,,191,g,4.0,9.798,MMO:0000016,body weighing method,,0.0,,,,,fasting (between 16 and 18 hours),68768,fasting (between 16 and 18 hours),,,,,,,, 1012,"Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.",body mass,,RS:0000134,BN/Crl,female,60 days,6,,CMO:0000012,body weight,,,,155,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,,,,fasting (between 16 and 18 hours),68769,fasting (between 16 and 18 hours),,,,,,,, 1012,"Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.",body mass,,RS:0002495,GK/Ox,male,60 days,6,,CMO:0000012,body weight,,,,224,g,7.0,17.1464,MMO:0000016,body weighing method,,0.0,,,,,fasting (between 16 and 18 hours),68770,fasting (between 16 and 18 hours),,,,,,,, 1012,"Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.",body mass,,RS:0002495,GK/Ox,female,60 days,6,,CMO:0000012,body weight,,,,176,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,,,,fasting (between 16 and 18 hours),68771,fasting (between 16 and 18 hours),,,,,,,, 1123,"Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5.",body mass,,RS:0001087,WOKW/K,not specified,224 days,12,,CMO:0000012,body weight,,,,513,g,5.7735,20.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,69108,control condition,,,,,,,, 1123,"Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5.",body mass,,RS:0000243,DA/K,not specified,224 days,12,,CMO:0000012,body weight,,,,254,g,9.5263,33.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,69109,control condition,,,,,,,, 1123,"Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5.",body mass,,RS:0001087,WOKW/K,not specified,224 days,12,,CMO:0000105,body mass index (BMI),,,,0.87,g/cm2,0.0147,0.051,MMO:0000016,body weighing method,,0.0,,,,,control condition,69110,control condition,,,,,,,, 1123,"Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5.",body mass,,RS:0000243,DA/K,not specified,224 days,12,,CMO:0000105,body mass index (BMI),,,,0.615,g/cm2,0.0124,0.043,MMO:0000016,body weighing method,,0.0,,,,,control condition,69111,control condition,,,,,,,, 1128,"Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78.",body mass,,RS:0000021,ACI/Eur,male,98 days to 91 days,21,,CMO:0000012,body weight,,,,242,g,3.0551,14.0,MMO:0000016,body weighing method,,0.0,performed at 5 to 6 weeks of age,unilateral nephrectomy,39,days,unilateral nephrectomy,69139,unilateral nephrectomy,,,,,,,, 1128,"Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78.",body mass,,RS:0000018,FHH/Eur,male,98 days to 91 days,26,,CMO:0000012,body weight,,,,310,g,2.9417,15.0,MMO:0000016,body weighing method,,0.0,performed at 5 to 6 weeks of age,unilateral nephrectomy,39,days,unilateral nephrectomy,69140,unilateral nephrectomy,,,,,,,, 1057,"Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30.",body mass,,RS:0000811,SS/JrHsdMcwi,not specified,84 days,N/A,,CMO:0000012,body weight,,,,395,g,10.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (4 %) (for 21 days),69205,controlled sodium content diet (4 %) (for 21 days),,,,,,,, 1057,"Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30.",body mass,,RS:0002438,SS-Rag1em1Mcwi,not specified,84 days,N/A,,CMO:0000012,body weight,,,,400,g,10.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (4 %) (for 21 days),69206,controlled sodium content diet (4 %) (for 21 days),,,,,,,, 1057,"Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30.",body mass,,RS:0000811,SS/JrHsdMcwi,not specified,84 days,4,,CMO:0000012,body weight,,,,343,g,16.0,32.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (4 %) (for 21 days),69287,controlled sodium content diet (4 %) (for 21 days),,,,,,,, 1057,"Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30.",body mass,,RS:0002427,SS-Rag1em2Mcwi,not specified,84 days,4,,CMO:0000012,body weight,,,,354,g,5.0,10.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (4 %) (for 21 days),69288,controlled sodium content diet (4 %) (for 21 days),,,,,,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",body mass,,RS:0000145,BN/NHsdMcwi,female,92 days to 89 days,24,,CMO:0000012,body weight,,,,168,g,2.3,11.2677,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) and controlled sodium content diet (8 %) (between 22 and 24 days),69439,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),controlled sodium content diet (8 %) (between 22 and 24 days),,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",body mass,,RS:0000811,SS/JrHsdMcwi,female,92 days to 89 days,16,,CMO:0000012,body weight,,,,211,g,6.0,24.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) and controlled sodium content diet (8 %) (between 22 and 24 days),69440,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),controlled sodium content diet (8 %) (between 22 and 24 days),,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",body mass,,RS:0000145,BN/NHsdMcwi,female,84 days,33,,CMO:0000012,body weight,,,,167,g,3.4,19.5315,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) and controlled sodium content diet (8 %) (between 22 and 24 days),69441,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),controlled sodium content diet (8 %) (between 22 and 24 days),,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",body mass,,RS:0000811,SS/JrHsdMcwi,female,84 days,28,,CMO:0000012,body weight,,,,221,g,2.7,14.2871,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) and controlled sodium content diet (8 %) (between 22 and 24 days),69442,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),controlled sodium content diet (8 %) (between 22 and 24 days),,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000242,DA/Ztm,both,200 days to 120 days,15,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,12.8,%,0.6,2.3238,MMO:0000016,body weighing method,,0.0,,,,,squalene (200 ul) ,69794,squalene (200 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000227,DA.PVG.1AV1-(D4Rat155-D4Rat84),both,200 days to 120 days,11,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,9.6,%,1.4,4.6433,MMO:0000016,body weighing method,,0.0,,,,,squalene (200 ul) ,69795,squalene (200 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000242,DA/Ztm,both,200 days to 120 days,16,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.2,%,1.8,7.2,MMO:0000016,body weighing method,,0.0,,,,,Freund's complete adjuvant (100 ul) ,69796,Freund's complete adjuvant (100 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000227,DA.PVG.1AV1-(D4Rat155-D4Rat84),both,200 days to 120 days,14,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,5.9,%,3.7,13.8441,MMO:0000016,body weighing method,,0.0,,,,,Freund's complete adjuvant (100 ul) ,69797,Freund's complete adjuvant (100 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000242,DA/Ztm,both,200 days to 120 days,12,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,13.4,%,1.4,4.8497,MMO:0000016,body weighing method,,0.0,,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69798,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) ,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000227,DA.PVG.1AV1-(D4Rat155-D4Rat84),both,200 days to 120 days,14,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,2.8,%,1.0,3.7417,MMO:0000016,body weighing method,,0.0,,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69799,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) ,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000228,DA.PVG.1AV1-(D4Rat155-Spr),both,200 days to 120 days,14,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,12.5,%,0.9,3.3675,MMO:0000016,body weighing method,,0.0,,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69800,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) ,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000226,DA.PVG.1AV1-(D4Mgh17-D4Rat56),both,200 days to 120 days,11,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,0.7,%,1.6,5.3066,MMO:0000016,body weighing method,,0.0,,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69801,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) ,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000242,DA/Ztm,male,200 days to 120 days,9,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,7.5,%,2.1,6.3,MMO:0000016,body weighing method,,0.0,,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69802,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) ,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000226,DA.PVG.1AV1-(D4Mgh17-D4Rat56),male,200 days to 120 days,13,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,6.6,%,1.3,4.6872,MMO:0000016,body weighing method,,0.0,,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69803,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) ,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000242,DA/Ztm,both,200 days to 120 days,17,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,14.1,%,1.6,6.597,MMO:0000016,body weighing method,,0.0,,,,,pristane (150 ul) ,69804,pristane (150 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000227,DA.PVG.1AV1-(D4Rat155-D4Rat84),both,200 days to 120 days,16,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,8.8,%,2.2,8.8,MMO:0000016,body weighing method,,0.0,,,,,pristane (150 ul) ,69805,pristane (150 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000228,DA.PVG.1AV1-(D4Rat155-Spr),both,200 days to 120 days,24,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,10.6,%,1.1,5.3889,MMO:0000016,body weighing method,,0.0,,,,,pristane (150 ul) ,69806,pristane (150 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000242,DA/Ztm,both,200 days to 120 days,9,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,12.8,%,0.9,2.7,MMO:0000016,body weighing method,,0.0,,,,,squalene (200 ul) ,69807,squalene (200 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000229,DA.PVG.1AV1-(D4Rat63-D4Rat203),both,200 days to 120 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,6.6,%,2.5,7.9057,MMO:0000016,body weighing method,,0.0,,,,,squalene (200 ul) ,69808,squalene (200 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000242,DA/Ztm,both,200 days to 120 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,22.8,%,1.1,3.4785,MMO:0000016,body weighing method,,0.0,,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69809,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) ,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000229,DA.PVG.1AV1-(D4Rat63-D4Rat203),both,200 days to 120 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,14.6,%,1.8,5.6921,MMO:0000016,body weighing method,,0.0,,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69810,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) ,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000242,DA/Ztm,both,200 days to 120 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,14.3,%,2.5,7.9057,MMO:0000016,body weighing method,,0.0,,,,,pristane (150 ul) ,69811,pristane (150 ul) ,,,,,,,, 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",body mass,,RS:0000229,DA.PVG.1AV1-(D4Rat63-D4Rat203),both,200 days to 120 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,12.6,%,2.7,8.5381,MMO:0000016,body weighing method,,0.0,,,,,pristane (150 ul) ,69812,pristane (150 ul) ,,,,,,,, 1258,"Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8",body mass,,RS:0000242,DA/Ztm,male,103 days to 56 days,9,,CMO:0000420,body weight gain,,,,32,g,8.3333,25.0,MMO:0000016,body weighing method,,0.0,,,,,spinal cord homogenate (10 mg) ,69948,spinal cord homogenate (10 mg) ,,,,,,,, 1258,"Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8",body mass,,RS:0000261,E3/Ztm,female,103 days to 56 days,12,,CMO:0000420,body weight gain,,,,80,g,0.866,3.0,MMO:0000016,body weighing method,,0.0,,,,,spinal cord homogenate (10 mg) ,69956,spinal cord homogenate (10 mg) ,,,,,,,, 1258,"Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8",body mass,,RS:0000261,E3/Ztm,male,103 days to 56 days,3,,CMO:0000420,body weight gain,,,,39,g,5.1962,9.0,MMO:0000016,body weighing method,,0.0,,,,,spinal cord homogenate (10 mg) ,69957,spinal cord homogenate (10 mg) ,,,,,,,, 850,"Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89",body mass,,RS:0000154,BN/SsN,both,126 days to 66 days,13,,CMO:0001399,body weight loss,,(weight loss),,0,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,variable,immunized,10,days,type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) ,69958,type II collagen (2 mg/kg) ,Freund's incomplete adjuvant (50 %) ,,,,,,, 850,"Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89",body mass,,RS:0000239,DA/Bkl,both,126 days to 66 days,105,,CMO:0001399,body weight loss,,(weight loss),,19,%,0.488,5.0,MMO:0000016,body weighing method,,0.0,variable,immunized,10,days,type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) ,69960,type II collagen (2 mg/kg) ,Freund's incomplete adjuvant (50 %) ,,,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",body mass,,RS:0000069,BB.SHR-(Gnal-D18Mit9)/K,male,84 days,15,,CMO:0000012,body weight,,,,324,g,6.455,25.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,70097,control condition,,,,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",body mass,,RS:0000069,BB.SHR-(Gnal-D18Mit9)/K,female,84 days,10,,CMO:0000012,body weight,,,,206,g,9.4868,30.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,70098,control condition,,,,,,,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000012,body weight,,,,376.9,g,3.021,7.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,70205,control condition,,,,,,,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000012,body weight,,,,274.1,g,8.3691,20.5,MMO:0000016,body weighing method,,0.0,,,,,control condition,70206,control condition,,,,,,,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000012,body weight,,,,398,g,0.8573,2.1,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days),70207,controlled sucrose content diet (for 7 days),,,,,,,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000012,body weight,,,,291.1,g,10.2879,25.2,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days),70208,controlled sucrose content diet (for 7 days),,,,,,,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000012,body weight,,,,352.9,g,1.5513,3.8,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70211,controlled sucrose content diet (for 7 days),,,dexamethasone (0.03 mg/ml) (for 3 days),,,,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",body mass,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000012,body weight,,,,257.6,g,10.2879,25.2,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days),70212,controlled sucrose content diet (for 7 days),,,dexamethasone (0.03 mg/ml) (for 3 days),,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,35 days,12,,CMO:0000012,body weight,,week one,,92.6,g,3.0311,10.5,MMO:0000016,body weighing method,,0.0,,,,,controlled ethanol content drinking water (1 %) ,75747,controlled ethanol content drinking water (1 %) ,,,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,35 days,12,,CMO:0000012,body weight,,week one,,87.8,g,3.926,13.6,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) and controlled ethanol content drinking water (1 %) ,75748,controlled fructose content drinking water (5 %) ,controlled ethanol content drinking water (1 %) ,,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,35 days,12,,CMO:0000012,body weight,,week one,,84.7,g,3.2043,11.1,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) and controlled bisphenol A content drinking water (0.025 mg/l) ,75749,controlled fructose content drinking water (5 %) ,controlled bisphenol A content drinking water (0.025 mg/l) ,,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,35 days,12,,CMO:0000012,body weight,,week one,,88.7,g,2.9734,10.3,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) and controlled bisphenol A content drinking water (0.25 mg/l) ,75750,controlled fructose content drinking water (5 %) ,controlled bisphenol A content drinking water (0.25 mg/l) ,,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,35 days,12,,CMO:0000012,body weight,,week one,,88.3,g,3.3775,11.7,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) and controlled bisphenol A content drinking water (2.5 mg/l) ,75751,controlled fructose content drinking water (5 %) ,controlled bisphenol A content drinking water (2.5 mg/l) ,,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days,11,,CMO:0000012,body weight,,week one,,172.3,g,1.6282,5.4,MMO:0000016,body weighing method,,0.0,,,,,controlled ethanol content drinking water (1 %) (for 70 days),75752,controlled ethanol content drinking water (1 %) (for 70 days),,,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days,12,,CMO:0000012,body weight,,week one,,171.7,g,2.0785,7.2,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) (for 70 days) and controlled ethanol content drinking water (1 %) (for 70 days),75753,controlled fructose content drinking water (5 %) (for 70 days),controlled ethanol content drinking water (1 %) (for 70 days),,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days,12,,CMO:0000012,body weight,,week one,,173.7,g,2.8579,9.9,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (0.025 mg/l) (for 70 days),75754,controlled fructose content drinking water (5 %) (for 70 days),controlled bisphenol A content drinking water (0.025 mg/l) (for 70 days),,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days,12,,CMO:0000012,body weight,,week one,,172.9,g,3.4064,11.8,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (0.25 mg/l) (for 70 days),75755,controlled fructose content drinking water (5 %) (for 70 days),controlled bisphenol A content drinking water (0.25 mg/l) (for 70 days),,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days,12,,CMO:0000012,body weight,,week one,,175.1,g,2.3671,8.2,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (2.5 mg/l) (for 70 days),75756,controlled fructose content drinking water (5 %) (for 70 days),controlled bisphenol A content drinking water (2.5 mg/l) (for 70 days),,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days to 35 days,12,,CMO:0000420,body weight gain,,week one,,80.1,g,2.5981,9.0,MMO:0000016,body weighing method,,0.0,,,,,controlled ethanol content drinking water (1 %) (for 70 days),75757,controlled ethanol content drinking water (1 %) (for 70 days),,,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days to 35 days,12,,CMO:0000420,body weight gain,,week one,,86.2,g,4.1569,14.4,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) (for 70 days) and controlled ethanol content drinking water (1 %) (for 70 days),75758,controlled fructose content drinking water (5 %) (for 70 days),controlled ethanol content drinking water (1 %) (for 70 days),,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days to 35 days,12,,CMO:0000420,body weight gain,,week one,,88.3,g,2.2228,7.7,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (0.025 mg/l) (for 70 days),75759,controlled fructose content drinking water (5 %) (for 70 days),controlled bisphenol A content drinking water (0.025 mg/l) (for 70 days),,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days to 35 days,12,,CMO:0000420,body weight gain,,week one,,82.6,g,2.5692,8.9,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (0.25 mg/l) (for 70 days),75760,controlled fructose content drinking water (5 %) (for 70 days),controlled bisphenol A content drinking water (0.25 mg/l) (for 70 days),,,,,,, 1538,"Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8.",body mass,,RS:0000695,Crl:SD,female,105 days to 35 days,12,,CMO:0000420,body weight gain,,week one,,86.4,g,4.0126,13.9,MMO:0000016,body weighing method,,0.0,,,,,controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (2.5 mg/l) (for 70 days),75761,controlled fructose content drinking water (5 %) (for 70 days),controlled bisphenol A content drinking water (2.5 mg/l) (for 70 days),,,,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,6,,CMO:0000012,body weight,,,,282.33,g,20.46,50.1166,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 14 days),75901,gestation (for 14 days),,,,,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,6,,CMO:0000012,body weight,,,,355.48,g,29.85,73.1173,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 20 days),75902,gestation (for 20 days),,,,,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,6,,CMO:0000012,body weight,,,,261.98,g,19.72,48.3039,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then lactation (for 7 days),75903,gestation (for 21 days),,,lactation (for 7 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,6,,CMO:0000012,body weight,,,,264.54,g,14.41,35.2971,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then lactation (for 14 days),75904,gestation (for 21 days),,,lactation (for 14 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,6,,CMO:0000012,body weight,,,,266.62,g,16.51,40.4411,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then lactation (for 21 days),75905,gestation (for 21 days),,,lactation (for 21 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,290.3,g,24.82,70.2016,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 14 days) then controlled bisphenol A content drinking water (0.01 mg/l) (for 3 days),75906,gestation (for 14 days),,,controlled bisphenol A content drinking water (0.01 mg/l) (for 3 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,361.54,g,33.76,95.4877,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 20 days) then controlled bisphenol A content drinking water (0.01 mg/l) (for 9 days),75907,gestation (for 20 days),,,controlled bisphenol A content drinking water (0.01 mg/l) (for 9 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,260.16,g,27.93,78.998,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (0.01 mg/l) (for 17 days) then lactation (for 7 days),75908,gestation (for 21 days),,,controlled bisphenol A content drinking water (0.01 mg/l) (for 17 days),,,lactation (for 7 days),, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,261.4,g,18.62,52.6653,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (0.01 mg/l) (for 24 days) then lactation (for 14 days),75909,gestation (for 21 days),,,controlled bisphenol A content drinking water (0.01 mg/l) (for 24 days),,,lactation (for 14 days),, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,258.37,g,14.66,41.4647,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (0.01 mg/l) (for 31 days) then lactation (for 21 days),75910,gestation (for 21 days),,,controlled bisphenol A content drinking water (0.01 mg/l) (for 31 days),,,lactation (for 21 days),, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,287.17,g,20.44,57.8131,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 14 days) then controlled bisphenol A content drinking water (0.1 mg/l) (for 3 days),75911,gestation (for 14 days),,,controlled bisphenol A content drinking water (0.1 mg/l) (for 3 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,363.35,g,28.59,80.8647,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 20 days) then controlled bisphenol A content drinking water (0.1 mg/l) (for 9 days),75912,gestation (for 20 days),,,controlled bisphenol A content drinking water (0.1 mg/l) (for 9 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,265.19,g,15.46,43.7275,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (0.1 mg/l) (for 17 days) then lactation (for 7 days),75913,gestation (for 21 days),,,controlled bisphenol A content drinking water (0.1 mg/l) (for 17 days),,,lactation (for 7 days),, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,264.83,g,21.28,60.1889,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (0.1 mg/l) (for 24 days) then lactation (for 14 days),75914,gestation (for 21 days),,,controlled bisphenol A content drinking water (0.1 mg/l) (for 24 days),,,lactation (for 14 days),, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,260.19,g,18.83,53.2593,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (0.1 mg/l) (for 31 days) then lactation (for 21 days),75915,gestation (for 21 days),,,controlled bisphenol A content drinking water (0.1 mg/l) (for 31 days),,,lactation (for 21 days),, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,274.58,g,34.95,98.8535,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 14 days) then controlled bisphenol A content drinking water (1 mg/l) (for 3 days),75916,gestation (for 14 days),,,controlled bisphenol A content drinking water (1 mg/l) (for 3 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,347.63,g,30.6,86.5499,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 20 days) then controlled bisphenol A content drinking water (1 mg/l) (for 9 days),75917,gestation (for 20 days),,,controlled bisphenol A content drinking water (1 mg/l) (for 9 days),,,,, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,259.23,g,24.17,68.3631,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (1 mg/l) (for 17 days) then lactation (for 7 days),75918,gestation (for 21 days),,,controlled bisphenol A content drinking water (1 mg/l) (for 17 days),,,lactation (for 7 days),, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,257.34,g,26.96,76.2544,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (1 mg/l) (for 24 days) then lactation (for 14 days),75919,gestation (for 21 days),,,controlled bisphenol A content drinking water (1 mg/l) (for 24 days),,,lactation (for 14 days),, 1539,"Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17.",body mass,,RS:0000696,CrljJcl:SD,female,0 days,8,,CMO:0000012,body weight,,,,260.55,g,27.27,77.1312,MMO:0000016,body weighing method,,0.0,,,,,gestation (for 21 days) then controlled bisphenol A content drinking water (1 mg/l) (for 31 days) then lactation (for 21 days),75920,gestation (for 21 days),,,controlled bisphenol A content drinking water (1 mg/l) (for 31 days),,,lactation (for 21 days),, 1544,"Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90.",body mass,,RS:0001014,Hsd:WI,male,0 days,6,,CMO:0000012,body weight,,,,140.6,g,0.5307,1.3,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 10 days),75951,vehicle control condition (for 10 days),,,,,,,, 1544,"Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90.",body mass,,RS:0001014,Hsd:WI,male,0 days,6,,CMO:0000012,body weight,,,,137.6,g,0.4491,1.1,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) ,75952,vehicle control condition (for 10 days),,,cisplatin (7.5 mg/kg) ,,,,, 1544,"Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90.",body mass,,RS:0001014,Hsd:WI,male,0 days,6,,CMO:0000012,body weight,,,,142.5,g,0.7348,1.8,MMO:0000016,body weighing method,,0.0,,,,,1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) ,75953,1H-pyrazole (10 mg/kg/d) (for 10 days),,,cisplatin (7.5 mg/kg) ,,,,, 1544,"Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90.",body mass,,RS:0001014,Hsd:WI,male,0 days,6,,CMO:0000012,body weight,,,,143.6,g,0.4082,1.0,MMO:0000016,body weighing method,,0.0,,,,,silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) ,75954,silymarin (50 mg/kg/d) (for 10 days),,,cisplatin (7.5 mg/kg) ,,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,70 days,8,,CMO:0000012,body weight,,,,353.1,g,10.8,30.547,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days),75955,vehicle control condition (for 30 days),controlled in utero environment (for 9 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,70 days,8,,CMO:0000012,body weight,,,,338.8,g,9.9,28.0014,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days),75960,controlled in utero environment (for 9 days),bisphenol A (2.5 ug/kg) (for 30 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,70 days,8,,CMO:0000012,body weight,,,,326.6,g,11.6,32.8098,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days),75961,controlled in utero environment (for 9 days),bisphenol A (25 ug/kg) (for 30 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days,8,,CMO:0000012,body weight,,,,457.7,g,15.9,44.972,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days),75962,vehicle control condition (for 30 days),controlled in utero environment (for 9 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days,8,,CMO:0000012,body weight,,,,442.5,g,12.5,35.3553,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days),75963,controlled in utero environment (for 9 days),bisphenol A (2.5 ug/kg) (for 30 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days,8,,CMO:0000012,body weight,,,,426.1,g,15.4,43.5578,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days),75964,controlled in utero environment (for 9 days),bisphenol A (25 ug/kg) (for 30 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days to 71 days,8,,CMO:0000420,body weight gain,,,,104.6,g,5.9,16.6877,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days),75969,vehicle control condition (for 30 days),controlled in utero environment (for 9 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days to 71 days,8,,CMO:0000420,body weight gain,,,,103.7,g,4.2,11.8794,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days),75970,controlled in utero environment (for 9 days),bisphenol A (2.5 ug/kg) (for 30 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days to 71 days,8,,CMO:0000420,body weight gain,,,,99.5,g,5.1,14.425,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days),75971,controlled in utero environment (for 9 days),bisphenol A (25 ug/kg) (for 30 days),,maternal milk (for 21 days),,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,5,,CMO:0000012,body weight,,,,388,g,16.8152,37.6,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 91 days),76041,vehicle control condition (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,6,,CMO:0000012,body weight,,,,314.83,g,6.1523,15.07,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (125 mg/kg/d) (for 91 days),76042,bisphenol A (125 mg/kg/d) (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,6,,CMO:0000012,body weight,,,,336.83,g,12.6557,31.0,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (250 mg/kg/d) (for 91 days),76044,bisphenol A (250 mg/kg/d) (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,6,,CMO:0000012,body weight,,,,326.67,g,14.9786,36.69,MMO:0000016,body weighing method,,0.0,,,,,octylphenol (125 mg/kg/d) (for 91 days),76047,octylphenol (125 mg/kg/d) (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,6,,CMO:0000012,body weight,,,,325.33,g,12.3985,30.37,MMO:0000016,body weighing method,,0.0,,,,,octylphenol (250 mg/kg/d) (for 91 days),76050,octylphenol (250 mg/kg/d) (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,5,,CMO:0002216,change in body weight to body weight ratio,,,,255,%,13.4164,30.0,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 91 days),76065,vehicle control condition (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,6,,CMO:0002216,change in body weight to body weight ratio,,,,201.5,%,17.1464,42.0,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (125 mg/kg/d) (for 91 days),76066,bisphenol A (125 mg/kg/d) (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,6,,CMO:0002216,change in body weight to body weight ratio,,,,215.9,%,15.1868,37.2,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (250 mg/kg/d) (for 91 days),76067,bisphenol A (250 mg/kg/d) (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,6,,CMO:0002216,change in body weight to body weight ratio,,,,242.2,%,18.7386,45.9,MMO:0000016,body weighing method,,0.0,,,,,octylphenol (125 mg/kg/d) (for 91 days),76068,octylphenol (125 mg/kg/d) (for 91 days),,,,,,,, 1545,"Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796.",body mass,,RS:0001014,Hsd:WI,male,126 days to 119 days,6,,CMO:0002216,change in body weight to body weight ratio,,,,212.8,%,16.9015,41.4,MMO:0000016,body weighing method,,0.0,,,,,octylphenol (250 mg/kg/d) (for 91 days),76069,octylphenol (250 mg/kg/d) (for 91 days),,,,,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,70 days,8,,CMO:0000012,body weight,,,,345.8,g,13.1,37.0524,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days),76140,vehicle control condition (for 30 days),controlled in utero environment (for 9 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,70 days,8,,CMO:0000012,body weight,,,,339.6,g,9.5,26.8701,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days),76146,controlled in utero environment (for 9 days),bisphenol A (2.5 ug/kg) (for 30 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,70 days,8,,CMO:0000012,body weight,,,,338.5,g,8.3,23.4759,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days),76147,controlled in utero environment (for 9 days),bisphenol A (25 ug/kg) (for 30 days),,maternal milk (for 21 days),,,,, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days,8,,CMO:0000012,body weight,,,,491.1,g,20.4,57.6999,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days),76148,vehicle control condition (for 30 days),controlled in utero environment (for 9 days),,maternal milk (for 21 days),,,controlled fat content diet (21.2 %) (for 28 days),, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days,8,,CMO:0000012,body weight,,,,485.7,g,16.9,47.8004,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days),76154,controlled in utero environment (for 9 days),bisphenol A (2.5 ug/kg) (for 30 days),,maternal milk (for 21 days),,,controlled fat content diet (21.2 %) (for 28 days),, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days,8,,CMO:0000012,body weight,,,,486.9,g,8.7,24.6073,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days),76155,controlled in utero environment (for 9 days),bisphenol A (25 ug/kg) (for 30 days),,maternal milk (for 21 days),,,controlled fat content diet (21.2 %) (for 28 days),, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days to 71 days,8,,CMO:0000420,body weight gain,,,,145.3,g,9.3,26.3044,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days),76161,vehicle control condition (for 30 days),controlled in utero environment (for 9 days),,maternal milk (for 21 days),,,controlled fat content diet (21.2 %) (for 28 days),, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days to 71 days,8,,CMO:0000420,body weight gain,,,,146.1,g,9.1,25.7387,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days),76162,controlled in utero environment (for 9 days),bisphenol A (2.5 ug/kg) (for 30 days),,maternal milk (for 21 days),,,controlled fat content diet (21.2 %) (for 28 days),, 1543,"Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26.",body mass,,RS:0002943,BluHsd:LE,male,98 days to 71 days,8,,CMO:0000420,body weight gain,,,,150.1,g,4.7,13.2936,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days),76163,controlled in utero environment (for 9 days),bisphenol A (25 ug/kg) (for 30 days),,maternal milk (for 21 days),,,controlled fat content diet (21.2 %) (for 28 days),, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,0 days,18,,CMO:0000420,body weight gain,,G7-G21,,82.4,g,6.2225,26.4,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 14 days),76270,vehicle control condition (for 14 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,0 days,21,,CMO:0000420,body weight gain,,G7-G21,,91.2,g,3.0551,14.0,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (0.025 mg/kg/d) (for 14 days),76271,bisphenol A (0.025 mg/kg/d) (for 14 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,0 days,17,,CMO:0000420,body weight gain,,G7-G21,,82.9,g,5.4571,22.5,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (0.25 mg/kg/d) (for 14 days),76272,bisphenol A (0.25 mg/kg/d) (for 14 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,0 days,18,,CMO:0000420,body weight gain,,G7-G21,,81.1,g,4.9026,20.8,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (5 mg/kg/d) (for 14 days),76273,bisphenol A (5 mg/kg/d) (for 14 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,0 days,18,,CMO:0000420,body weight gain,,G7-G21,,78.8,g,4.0305,17.1,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (50 mg/kg/d) (for 14 days),76274,bisphenol A (50 mg/kg/d) (for 14 days),,,,,,,, 932,"Ways JA, et al., Genomics 2002 Jul;80(1):13-20.",body mass,,RS:0000186,COP/OlaHsd,male,84 days to 77 days,N/A,,CMO:0000012,body weight,,,,228,g,7.0,,MMO:0000016,body weighing method,,,timing method,,,,control condition,84622,control condition,,,,,,,, 932,"Ways JA, et al., Genomics 2002 Jul;80(1):13-20.",body mass,,RS:0000244,DA/OlaHsd,male,84 days to 77 days,N/A,,CMO:0000012,body weight,,,,231,g,10.0,,MMO:0000016,body weighing method,,0.0,timing method,,,,control condition,84623,control condition,,,,,,,, 1599,"Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17.",body mass,,RS:0000363,F344/NHsd,male,267 days to 123 days,8,,CMO:0000012,body weight,,,,379.3,g,9.2,26.0215,MMO:0000016,body weighing method,,0.0,,,,,control condition,84700,control condition,,,,,,,, 1599,"Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17.",body mass,,RS:0000363,F344/NHsd,male,945 days to 579 days,9,,CMO:0000012,body weight,,,,424.8,g,14.5,43.5,MMO:0000016,body weighing method,,0.0,,,,,control condition,84701,control condition,,,,,,,, 1599,"Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17.",body mass,,RS:0000363,F344/NHsd,male,882 days to 714 days,5,,CMO:0000012,body weight,,,,429.1,g,30.0,67.082,MMO:0000016,body weighing method,,0.0,,,,,control condition,84702,control condition,,,,,,,, 1599,"Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17.",body mass,,RS:0000363,F344/NHsd,male,264 days to 132 days,9,,CMO:0000012,body weight,,,,375.7,g,8.1,24.3,MMO:0000016,body weighing method,,0.0,,,,,fasting (for 16 hours),84703,fasting (for 16 hours),,,,,,,, 1599,"Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17.",body mass,,RS:0000363,F344/NHsd,male,267 days to 123 days,8,,CMO:0000012,body weight,,,,371.3,g,8.3,23.4759,MMO:0000016,body weighing method,,0.0,,,,,fasting (for 16 hours),84704,fasting (for 16 hours),,,,,,,, 1599,"Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17.",body mass,,RS:0000363,F344/NHsd,male,945 days to 579 days,9,,CMO:0000012,body weight,,,,419.9,g,12.2,36.6,MMO:0000016,body weighing method,,0.0,,,,,fasting (for 16 hours),84705,fasting (for 16 hours),,,,,,,, 1599,"Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17.",body mass,,RS:0000363,F344/NHsd,male,882 days to 714 days,5,,CMO:0000012,body weight,,,,415.7,g,28.9,64.6224,MMO:0000016,body weighing method,,0.0,,,,,fasting (for 16 hours),84706,fasting (for 16 hours),,,,,,,, 1599,"Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17.",body mass,,RS:0000363,F344/NHsd,male,264 days to 132 days,5,,CMO:0000012,body weight,,,,381.2,g,9.4,21.019,MMO:0000016,body weighing method,,0.0,,,,,control condition,84708,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,56 days to 42 days,6,,CMO:0000012,body weight,,,,180.4,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84760,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,64 days to 50 days,6,,CMO:0000012,body weight,,,,207.4,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84761,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,71 days to 57 days,6,,CMO:0000012,body weight,,,,225.6,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84762,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,78 days to 64 days,6,,CMO:0000012,body weight,,,,242.6,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84763,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,84 days to 70 days,6,,CMO:0000012,body weight,,,,257.3,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84764,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,56 days to 42 days,6,,CMO:0000012,body weight,,,,182.3,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 1 days),84765,acetaminophen (250 mg/kg) (for 1 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,64 days to 50 days,6,,CMO:0000012,body weight,,,,211,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 8 days),84766,acetaminophen (250 mg/kg) (for 8 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,71 days to 57 days,6,,CMO:0000012,body weight,,,,227.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 15 days),84767,acetaminophen (250 mg/kg) (for 15 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,78 days to 64 days,6,,CMO:0000012,body weight,,,,244,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 22 days),84768,acetaminophen (250 mg/kg) (for 22 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,84 days to 70 days,6,,CMO:0000012,body weight,,,,258.5,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 28 days),84769,acetaminophen (250 mg/kg) (for 28 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,56 days to 42 days,6,,CMO:0000012,body weight,,,,181.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 1 days),84770,acetaminophen (500 mg/kg) (for 1 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,64 days to 50 days,6,,CMO:0000012,body weight,,,,209.3,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 8 days),84771,acetaminophen (500 mg/kg) (for 8 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,71 days to 57 days,6,,CMO:0000012,body weight,,,,229.6,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 15 days),84772,acetaminophen (500 mg/kg) (for 15 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,78 days to 64 days,6,,CMO:0000012,body weight,,,,241.1,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 22 days),84773,acetaminophen (500 mg/kg) (for 22 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,84 days to 70 days,6,,CMO:0000012,body weight,,,,256.6,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 28 days),84774,acetaminophen (500 mg/kg) (for 28 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,56 days to 42 days,6,,CMO:0000012,body weight,,,,182.4,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 1 days),84775,acetaminophen (1000 mg/kg) (for 1 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,64 days to 50 days,6,,CMO:0000012,body weight,,,,211.6,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 8 days),84776,acetaminophen (1000 mg/kg) (for 8 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,71 days to 57 days,6,,CMO:0000012,body weight,,,,229.6,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 15 days),84777,acetaminophen (1000 mg/kg) (for 15 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,78 days to 64 days,6,,CMO:0000012,body weight,,,,246.8,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 22 days),84778,acetaminophen (1000 mg/kg) (for 22 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,84 days to 70 days,6,,CMO:0000012,body weight,,,,262.4,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 28 days),84779,acetaminophen (1000 mg/kg) (for 28 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,56 days to 42 days,6,,CMO:0000012,body weight,,,,184.1,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84781,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,64 days to 50 days,6,,CMO:0000012,body weight,,,,205.4,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84782,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,71 days to 57 days,6,,CMO:0000012,body weight,,,,228,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84784,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,78 days to 64 days,6,,CMO:0000012,body weight,,,,246.1,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84786,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,84 days to 70 days,6,,CMO:0000012,body weight,,,,255.5,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84788,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,56 days to 42 days,6,,CMO:0000012,body weight,,,,190.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 1 days),84789,acetaminophen (1000 mg/kg) (for 1 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,64 days to 50 days,6,,CMO:0000012,body weight,,,,208.8,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 8 days),84790,acetaminophen (1000 mg/kg) (for 8 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,71 days to 57 days,6,,CMO:0000012,body weight,,,,231.9,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 15 days),84791,acetaminophen (1000 mg/kg) (for 15 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,78 days to 64 days,6,,CMO:0000012,body weight,,,,252.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 22 days),84792,acetaminophen (1000 mg/kg) (for 22 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,male,84 days to 70 days,6,,CMO:0000012,body weight,,,,264,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 28 days),84793,acetaminophen (1000 mg/kg) (for 28 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,56 days to 42 days,6,,CMO:0000012,body weight,,,,136.2,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84794,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,64 days to 50 days,6,,CMO:0000012,body weight,,,,148.3,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84795,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,71 days to 57 days,6,,CMO:0000012,body weight,,,,156.6,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84796,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,78 days to 64 days,6,,CMO:0000012,body weight,,,,167,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84797,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,84 days to 70 days,6,,CMO:0000012,body weight,,,,172.8,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84798,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,56 days to 42 days,6,,CMO:0000012,body weight,,,,136.3,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 1 days),84799,acetaminophen (250 mg/kg) (for 1 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,64 days to 50 days,6,,CMO:0000012,body weight,,,,152.8,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 8 days),84800,acetaminophen (250 mg/kg) (for 8 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,71 days to 57 days,6,,CMO:0000012,body weight,,,,161.2,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 15 days),84801,acetaminophen (250 mg/kg) (for 15 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,78 days to 64 days,6,,CMO:0000012,body weight,,,,170,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 22 days),84802,acetaminophen (250 mg/kg) (for 22 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,84 days to 70 days,6,,CMO:0000012,body weight,,,,175.3,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (250 mg/kg) (for 28 days),84803,acetaminophen (250 mg/kg) (for 28 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,56 days to 42 days,6,,CMO:0000012,body weight,,,,134.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 1 days),84804,acetaminophen (500 mg/kg) (for 1 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,64 days to 50 days,6,,CMO:0000012,body weight,,,,147.9,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 8 days),84805,acetaminophen (500 mg/kg) (for 8 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,71 days to 57 days,6,,CMO:0000012,body weight,,,,151.9,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 15 days),84806,acetaminophen (500 mg/kg) (for 15 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,78 days to 64 days,6,,CMO:0000012,body weight,,,,157.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 22 days),84807,acetaminophen (500 mg/kg) (for 22 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,84 days to 70 days,6,,CMO:0000012,body weight,,,,162.5,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (500 mg/kg) (for 28 days),84808,acetaminophen (500 mg/kg) (for 28 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,56 days to 42 days,6,,CMO:0000012,body weight,,,,134.2,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 1 days),84809,acetaminophen (1000 mg/kg) (for 1 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,64 days to 50 days,6,,CMO:0000012,body weight,,,,147,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 8 days),84810,acetaminophen (1000 mg/kg) (for 8 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,71 days to 57 days,6,,CMO:0000012,body weight,,,,150.9,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 15 days),84811,acetaminophen (1000 mg/kg) (for 15 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,78 days to 64 days,6,,CMO:0000012,body weight,,,,157.9,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 22 days),84812,acetaminophen (1000 mg/kg) (for 22 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,84 days to 70 days,6,,CMO:0000012,body weight,,,,166.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 28 days),84813,acetaminophen (1000 mg/kg) (for 28 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,56 days to 42 days,6,,CMO:0000012,body weight,,,,137.3,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84814,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,64 days to 50 days,6,,CMO:0000012,body weight,,,,143.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84815,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,71 days to 57 days,6,,CMO:0000012,body weight,,,,151.6,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84816,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,78 days to 64 days,6,,CMO:0000012,body weight,,,,159.1,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84817,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,84 days to 70 days,6,,CMO:0000012,body weight,,,,160.5,g,,,MMO:0000016,body weighing method,,0.0,,,,,control condition,84818,control condition,,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,56 days to 42 days,6,,CMO:0000012,body weight,,,,139,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 1 days),84819,acetaminophen (1000 mg/kg) (for 1 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,64 days to 50 days,6,,CMO:0000012,body weight,,,,146.1,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 8 days),84820,acetaminophen (1000 mg/kg) (for 8 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,71 days to 57 days,6,,CMO:0000012,body weight,,,,153.9,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 15 days),84821,acetaminophen (1000 mg/kg) (for 15 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,78 days to 64 days,6,,CMO:0000012,body weight,,,,160.7,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 22 days),84822,acetaminophen (1000 mg/kg) (for 22 days),,,,,,,, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",body mass,,RS:0000681,SD,female,84 days to 70 days,6,,CMO:0000012,body weight,,,,164.5,g,,,MMO:0000016,body weighing method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 28 days),84823,acetaminophen (1000 mg/kg) (for 28 days),,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,71 days,19,,CMO:0000012,body weight,,,,373,g,4.5883,20.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,85310,standard diet,,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,71 days,19,,CMO:0000012,body weight,,,,288,g,3.6707,16.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) ,85311,standard diet,restricted feeding (4 h) ,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,84 days,19,,CMO:0000012,body weight,,,,419,g,8.7178,38.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,85312,standard diet,,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,84 days,19,,CMO:0000012,body weight,,,,328,g,4.8177,21.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) ,85313,standard diet,restricted feeding (4 h) ,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,105 days,19,,CMO:0000012,body weight,,,,481,g,11.7002,51.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,85314,standard diet,,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,105 days,19,,CMO:0000012,body weight,,,,374,g,5.2766,23.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) ,85315,standard diet,restricted feeding (4 h) ,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,126 days,19,,CMO:0000012,body weight,,,,526,g,13.3061,58.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,85316,standard diet,,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,126 days,19,,CMO:0000012,body weight,,,,401,g,4.8177,21.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) ,85317,standard diet,restricted feeding (4 h) ,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,147 days,19,,CMO:0000012,body weight,,,,563,g,13.5355,59.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,85318,standard diet,,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,147 days,19,,CMO:0000012,body weight,,,,430,g,5.9648,26.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) ,85319,standard diet,restricted feeding (4 h) ,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,168 days,19,,CMO:0000012,body weight,,,,588,g,14.4532,63.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,85320,standard diet,,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,168 days,19,,CMO:0000012,body weight,,,,444,g,6.6531,29.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) ,85321,standard diet,restricted feeding (4 h) ,,,,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,71 days,8,,CMO:0000012,body weight,,,,371,g,5.6569,16.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (300 mg/kg) (for 1 days),85519,standard diet,,,acetaminophen (300 mg/kg) (for 1 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,71 days,8,,CMO:0000012,body weight,,,,375,g,6.364,18.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (500 mg/kg) (for 1 days),85520,standard diet,,,acetaminophen (500 mg/kg) (for 1 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,71 days,8,,CMO:0000012,body weight,,,,287,g,6.7175,19.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 1 days),85522,standard diet,restricted feeding (4 h) ,,acetaminophen (300 mg/kg) (for 1 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,71 days,8,,CMO:0000012,body weight,,,,287,g,5.3033,15.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 1 days),85523,standard diet,restricted feeding (4 h) ,,acetaminophen (500 mg/kg) (for 1 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,84 days,8,,CMO:0000012,body weight,,,,418,g,6.7175,19.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (300 mg/kg) (for 14 days),85525,standard diet,,,acetaminophen (300 mg/kg) (for 14 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,84 days,8,,CMO:0000012,body weight,,,,413,g,6.0104,17.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (500 mg/kg) (for 14 days),85526,standard diet,,,acetaminophen (500 mg/kg) (for 14 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,84 days,8,,CMO:0000012,body weight,,,,333,g,8.1317,23.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 14 days),85528,standard diet,restricted feeding (4 h) ,,acetaminophen (300 mg/kg) (for 14 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,84 days,8,,CMO:0000012,body weight,,,,321,g,7.7782,22.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 14 days),85529,standard diet,restricted feeding (4 h) ,,acetaminophen (500 mg/kg) (for 14 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,105 days,8,,CMO:0000012,body weight,,,,477,g,7.4246,21.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (300 mg/kg) (for 35 days),85531,standard diet,,,acetaminophen (300 mg/kg) (for 35 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,105 days,8,,CMO:0000012,body weight,,,,472,g,8.4853,24.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (500 mg/kg) (for 35 days),85532,standard diet,,,acetaminophen (500 mg/kg) (for 35 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,105 days,8,,CMO:0000012,body weight,,,,375,g,12.7279,36.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 35 days),85534,standard diet,restricted feeding (4 h) ,,acetaminophen (300 mg/kg) (for 35 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,105 days,8,,CMO:0000012,body weight,,,,365,g,6.364,18.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 35 days),85535,standard diet,restricted feeding (4 h) ,,acetaminophen (500 mg/kg) (for 35 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,126 days,8,,CMO:0000012,body weight,,,,522,g,8.1317,23.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (300 mg/kg) (for 56 days),85537,standard diet,,,acetaminophen (300 mg/kg) (for 56 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,126 days,8,,CMO:0000012,body weight,,,,516,g,12.7279,36.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (500 mg/kg) (for 56 days),85538,standard diet,,,acetaminophen (500 mg/kg) (for 56 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,126 days,8,,CMO:0000012,body weight,,,,404,g,12.3744,35.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 56 days),85540,standard diet,restricted feeding (4 h) ,,acetaminophen (300 mg/kg) (for 56 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,126 days,8,,CMO:0000012,body weight,,,,400,g,7.7782,22.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 56 days),85541,standard diet,restricted feeding (4 h) ,,acetaminophen (500 mg/kg) (for 56 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,147 days,8,,CMO:0000012,body weight,,,,557,g,8.1317,23.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (300 mg/kg) (for 77 days),85543,standard diet,,,acetaminophen (300 mg/kg) (for 77 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,147 days,8,,CMO:0000012,body weight,,,,549,g,12.7279,36.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (500 mg/kg) (for 77 days),85544,standard diet,,,acetaminophen (500 mg/kg) (for 77 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,147 days,8,,CMO:0000012,body weight,,,,432,g,17.3241,49.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 77 days),85546,standard diet,restricted feeding (4 h) ,,acetaminophen (300 mg/kg) (for 77 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,147 days,8,,CMO:0000012,body weight,,,,431,g,8.4853,24.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 77 days),85547,standard diet,restricted feeding (4 h) ,,acetaminophen (500 mg/kg) (for 77 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,168 days,8,,CMO:0000012,body weight,,,,581,g,9.1924,26.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (300 mg/kg) (for 98 days),85549,standard diet,,,acetaminophen (300 mg/kg) (for 98 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,168 days,8,,CMO:0000012,body weight,,,,564,g,15.2028,43.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet then acetaminophen (500 mg/kg) (for 98 days),85550,standard diet,,,acetaminophen (500 mg/kg) (for 98 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,168 days,8,,CMO:0000012,body weight,,,,447,g,16.617,47.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 98 days),85552,standard diet,restricted feeding (4 h) ,,acetaminophen (300 mg/kg) (for 98 days),,,,, 1604,"Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29.",body mass,,RS:0000064,Crl:CD(SD),male,168 days,8,,CMO:0000012,body weight,,,,440,g,9.1924,26.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 98 days),85553,standard diet,restricted feeding (4 h) ,,acetaminophen (500 mg/kg) (for 98 days),,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,1 days,17,,CMO:0000012,body weight,,,,6.2,g,0.1213,0.5,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 1 days),96612,vehicle control condition (for 1 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,17 days to 16 days,20,,CMO:0000012,body weight,,,,29.9,g,0.9615,4.3,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (0.025 mg/kg/d) (between 16 and 17 days),96613,bisphenol A (0.025 mg/kg/d) (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,1 days,17,,CMO:0000012,body weight,,,,6.1,g,0.1213,0.5,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (0.25 mg/kg/d) (for 1 days),96614,bisphenol A (0.25 mg/kg/d) (for 1 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,1 days,17,,CMO:0000012,body weight,,,,6.3,g,0.1213,0.5,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (5 mg/kg/d) (for 1 days),96615,bisphenol A (5 mg/kg/d) (for 1 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,1 days,17,,CMO:0000012,body weight,,,,5.9,g,0.2183,0.9,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (50 mg/kg/d) (for 1 days),96616,bisphenol A (50 mg/kg/d) (for 1 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,17 days to 16 days,18,,CMO:0000012,body weight,,,,28.6,g,1.0842,4.6,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (between 16 and 17 days),96632,vehicle control condition (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,1 days,17,,CMO:0000012,body weight,,,,6.3,g,0.1213,0.5,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (0.025 mg/kg/d) (for 1 days),96633,bisphenol A (0.025 mg/kg/d) (for 1 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,17 days to 16 days,14,,CMO:0000012,body weight,,,,28.3,g,0.6147,2.3,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (0.25 mg/kg/d) (between 16 and 17 days),96634,bisphenol A (0.25 mg/kg/d) (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,17 days to 16 days,16,,CMO:0000012,body weight,,,,28.6,g,0.75,3.0,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (5 mg/kg/d) (between 16 and 17 days),96635,bisphenol A (5 mg/kg/d) (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,male,17 days to 16 days,17,,CMO:0000012,body weight,,,,28.7,g,1.2854,5.3,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (50 mg/kg/d) (between 16 and 17 days),96636,bisphenol A (50 mg/kg/d) (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,17 days to 16 days,15,,CMO:0000012,body weight,,,,29.1,g,0.6713,2.6,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (between 16 and 17 days),96687,vehicle control condition (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,17 days to 16 days,20,,CMO:0000012,body weight,,,,31.2,g,0.8944,4.0,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (0.025 mg/kg/d) (between 16 and 17 days),96688,bisphenol A (0.025 mg/kg/d) (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,17 days to 16 days,16,,CMO:0000012,body weight,,,,29.4,g,1.175,4.7,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (0.25 mg/kg/d) (between 16 and 17 days),96689,bisphenol A (0.25 mg/kg/d) (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,17 days to 16 days,18,,CMO:0000012,body weight,,,,30.9,g,0.7071,3.0,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (5 mg/kg/d) (between 16 and 17 days),96690,bisphenol A (5 mg/kg/d) (between 16 and 17 days),,,,,,,, 1559,"Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014.",body mass,,RS:0001592,HanTac:WH,female,17 days to 16 days,16,,CMO:0000012,body weight,,,,29.6,g,1.325,5.3,MMO:0000016,body weighing method,,0.0,,,,,bisphenol A (50 mg/kg/d) (between 16 and 17 days),96691,bisphenol A (50 mg/kg/d) (between 16 and 17 days),,,,,,,, 1660,"Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2.",body mass,,RS:0003771,W/Nin,male,284 days,6,,CMO:0000012,body weight,,,,424,g,19.8,48.4999,MMO:0000016,body weighing method,,0.0,,,,,controlled retinyl palmitate content diet (2.6 mg/kg) (between 36 and 42 days) then fasting (for 12 hours),96717,controlled retinyl palmitate content diet (2.6 mg/kg) (between 36 and 42 days),,,fasting (for 12 hours),,,,, 1660,"Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2.",body mass,,RS:0003771,W/Nin,male,284 days,6,,CMO:0000012,body weight,,,,455,g,7.1,17.3914,MMO:0000016,body weighing method,,0.0,,,,,controlled retinyl palmitate content diet (26 mg/kg) (between 36 and 42 days) then fasting (for 12 hours),96718,controlled retinyl palmitate content diet (26 mg/kg) (between 36 and 42 days),,,fasting (for 12 hours),,,,, 1660,"Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2.",body mass,,RS:0003771,W/Nin,male,284 days,6,,CMO:0000012,body weight,,,,441,g,19.2,47.0302,MMO:0000016,body weighing method,,0.0,,,,,controlled retinyl palmitate content diet (52 mg/kg) (between 36 and 42 days) then fasting (for 12 hours),96719,controlled retinyl palmitate content diet (52 mg/kg) (between 36 and 42 days),,,fasting (for 12 hours),,,,, 1660,"Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2.",body mass,,RS:0003771,W/Nin,male,284 days,6,,CMO:0000012,body weight,,,,454,g,13.3,32.5782,MMO:0000016,body weighing method,,0.0,,,,,controlled retinyl palmitate content diet (129 mg/kg) (between 36 and 42 days) then fasting (for 12 hours),96720,controlled retinyl palmitate content diet (129 mg/kg) (between 36 and 42 days),,,fasting (for 12 hours),,,,, 1660,"Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2.",body mass,,RS:0003774,W-LeprfaNin,male,284 days,6,,CMO:0000012,body weight,,,,926,g,56.2,137.6613,MMO:0000016,body weighing method,,0.0,,,,,controlled retinyl palmitate content diet (2.6 mg/kg) (between 36 and 42 days) then fasting (for 12 hours),96721,controlled retinyl palmitate content diet (2.6 mg/kg) (between 36 and 42 days),,,fasting (for 12 hours),,,,, 1660,"Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2.",body mass,,RS:0003774,W-LeprfaNin,male,284 days,6,,CMO:0000012,body weight,,,,883,g,38.9,95.2852,MMO:0000016,body weighing method,,0.0,,,,,controlled retinyl palmitate content diet (26 mg/kg) (between 36 and 42 days) then fasting (for 12 hours),96722,controlled retinyl palmitate content diet (26 mg/kg) (between 36 and 42 days),,,fasting (for 12 hours),,,,, 1660,"Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2.",body mass,,RS:0003774,W-LeprfaNin,male,284 days,6,,CMO:0000012,body weight,,,,811,g,33.4,81.813,MMO:0000016,body weighing method,,0.0,,,,,controlled retinyl palmitate content diet (52 mg/kg) (between 36 and 42 days) then fasting (for 12 hours),96723,controlled retinyl palmitate content diet (52 mg/kg) (between 36 and 42 days),,,fasting (for 12 hours),,,,, 1660,"Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2.",body mass,,RS:0003774,W-LeprfaNin,male,284 days,6,,CMO:0000012,body weight,,,,778,g,23.8,58.2979,MMO:0000016,body weighing method,,0.0,,,,,controlled retinyl palmitate content diet (129 mg/kg) (between 36 and 42 days) then fasting (for 12 hours),96724,controlled retinyl palmitate content diet (129 mg/kg) (between 36 and 42 days),,,fasting (for 12 hours),,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",body mass,,RS:0000924,SS/JrTol,male,75 days to 73 days,10,,CMO:0000012,body weight,,,,338,g,4.0,12.6491,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),96966,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",body mass,,RS:0003862,SS.LEW-(D1Rat200-D1Mco136)/Bj,male,75 days to 73 days,10,,CMO:0000012,body weight,,,,331,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),96968,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0001819,BXH2/Cub,male,127 days,18,,CMO:0000012,body weight,,,,194,g,3.0,12.7279,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97100,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0000725,SHR.BN-(D8Mit5-D8Mgh6)/Ipcv,male,127 days,13,,CMO:0000012,body weight,,,,328,g,4.0,14.4222,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97101,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002095,PXO5-2/Cub,male,127 days,10,,CMO:0000012,body weight,,,,220.6,g,3.3,10.4355,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97157,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002094,PXO5-1/Cub,male,127 days,11,,CMO:0000012,body weight,,,,235.1,g,4.8,15.9198,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97158,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002098,PXO6-3/Cub,male,127 days,10,,CMO:0000012,body weight,,,,235.6,g,6.8,21.5035,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97159,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002103,PXO9/Cub,male,127 days,9,,CMO:0000012,body weight,,,,245,g,6.2,18.6,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97160,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002099,PXO7-1/Cub,male,127 days,8,,CMO:0000012,body weight,,,,250.9,g,3.8,10.748,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97161,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002096,PXO6-1/Cub,male,127 days,10,,CMO:0000012,body weight,,,,251.2,g,5.5,17.3925,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97162,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002086,PXO1/Cub,male,127 days,11,,CMO:0000012,body weight,,,,257.2,g,5.2,17.2464,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97163,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002090,PXO2/Cub,male,127 days,11,,CMO:0000012,body weight,,,,270.2,g,4.7,15.5881,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97164,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002097,PXO6-2/Cub,male,127 days,8,,CMO:0000012,body weight,,,,278.6,g,5.2,14.7078,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97165,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002101,PXO8-1/Cub,male,127 days,10,,CMO:0000012,body weight,,,,279.1,g,4.2,13.2816,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97166,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002102,PXO8-2/Cub,male,127 days,13,,CMO:0000012,body weight,,,,291.4,g,4.8,17.3066,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97167,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002089,PXO10/Cub,male,127 days,12,,CMO:0000012,body weight,,,,295.6,g,7.2,24.9415,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97168,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002093,PXO4/Cub,male,127 days,9,,CMO:0000012,body weight,,,,300.1,g,5.1,15.3,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97169,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002091,PXO3-1/Cub,male,127 days,10,,CMO:0000012,body weight,,,,306.3,g,5.1,16.1276,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97170,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1858,"Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014.",body mass,,RS:0002092,PXO3-2/Cub,male,127 days,9,,CMO:0000012,body weight,,,,307.6,g,5.8,17.4,MMO:0000016,body weighing method,,0.0,,,,,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours),97171,controlled sucrose content diet (70 % of calories) (between 0 and 168 hours),controlled protein content diet (19.6 % of calories) (between 0 and 168 hours),controlled fat content diet (10.4 % of calories) (between 0 and 168 hours),fasting (between 0 and 16 hours),,,,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",body mass,,RS:0000364,F344/NSlc,male,175 days to 168 days,20,,CMO:0000012,body weight,,,,380.2,g,12.73,56.9303,MMO:0000016,body weighing method,,0.0,,,,,control condition,97718,control condition,,,,,,,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",body mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,22,,CMO:0000012,body weight,,,,301.64,g,7.17,33.6303,MMO:0000016,body weighing method,,0.0,,,,,control condition,97719,control condition,,,,,,,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",body mass,,RS:0001991,F344.ZUC-Leprfa/Tj,male,175 days to 168 days,16,,CMO:0000012,body weight,,,,590.04,g,7.75,31.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,97720,control condition,,,,,,,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",body mass,,RS:0004089,"F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj",male,175 days to 168 days,5,,CMO:0000012,body weight,,,,461.5,g,13.65,30.5223,MMO:0000016,body weighing method,,0.0,,,,,control condition,97721,control condition,,,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004100,SHR-Ndufc2em1Mcwi+/+,not specified,70 days,10,,CMO:0000012,body weight,,,,235,g,4.7434,15.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97877,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004100,SHR-Ndufc2em1Mcwi+/+,not specified,98 days,10,,CMO:0000012,body weight,,,,287,g,3.7947,12.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97878,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004100,SHR-Ndufc2em1Mcwi+/+,not specified,126 days,10,,CMO:0000012,body weight,,,,309,g,8.5381,27.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97879,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004098,SHR-Ndufc2em1Mcwi-/+,not specified,126 days,17,,CMO:0000012,body weight,,,,308,g,5.0932,21.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97897,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004098,SHR-Ndufc2em1Mcwi-/+,not specified,98 days,17,,CMO:0000012,body weight,,,,281,g,4.3656,18.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97898,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004098,SHR-Ndufc2em1Mcwi-/+,not specified,70 days,17,,CMO:0000012,body weight,,,,235,g,3.3955,14.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97899,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004101,SHR-Ndufc2em2Mcwi+/+,not specified,70 days,12,,CMO:0000012,body weight,,,,239,g,3.7528,13.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97900,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004101,SHR-Ndufc2em2Mcwi+/+,not specified,98 days,12,,CMO:0000012,body weight,,,,299,g,4.6188,16.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97901,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004101,SHR-Ndufc2em2Mcwi+/+,not specified,126 days,12,,CMO:0000012,body weight,,,,314,g,14.1451,49.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97902,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004099,SHR-Ndufc2em2Mcwi-/+,not specified,70 days,26,,CMO:0000012,body weight,,,,237,g,5.2951,27.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97903,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004099,SHR-Ndufc2em2Mcwi-/+,not specified,98 days,24,,CMO:0000012,body weight,,,,293,g,6.1237,30.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97904,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0004099,SHR-Ndufc2em2Mcwi-/+,not specified,126 days,16,,CMO:0000012,body weight,,,,312,g,9.0,36.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97905,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0003421,SHR/Bbb,not specified,70 days,18,,CMO:0000012,body weight,,,,220,g,3.0641,13.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97906,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0003421,SHR/Bbb,not specified,98 days,18,,CMO:0000012,body weight,,,,260,g,3.7712,16.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97907,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0003421,SHR/Bbb,not specified,126 days,18,,CMO:0000012,body weight,,,,289,g,1.8856,8.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97908,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0001444,SHRSP/Bbb,not specified,70 days,18,,CMO:0000012,body weight,,,,177,g,1.4142,6.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97909,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",body mass,,RS:0001444,SHRSP/Bbb,not specified,91 days,5,,CMO:0000012,body weight,,,,192,g,2.6833,6.0,MMO:0000016,body weighing method,,0.0,,,,,controlled protein content diet (19.7 %) (for 49 days) and controlled potassium content diet (6.3 mg/g) (for 49 days) and controlled sodium content diet (3.7 mg/g) (for 49 days),97910,controlled protein content diet (19.7 %) (for 49 days),controlled potassium content diet (6.3 mg/g) (for 49 days),controlled sodium content diet (3.7 mg/g) (for 49 days),,,,,, 1978,"Kotoh J, et al., J Vet Med Sci. 2016 Aug 11.",body mass,,RS:0000364,F344/NSlc,male,175 days,8,,CMO:0000012,body weight,,,,412.03,g,8.93,25.2579,MMO:0000016,body weighing method,,0.0,,,,,control condition,98031,control condition,,,,,,,, 1978,"Kotoh J, et al., J Vet Med Sci. 2016 Aug 11.",body mass,,RS:0000478,F344.OLETF-(D5Rat166-D5Rat90)/Tj,male,175 days,8,,CMO:0000012,body weight,,,,400.67,g,5.22,14.7644,MMO:0000016,body weighing method,,0.0,,,,,control condition,98032,control condition,,,,,,,, 1978,"Kotoh J, et al., J Vet Med Sci. 2016 Aug 11.",body mass,,RS:0001991,F344.ZUC-Leprfa/Tj,male,175 days,10,,CMO:0000012,body weight,,,,607.3,g,14.1,44.5881,MMO:0000016,body weighing method,,0.0,,,,,control condition,98033,control condition,,,,,,,, 1978,"Kotoh J, et al., J Vet Med Sci. 2016 Aug 11.",body mass,,RS:0004218,"F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj",male,175 days,5,,CMO:0000012,body weight,,,,595.36,g,17.66,39.489,MMO:0000016,body weighing method,,0.0,,,,,control condition,98034,control condition,,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",body mass,,RS:0003184,SS-Renem1Mcwi+/+,male,70 days,5,,CMO:0000012,body weight,,,,301,g,18.06,40.3834,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 49 days),98191,controlled sodium content diet (0.4 %) (for 49 days),,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",body mass,,RS:0003155,SS-Renem1Mcwi-/-,male,70 days,8,,CMO:0000012,body weight,,,,220.5,g,10.7,30.2642,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 49 days),98192,controlled sodium content diet (0.4 %) (for 49 days),,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",body mass,,RS:0004313,SS-Renem1Mcwi+/-,male,70 days,9,,CMO:0000012,body weight,,,,321,g,11.14,33.42,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 49 days),98291,controlled sodium content diet (0.4 %) (for 49 days),,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",body mass,,RS:0003184,SS-Renem1Mcwi+/+,female,70 days,8,,CMO:0000012,body weight,,,,204.5,g,3.31,9.3621,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 49 days),98292,controlled sodium content diet (0.4 %) (for 49 days),,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",body mass,,RS:0004313,SS-Renem1Mcwi+/-,female,70 days,8,,CMO:0000012,body weight,,,,203.13,g,3.02,8.5418,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 49 days),98293,controlled sodium content diet (0.4 %) (for 49 days),,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",body mass,,RS:0003155,SS-Renem1Mcwi-/-,female,70 days,4,,CMO:0000012,body weight,,,,148.75,g,4.94,9.88,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 49 days),98294,controlled sodium content diet (0.4 %) (for 49 days),,,,,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",body mass,,RS:0003090,SS-Plod1em1Mcwi-/-,male,69 days to 60 days,N/A,,CMO:0000012,body weight,,,,298,g,6.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days),98465,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 12 days),,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,69 days to 60 days,N/A,,CMO:0000012,body weight,,,,330,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days),98466,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 12 days),,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",body mass,,RS:0003073,SS-Nppaem4Mcwi-/-,male,69 days to 60 days,N/A,,CMO:0000012,body weight,,,,299,g,5.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days),98467,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 12 days),,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",body mass,,RS:0003267,SS-Clcn6em2Mcwi,male,69 days to 60 days,N/A,,CMO:0000012,body weight,,,,282,g,5.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days),98468,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 12 days),,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",body mass,,RS:0003127,SS-Mthfrem1Mcwi-/+,male,69 days to 60 days,N/A,,CMO:0000012,body weight,,,,333,g,10.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days),98469,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 12 days),,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",body mass,,RS:0003018,SS-Agtrapem4Mcwi-/-,male,69 days to 60 days,N/A,,CMO:0000012,body weight,,,,327,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days),98470,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 12 days),,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",body mass,,RS:0000922,SS/Hsd,male,69 days to 60 days,N/A,,CMO:0000012,body weight,,,,321,g,5.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days),98471,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 12 days),,,,, 2158,"Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26.",body mass,,RS:0000681,SD,male,1 days,43,,CMO:0000012,body weight,,,,4.9,g,0.0595,0.39,MMO:0000016,body weighing method,,1.0,,,,,in utero condition (for 7 days) and dibutyl phthalate (850 mg/kg/d) (for 7 days),98735,in utero condition (for 7 days),dibutyl phthalate (850 mg/kg/d) (for 7 days),,,,,,, 2158,"Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26.",body mass,,RS:0000681,SD,male,1 days,N/A,,CMO:0000012,body weight,,,,6.34,g,,0.34,MMO:0000016,body weighing method,,1.0,,,,,in utero condition (for 7 days) and corn oil (for 7 days),98736,in utero condition (for 7 days),corn oil (for 7 days),,,,,,, 2159,"Ma Z, et al., Eur J Appl Physiol. 2013 Oct;113(10):2473-86. doi: 10.1007/s00421-013-2685-9. Epub 2013 Jun 28.",body mass,,RS:0001013,WI,female,0 days,16,,CMO:0000012,body weight,,,,267.2,g,3.35,13.4,MMO:0000016,body weighing method,,1.0,following 8 wk protocol,swim,1,days,swimming with water weights (for 1 hours),98747,swimming with water weights (for 1 hours),,,,,,,, 2159,"Ma Z, et al., Eur J Appl Physiol. 2013 Oct;113(10):2473-86. doi: 10.1007/s00421-013-2685-9. Epub 2013 Jun 28.",body mass,,RS:0001013,WI,female,0 days,16,,CMO:0000012,body weight,,,,274.8,g,4.475,17.9,MMO:0000016,body weighing method,,1.0,following 8 wk protocol,,,,swimming (for 0.2 hours),98748,swimming (for 0.2 hours),,,,,,,, 2160,"Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,302,g,5.0,12.2474,MMO:0000016,body weighing method,,1.0,,ACF,360,min,artificial aortocaval fistula (for 6 hours),98755,artificial aortocaval fistula (for 6 hours),,,,,,,, 2160,"Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,291,g,10.0,24.4949,MMO:0000016,body weighing method,,1.0,,sham ACF,360,min,sham surgical control condition (for 6 hours),98756,sham surgical control condition (for 6 hours),,,,,,,, 2160,"Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,267,g,4.0,9.798,MMO:0000016,body weighing method,,1.0,,ACF,720,min,artificial aortocaval fistula (for 12 hours),98771,artificial aortocaval fistula (for 12 hours),,,,,,,, 2160,"Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,271,g,6.0,14.6969,MMO:0000016,body weighing method,,1.0,,sham ACF,720,min,sham surgical control condition (for 12 hours),98772,sham surgical control condition (for 12 hours),,,,,,,, 2160,"Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,291,g,6.0,14.6969,MMO:0000016,body weighing method,,1.0,,ACF,2,days,artificial aortocaval fistula (for 2 days),98773,artificial aortocaval fistula (for 2 days),,,,,,,, 2160,"Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,282,g,16.0,39.1918,MMO:0000016,body weighing method,,1.0,,sham ACF,2,days,sham surgical control condition (for 2 days),98774,sham surgical control condition (for 2 days),,,,,,,, 2160,"Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,281,g,4.0,9.798,MMO:0000016,body weighing method,,1.0,,ACF,5,days,artificial aortocaval fistula (for 5 days),98775,artificial aortocaval fistula (for 5 days),,,,,,,, 2160,"Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,284,g,4.0,9.798,MMO:0000016,body weighing method,,1.0,,sham ACF,5,days,sham surgical control condition (between 120 and 12 hours),98776,sham surgical control condition (between 120 and 12 hours),,,,,,,, 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,257,g,4.0,10.583,MMO:0000016,body weighing method,,0.0,,unx,,,left nephrectomy then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) ,98926,left nephrectomy,,,puromycin (100 mg/kg) ,,,anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,9,,CMO:0000012,body weight,,,,258,g,3.0,9.0,MMO:0000016,body weighing method,,0.0,,unx,,,left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) ,98927,left nephrectomy,,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,256,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,unx,,,left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) ,98928,left nephrectomy,,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (0.5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,301,g,5.0,13.2288,MMO:0000016,body weighing method,,0.0,,unx,28,days,left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) ,98929,left nephrectomy (for 28 days),,,puromycin (100 mg/kg) ,,,anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,9,,CMO:0000012,body weight,,,,300,g,5.0,15.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) ,98930,left nephrectomy (for 28 days),,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,296,g,11.0,29.1033,MMO:0000016,body weighing method,,0.0,,unx,28,days,left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) ,98931,left nephrectomy (for 28 days),,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (0.5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,318,g,15.0,39.6863,MMO:0000016,body weighing method,,0.0,,unx,56,days,left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) ,98932,left nephrectomy (for 56 days),,,puromycin (100 mg/kg) ,,,anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,9,,CMO:0000012,body weight,,,,308,g,10.0,30.0,MMO:0000016,body weighing method,,0.0,,unx,56,days,left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) ,98933,left nephrectomy (for 56 days),,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,386,g,7.0,18.5203,MMO:0000016,body weighing method,,0.0,,unx,56,days,left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) ,98934,left nephrectomy (for 56 days),,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (0.5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,267,g,7.0,18.5203,MMO:0000016,body weighing method,,0.0,,unx,70,days,left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) ,98935,left nephrectomy (for 70 days),,,puromycin (100 mg/kg) ,,,anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,9,,CMO:0000012,body weight,,,,281,g,15.0,45.0,MMO:0000016,body weighing method,,0.0,,unx,70,days,left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) ,98936,left nephrectomy (for 70 days),,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,346,g,17.0,44.9778,MMO:0000016,body weighing method,,0.0,,unx,70,days,left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) ,98937,left nephrectomy (for 70 days),,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (0.5 mg/kg) ,,puromycin (40 mg/kg) 2179,"Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,9,,CMO:0000009,mean arterial blood pressure,,,,129,mmHg,4.0,12.0,MMO:0000016,body weighing method,,0.0,,unx,70,days,left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) ,98948,left nephrectomy (for 70 days),,,puromycin (100 mg/kg) ,,,anti-transforming growth factor beta antibody (5 mg/kg) ,,puromycin (80 mg/kg) 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0001486,SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi,male,63 days to 49 days,9,,CMO:0000012,body weight,,,,273.3,g,6.8,20.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,98997,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0001486,SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi,male,70 days to 56 days,9,,CMO:0000012,body weight,,,,288,g,7.6,22.8,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),98998,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0004397,SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi,male,63 days to 49 days,12,,CMO:0000012,body weight,,,,268.3,g,7.5,25.9808,MMO:0000016,body weighing method,,0.0,,,,,control condition,98999,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0004397,SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi,male,70 days to 56 days,12,,CMO:0000012,body weight,,,,288.4,g,7.4,25.6344,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),99000,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0004398,SS.BN-(D13Hmgc64-4582)/Mcwi,male,63 days to 49 days,13,,CMO:0000012,body weight,,,,262.3,g,9.8,35.3344,MMO:0000016,body weighing method,,0.0,,,,,control condition,99001,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0004398,SS.BN-(D13Hmgc64-4582)/Mcwi,male,70 days to 56 days,13,,CMO:0000012,body weight,,,,285.4,g,11.5,41.4638,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),99002,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0004399,SS.BN-(D13Rat25-RN34_13048990782)/Mcwi,male,63 days to 49 days,14,,CMO:0000012,body weight,,,,260.7,g,8.3,31.0558,MMO:0000016,body weighing method,,0.0,,,,,control condition,99003,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0004399,SS.BN-(D13Rat25-RN34_13048990782)/Mcwi,male,70 days to 56 days,14,,CMO:0000012,body weight,,,,281.8,g,6.7,25.0691,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),99004,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0000794,SS-Chr 13BN/Mcwi,male,63 days to 49 days,15,,CMO:0000012,body weight,,,,294.8,g,8.3,32.1458,MMO:0000016,body weighing method,,0.0,,,,,control condition,99005,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0000794,SS-Chr 13BN/Mcwi,male,70 days to 56 days,15,,CMO:0000012,body weight,,,,316.4,g,6.8,26.3363,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),99006,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0001797,BN-Chr 13SS/Mcwi,male,63 days to 49 days,12,,CMO:0000012,body weight,,,,215.3,g,6.9,23.9023,MMO:0000016,body weighing method,,0.0,,,,,control condition,99007,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0001797,BN-Chr 13SS/Mcwi,male,70 days to 56 days,12,,CMO:0000012,body weight,,,,227.3,g,6.9,23.9023,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),99008,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0004399,SS.BN-(D13Rat25-RN34_13048990782)/Mcwi,male,63 days to 49 days,10,,CMO:0000012,body weight,,,,262.6,g,9.2,29.093,MMO:0000016,body weighing method,,0.0,,,,,control condition,99009,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0004399,SS.BN-(D13Rat25-RN34_13048990782)/Mcwi,male,70 days to 56 days,10,,CMO:0000012,body weight,,,,275.8,g,9.6,30.3579,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days),99010,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,controlled losartan content drinking water (50 mg/kg/d) (for 7 days),,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0000811,SS/JrHsdMcwi,male,63 days to 49 days,5,,CMO:0000012,body weight,,,,249.8,g,14.4,32.1994,MMO:0000016,body weighing method,,0.0,,,,,control condition,99011,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0000811,SS/JrHsdMcwi,male,70 days to 56 days,5,,CMO:0000012,body weight,,,,271.8,g,13.4,29.9633,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),99012,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0000811,SS/JrHsdMcwi,male,63 days to 49 days,4,,CMO:0000012,body weight,,,,259.4,g,5.9,11.8,MMO:0000016,body weighing method,,0.0,,,,,control condition,99013,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0000811,SS/JrHsdMcwi,male,70 days to 56 days,4,,CMO:0000012,body weight,,,,270.8,g,7.8,15.6,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days),99014,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,angiotensin II (3 ng/kg/min) (for 7 days),,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0000811,SS/JrHsdMcwi,male,63 days to 49 days,3,,CMO:0000012,body weight,,,,278.8,g,3.0,5.1962,MMO:0000016,body weighing method,,0.0,,,,,control condition,99015,control condition,,,,,,,, 2198,"Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.",body mass,,RS:0000811,SS/JrHsdMcwi,male,70 days to 56 days,3,,CMO:0000012,body weight,,,,282.8,g,2.9,5.0229,MMO:0000016,body weighing method,,0.0,,,,,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days),99016,common peroneal nerve direct electrical stimulation (3 V) (for 8 hours),,,angiotensin II (3 ng/kg/min) (for 7 days),,,controlled losartan content drinking water (50 mg/kg/d) (for 7 days),, 2218,"Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.",body mass,,RS:0000742,WKY,not specified,1 days,26,,CMO:0000012,body weight,,,,6.64,g,0.14,0.7139,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (100 % of calories) (for 22 days),99073,controlled in utero environment (100 % of calories) (for 22 days),,,,,,,, 2218,"Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.",body mass,,RS:0000742,WKY,not specified,1 days,36,,CMO:0000012,body weight,,,,4.91,g,0.15,0.9,MMO:0000016,body weighing method,,0.0,,,,,in utero condition (30 % of calories) (for 22 days),99074,in utero condition (30 % of calories) (for 22 days),,,,,,,, 2218,"Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.",body mass,,RS:0000742,WKY,male,112 days,17,,CMO:0000012,body weight,,,,454,g,8.0,32.9848,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (100 % of calories) (for 22 days),99075,controlled in utero environment (100 % of calories) (for 22 days),,,,,,,, 2218,"Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.",body mass,,RS:0000742,WKY,male,112 days,18,,CMO:0000012,body weight,,,,436,g,11.0,46.669,MMO:0000016,body weighing method,,0.0,,,,,in utero condition (30 % of calories) (for 22 days),99076,in utero condition (30 % of calories) (for 22 days),,,,,,,, 2219,"Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14.",body mass,,RS:0000742,WKY,male,156 days,10,,CMO:0000012,body weight,,,,450.39,g,9.36,29.5989,MMO:0000016,body weighing method,,0.0,,,,days,vehicle control condition (1 null) ,99107,vehicle control condition (1 null) ,,,,,,,, 2219,"Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14.",body mass,,RS:0000742,WKY,male,156 days,10,,CMO:0000012,body weight,,,,259.65,g,18.96,59.9568,MMO:0000016,body weighing method,,0.0,,,,days,streptozotocin (60 mg/kg) ,99108,streptozotocin (60 mg/kg) ,,,,,,,, 2219,"Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14.",body mass,,RS:0000742,WKY,male,156 days,10,,CMO:0000012,body weight,,,,261.43,g,21.34,67.483,MMO:0000016,body weighing method,,0.0,,,,days,streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 null) ,99109,streptozotocin (60 mg/kg) ,,,gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 null) ,,,,, 2219,"Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14.",body mass,,RS:0000742,WKY,male,156 days,10,,CMO:0000012,body weight,,,,295.56,g,21.89,69.2223,MMO:0000016,body weighing method,,0.0,,,,days,streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) ,99110,streptozotocin (60 mg/kg) ,,,gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) ,,,,, 2219,"Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14.",body mass,,RS:0000742,WKY,male,156 days,10,,CMO:0000012,body weight,,,,287.24,g,20.18,63.8148,MMO:0000016,body weighing method,,0.0,,,,days,streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) ,99111,streptozotocin (60 mg/kg) ,,,benazepril (10 mg/kg/d) ,,,,, 2219,"Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14.",body mass,,RS:0000742,WKY,male,156 days,10,,CMO:0000012,body weight,,,,286.6,g,21.95,69.412,MMO:0000016,body weighing method,,0.0,,,,days,streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) ,99112,streptozotocin (60 mg/kg) ,,,benazepril (10 mg/kg/d) ,,,gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) ,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",body mass,,RS:0000284,OLETF,male,364 days,12,,CMO:0000012,body weight,,,,748.6,g,33.0,114.3154,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 84 days),99411,control condition (for 84 days),,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",body mass,,RS:0000284,OLETF,male,364 days,11,,CMO:0000012,body weight,,,,865.6,g,15.3,50.7444,MMO:0000016,body weighing method,,0.0,,,,,olmesartan medoxomil (0.35 mg/kg/d) (for 84 days),99412,olmesartan medoxomil (0.35 mg/kg/d) (for 84 days),,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",body mass,,RS:0000284,OLETF,male,364 days,12,,CMO:0000012,body weight,,,,792.3,g,10.5,36.3731,MMO:0000016,body weighing method,,0.0,,,,,olmesartan medoxomil (3.8 mg/kg/d) (for 84 days),99413,olmesartan medoxomil (3.8 mg/kg/d) (for 84 days),,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",body mass,,RS:0000284,OLETF,male,364 days,11,,CMO:0000012,body weight,,,,766.7,g,13.9,46.1011,MMO:0000016,body weighing method,,0.0,,,,,temocapril (3.9 mg/kg/d) (for 84 days),99414,temocapril (3.9 mg/kg/d) (for 84 days),,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",body mass,,RS:0001349,LETO,male,364 days,11,,CMO:0000012,body weight,,,,546.8,g,6.5,21.5581,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 84 days),99415,control condition (for 84 days),,,,,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",body mass,,RS:0000342,FHH/EurMcwi,male,56 days,6,,CMO:0000012,body weight,,,,207,g,3.1,7.5934,MMO:0000016,body weighing method,,0.0,,,,,control condition,99451,control condition,,,,,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",body mass,,RS:0001132,FHH-Nr4a1m1Mcwi,male,56 days,6,,CMO:0000012,body weight,,,,190,g,2.6,6.3687,MMO:0000016,body weighing method,,0.0,,,,,control condition,99452,control condition,,,,,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",body mass,,RS:0000342,FHH/EurMcwi,male,112 days,6,,CMO:0000012,body weight,,,,352,g,5.8,14.207,MMO:0000016,body weighing method,,0.0,,,,,control condition,99453,control condition,,,,,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",body mass,,RS:0001132,FHH-Nr4a1m1Mcwi,male,112 days,6,,CMO:0000012,body weight,,,,328,g,5.2,12.7373,MMO:0000016,body weighing method,,0.0,,,,,control condition,99454,control condition,,,,,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",body mass,,RS:0000342,FHH/EurMcwi,male,168 days,6,,CMO:0000012,body weight,,,,429,g,9.5,23.2702,MMO:0000016,body weighing method,,0.0,,,,,control condition,99455,control condition,,,,,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",body mass,,RS:0001132,FHH-Nr4a1m1Mcwi,male,168 days,6,,CMO:0000012,body weight,,,,352,g,14.0,34.2929,MMO:0000016,body weighing method,,0.0,,,,,control condition,99456,control condition,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003076,SS-Nppbem2Mcwi+/+,male,28 days,5,,CMO:0000012,body weight,,,,96,g,7.0,15.6525,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 28 days),99543,control condition (for 28 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,28 days,7,,CMO:0000012,body weight,,,,79,g,21.0,55.5608,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 28 days),99544,control condition (for 28 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003076,SS-Nppbem2Mcwi+/+,male,56 days,5,,CMO:0000012,body weight,,,,267,g,5.0,11.1803,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 56 days),99545,control condition (for 56 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,56 days,6,,CMO:0000012,body weight,,,,253,g,30.0,73.4847,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 56 days),99546,control condition (for 56 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003076,SS-Nppbem2Mcwi+/+,male,84 days,6,,CMO:0000012,body weight,,,,398,g,16.0,39.1918,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 84 days),99547,control condition (for 84 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,84 days,10,,CMO:0000012,body weight,,,,378,g,20.0,63.2456,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 84 days),99548,control condition (for 84 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003076,SS-Nppbem2Mcwi+/+,male,168 days,5,,CMO:0000012,body weight,,,,438,g,21.0,46.9574,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 168 days),99549,control condition (for 168 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,168 days,5,,CMO:0000012,body weight,,,,425,g,22.0,49.1935,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 168 days),99550,control condition (for 168 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003076,SS-Nppbem2Mcwi+/+,male,252 days,6,,CMO:0000012,body weight,,,,462,g,19.0,46.5403,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 252 days),99551,control condition (for 252 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,252 days,5,,CMO:0000012,body weight,,,,452,g,21.0,46.9574,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 252 days),99552,control condition (for 252 days),,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,84 days,7,,CMO:0000012,body weight,,,,378,g,20.0,52.915,MMO:0000016,body weighing method,,0.0,,,,,control condition,99756,control condition,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,84 days,6,,CMO:0000012,body weight,,,,347,g,28.0,68.5857,MMO:0000016,body weighing method,,0.0,,,,,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,99757,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,168 days,7,,CMO:0000012,body weight,,,,425,g,22.0,58.2065,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,99758,vehicle control condition,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,168 days,6,,CMO:0000012,body weight,,,,397,g,18.0,44.0908,MMO:0000016,body weighing method,,0.0,,,,,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,99759,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,252 days,7,,CMO:0000012,body weight,,,,452,g,21.0,55.5608,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,99760,vehicle control condition,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",body mass,,RS:0003075,SS-Nppbem2Mcwi-/-,male,252 days,6,,CMO:0000012,body weight,,,,446,g,20.0,48.9898,MMO:0000016,body weighing method,,0.0,,,,,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,99761,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,,,,,,,, 2338,"Ohashi H, et al., Jpn Circ J. 1986 Feb;50(2):140-6.",body mass,,RS:0000759,SHRSP,male,210 days,5,,CMO:0000012,body weight,,,,281,g,10.0623,22.5,MMO:0000016,body weighing method,,0.0,,,,,control condition,99846,control condition,,,,,,,, 2338,"Ohashi H, et al., Jpn Circ J. 1986 Feb;50(2):140-6.",body mass,,RS:0000759,SHRSP,male,245 days,6,,CMO:0000012,body weight,,,,310.5,g,6.0829,14.9,MMO:0000016,body weighing method,,0.0,,,,,controlled captopril content drinking water (100-400 mg/l) ,99847,controlled captopril content drinking water (100-400 mg/l) ,,,,,,,, 2338,"Ohashi H, et al., Jpn Circ J. 1986 Feb;50(2):140-6.",body mass,,RS:0000780,SHRSR/Ta,male,245 days,6,,CMO:0000012,body weight,,,,334.2,g,19.1468,46.9,MMO:0000016,body weighing method,,0.0,,,,,control condition,99848,control condition,,,,,,,, 2338,"Ohashi H, et al., Jpn Circ J. 1986 Feb;50(2):140-6.",body mass,,RS:0000742,WKY,male,245 days,7,,CMO:0000012,body weight,,,,373.6,g,11.1122,29.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,99849,control condition,,,,,,,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0000012,body weight,,,,526,g,10.253,29.0,MMO:0000016,body weighing method,,0.0,,stz,154,days,streptozotocin (60 mg/kg) then insulin,99871,streptozotocin (60 mg/kg) ,,,insulin,,,,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0000012,body weight,,,,563,g,12.3744,35.0,MMO:0000016,body weighing method,,0.0,,stz,154,days,streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days),99891,streptozotocin (60 mg/kg) ,,,insulin,,,Moexipril (30-35 mg/kg/d) (for 112 days),, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0000012,body weight,,,,675,g,12.3744,35.0,MMO:0000016,body weighing method,,0.0,,,,days,control condition,99892,control condition,,,,,,,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0000012,body weight,,,,588,g,27.5772,78.0,MMO:0000016,body weighing method,,0.0,,stz,224,days,streptozotocin (60 mg/kg) then insulin,99914,streptozotocin (60 mg/kg) ,,,insulin,,,,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0000012,body weight,,,,570,g,31.4663,89.0,MMO:0000016,body weighing method,,0.0,,stz,224,days,streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days),99915,streptozotocin (60 mg/kg) ,,,insulin,,,Moexipril (30-35 mg/kg/d) (for 112 days),, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0000012,body weight,,,,738,g,27.9307,79.0,MMO:0000016,body weighing method,,0.0,,,,days,control condition,99916,control condition,,,,,,,, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,7,,CMO:0000012,body weight,,,,268,g,13.0,34.3948,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then vehicle control condition,99935,unilateral nephrectomy (for 28 days),,,vehicle control condition,,,,, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,8,,CMO:0000012,body weight,,,,215,g,10.0,28.2843,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition,99936,unilateral nephrectomy (for 28 days),,,streptozotocin (35 mg/kg) ,,,vehicle control condition,, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,8,,CMO:0000012,body weight,,,,236,g,7.0,19.799,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days),99937,unilateral nephrectomy (for 28 days),,,streptozotocin (35 mg/kg) ,,,bosentan (100 mg/kg/d) (for 14 days),, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,8,,CMO:0000012,body weight,,,,233,g,5.0,14.1421,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days),99938,unilateral nephrectomy (for 28 days),,,streptozotocin (35 mg/kg) ,,,enalapril (10 mg/kg/d) (for 14 days),, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,6,,CMO:0000012,body weight,,,,229,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days),99939,unilateral nephrectomy (for 28 days),,,streptozotocin (35 mg/kg) ,,,enalapril (10 mg/kg/d) (for 14 days),bosentan (100 mg/kg/d) (for 14 days), 2398,"Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74.",body mass,,RS:0001834,Crl:WI(WU),male,91 days,14,,CMO:0000012,body weight,,,,334,g,8.0,29.9333,MMO:0000016,body weighing method,,0.0,,sham surgery,35,days,sham surgical control condition,100005,sham surgical control condition,,,,,,,, 2398,"Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74.",body mass,,RS:0001834,Crl:WI(WU),male,91 days,14,,CMO:0000012,body weight,,,,311,g,9.0,33.6749,MMO:0000016,body weighing method,,0.0,,aorta coarctation,35,days,abdominal aorta coarctation,100006,abdominal aorta coarctation,,,,,,,, 2398,"Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74.",body mass,,RS:0001834,Crl:WI(WU),male,91 days,8,,CMO:0000012,body weight,,,,282,g,11.0,31.1127,MMO:0000016,body weighing method,,0.0,,aorta coarctation,35,days,thoracic aorta coarctation,100007,thoracic aorta coarctation,,,,,,,, 2398,"Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74.",body mass,,RS:0001834,Crl:WI(WU),male,91 days,11,,CMO:0000012,body weight,,,,284,g,7.0,23.2164,MMO:0000016,body weighing method,,0.0,,aorta coarctation,35,days,abdominal aorta coarctation then quinapril (2 mg/kg/d) (for 14 days),100008,abdominal aorta coarctation,,,quinapril (2 mg/kg/d) (for 14 days),,,,, 2398,"Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74.",body mass,,RS:0001834,Crl:WI(WU),male,91 days,11,,CMO:0000012,body weight,,,,276,g,6.0,19.8997,MMO:0000016,body weighing method,,0.0,,aorta coarctation,35,days,abdominal aorta coarctation then quinapril (2 mg/kg/d) (for 14 days) and icatibant (0.4 mg/kg/d) (for 14 days),100009,abdominal aorta coarctation,,,quinapril (2 mg/kg/d) (for 14 days),icatibant (0.4 mg/kg/d) (for 14 days),,,, 2398,"Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74.",body mass,,RS:0001834,Crl:WI(WU),male,91 days,14,,CMO:0000012,body weight,,,,274,g,6.0,22.4499,MMO:0000016,body weighing method,,0.0,,aorta coarctation,35,days,abdominal aorta coarctation then losartan (3 mg/kg/d) (for 14 days),100010,abdominal aorta coarctation,,,losartan (3 mg/kg/d) (for 14 days),,,,, 2398,"Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74.",body mass,,RS:0001834,Crl:WI(WU),male,91 days,10,,CMO:0000012,body weight,,,,322,g,7.0,22.1359,MMO:0000016,body weighing method,,0.0,,aorta coarctation,35,days,abdominal aorta coarctation then losartan (3 mg/kg/d) (for 14 days) and icatibant (0.4 mg/kg/d) (for 14 days),100011,abdominal aorta coarctation,,,losartan (3 mg/kg/d) (for 14 days),icatibant (0.4 mg/kg/d) (for 14 days),,,, 2398,"Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74.",body mass,,RS:0001834,Crl:WI(WU),male,91 days,11,,CMO:0000012,body weight,,,,317,g,7.0,23.2164,MMO:0000016,body weighing method,,0.0,,aorta coarctation,35,days,abdominal aorta coarctation then icatibant (0.4 mg/kg/d) (for 14 days),100012,abdominal aorta coarctation,,,icatibant (0.4 mg/kg/d) (for 14 days),,,,, 2418,"McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27.",body mass,,RS:0000811,SS/JrHsdMcwi,male,42 days,27,,CMO:0000012,body weight,,,,176,g,6.0,31.1769,MMO:0000016,body weighing method,,0.0,,,,,control condition,100067,control condition,,,,,,,, 2418,"McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27.",body mass,,RS:0003288,SS-Leprem2Mcwi,male,42 days,19,,CMO:0000012,body weight,,,,238,g,8.0,34.8712,MMO:0000016,body weighing method,,0.0,,,,,control condition,100068,control condition,,,,,,,, 2418,"McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27.",body mass,,RS:0000811,SS/JrHsdMcwi,male,126 days,27,,CMO:0000012,body weight,,,,373,g,4.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,control condition,100069,control condition,,,,,,,, 2418,"McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27.",body mass,,RS:0003288,SS-Leprem2Mcwi,male,126 days,19,,CMO:0000012,body weight,,,,528,g,15.0,65.3835,MMO:0000016,body weighing method,,0.0,,,,,control condition,100070,control condition,,,,,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,56 days to 42 days,12,,CMO:0000012,body weight,,,,223,g,1.4,4.8497,MMO:0000016,body weighing method,,0.0,,lad occlusion,0,days,sham surgical control condition,100267,sham surgical control condition,,,,,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,56 days to 42 days,20,,CMO:0000012,body weight,,,,225,g,3.0,13.4164,MMO:0000016,body weighing method,,0.0,,lad occlusion,0,days,left anterior descending coronary artery occlusion then furosemide,100268,left anterior descending coronary artery occlusion,,,furosemide,,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,56 days to 42 days,30,,CMO:0000012,body weight,,,,225,g,1.8,9.859,MMO:0000016,body weighing method,,0.0,,lad occlusion,0,days,left anterior descending coronary artery occlusion then vehicle control condition,100269,left anterior descending coronary artery occlusion,,,vehicle control condition,,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,252 days to 238 days,12,,CMO:0000012,body weight,,,,566,g,17.0,58.8897,MMO:0000016,body weighing method,,0.0,,lad occlusion sham,196,days,sham surgical control condition (for 196 days),100270,sham surgical control condition (for 196 days),,,,,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,252 days to 238 days,20,,CMO:0000012,body weight,,,,583,g,56.0,250.4396,MMO:0000016,body weighing method,,0.0,,lad occlusion,196,days,left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days),100271,left anterior descending coronary artery occlusion (for 196 days),,,furosemide (10 ml/kg/d) (for 182 days),,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,252 days to 238 days,30,,CMO:0000012,body weight,,,,617,g,52.0,284.8157,MMO:0000016,body weighing method,,0.0,,lad occlusion,196,days,left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days),100272,left anterior descending coronary artery occlusion (for 196 days),,,vehicle control condition (for 182 days),,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,280 days to 266 days,5,,CMO:0000012,body weight,,,,562,g,22.0,49.1935,MMO:0000016,body weighing method,,0.0,,lad occlusion sham,210,days,sham surgical control condition (for 224 days),100273,sham surgical control condition (for 224 days),,,,,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,280 days to 266 days,16,,CMO:0000012,body weight,,,,599,g,35.0,140.0,MMO:0000016,body weighing method,,0.0,,lad occlusion,210,days,left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days),100274,left anterior descending coronary artery occlusion (for 224 days),,,furosemide (10 mg/kg/d) (for 161 days),,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",body mass,,RS:0000742,WKY,male,280 days to 266 days,32,,CMO:0000012,body weight,,,,574,g,38.0,214.9605,MMO:0000016,body weighing method,,0.0,,lad occlusion,210,days,left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days),100275,left anterior descending coronary artery occlusion (for 224 days),,,furosemide (10 mg/kg/d) (for 161 days),,,ramipril (1 mg/kg/d) (for 182 days),, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,10,,CMO:0000012,body weight,,,,241,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100391,0.9% sodium chloride solution (3 ml) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,11,,CMO:0000012,body weight,,,,249,g,11.0,36.4829,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,15,days,puromycin aminonucleoside (50 mg/kg) ,100392,puromycin aminonucleoside (50 mg/kg) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,10,,CMO:0000012,body weight,,,,241,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,15,days,controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) ,100393,controlled enalapril content drinking water (50 mg/l) (for 22 days),,,puromycin aminonucleoside (50 mg/kg) ,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,11,,CMO:0000012,body weight,,,,319,g,5.0,16.5831,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100394,0.9% sodium chloride solution (3 ml) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,12,,CMO:0000012,body weight,,,,323,g,5.0,17.3205,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,,,puromycin aminonucleoside (50 mg/kg) ,100395,puromycin aminonucleoside (50 mg/kg) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,12,,CMO:0000012,body weight,,,,312,g,4.0,13.8564,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,,,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) ,100396,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days),,,puromycin aminonucleoside (50 mg/kg) ,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,9,,CMO:0000012,body weight,,,,244,g,8.0,24.0,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100427,0.9% sodium chloride solution (3 ml) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,7,,CMO:0000012,body weight,,,,245,g,9.0,23.8118,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,15,days,puromycin aminonucleoside (50 mg/kg) ,100428,puromycin aminonucleoside (50 mg/kg) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,5,,CMO:0000012,body weight,,,,245,g,12.0,26.8328,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,15,days,controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) ,100429,controlled enalapril content drinking water (50 mg/l) (for 22 days),,,puromycin aminonucleoside (50 mg/kg) ,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,8,,CMO:0000012,body weight,,,,317,g,10.0,28.2843,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100430,0.9% sodium chloride solution (3 ml) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,9,,CMO:0000012,body weight,,,,297,g,4.0,12.0,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,,,puromycin aminonucleoside (50 mg/kg) ,100431,puromycin aminonucleoside (50 mg/kg) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,8,,CMO:0000012,body weight,,,,305,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,,,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) ,100432,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days),,,puromycin aminonucleoside (50 mg/kg) ,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,9,,CMO:0000012,body weight,,,,412,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100433,0.9% sodium chloride solution (3 ml) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,8,,CMO:0000012,body weight,,,,418,g,15.0,42.4264,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,490,days,puromycin aminonucleoside (50 mg/kg) ,100434,puromycin aminonucleoside (50 mg/kg) ,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",body mass,,RS:0000742,WKY,male,0 days,9,,CMO:0000012,body weight,,,,395,g,7.0,21.0,MMO:0000016,body weighing method,,0.0,,PA IV 50mg/kg,490,days,controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) ,100435,controlled enalapril content drinking water (50 mg/l) (for 497 days),,,puromycin aminonucleoside (50 mg/kg) ,,,,, 2499,"Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28.",body mass,,RS:0000681,SD,female,0 days,8,,CMO:0000012,body weight,,,,305.4,g,5.3,14.9907,MMO:0000016,body weighing method,,0.0,,-,0,days,control condition,100631,control condition,,,,,,,, 2499,"Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28.",body mass,,RS:0000681,SD,female,0 days,13,,CMO:0000012,body weight,,,,283.6,g,3.8,13.7011,MMO:0000016,body weighing method,,0.0,,unx,97,days,controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days),100632,controlled calcium content diet (0.6 %) (for 97 days),controlled content diet (0.9 %) (for 97 days),unilateral nephrectomy (for 97 days),vehicle control condition (100 ul) (for 90 days),,,,, 2499,"Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28.",body mass,,RS:0000681,SD,female,0 days,12,,CMO:0000012,body weight,,,,281.9,g,4.2,14.5492,MMO:0000016,body weighing method,,0.0,,unx,97,days,controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days),100633,controlled calcium content diet (0.6 %) (for 97 days),controlled content diet (0.9 %) (for 97 days),unilateral nephrectomy (for 97 days),enalapril (25 mg/l) (for 90 days),,,,, 2499,"Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28.",body mass,,RS:0000681,SD,female,0 days,10,,CMO:0000012,body weight,,,,291.9,g,6.4,20.2386,MMO:0000016,body weighing method,,0.0,,unx,97,days,controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days),100634,controlled calcium content diet (0.6 %) (for 97 days),controlled content diet (0.9 %) (for 97 days),unilateral nephrectomy (for 97 days),paricalcitol (0.8 mg/kg) (for 90 days),,,,, 2499,"Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28.",body mass,,RS:0000681,SD,female,0 days,12,,CMO:0000012,body weight,,,,290.6,g,6.8,23.5559,MMO:0000016,body weighing method,,0.0,,unx,97,days,controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days),100635,controlled calcium content diet (0.6 %) (for 97 days),controlled content diet (0.9 %) (for 97 days),unilateral nephrectomy (for 97 days),paricalcitol (0.8 mg/kg) (for 90 days),enalapril (25 mg/l) (for 90 days),,,, 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",body mass,,RS:0003328,SS/NEisSlc,male,91 days,12,,CMO:0000012,body weight,,,,347.6,g,6.85,23.7291,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (8 %) (for 42 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days),100696,controlled sodium content diet (8 %) (for 42 days),,,0.9% sodium chloride solution (0.3 ml) (for 42 days),,,,, 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",body mass,,RS:0003328,SS/NEisSlc,male,91 days,6,,CMO:0000012,body weight,,,,374.7,g,7.32,17.9303,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 91 days),100697,controlled sodium content diet (0.3 %) (for 91 days),,,,,,,, 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",body mass,,RS:0003329,SR/NEisSlc,male,91 days,6,,CMO:0000012,body weight,,,,405,g,17.8,43.6009,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 91 days),100698,controlled sodium content diet (0.3 %) (for 91 days),,,,,,,, 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",body mass,,RS:0003328,SS/NEisSlc,male,91 days,6,,CMO:0000012,body weight,,,,319.3,g,7.49,18.3467,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (8 %) (for 42 days) then cilazapril (10 mg/kg/d) (for 42 days),100699,controlled sodium content diet (8 %) (for 42 days),,,cilazapril (10 mg/kg/d) (for 42 days),,,,, 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",body mass,,RS:0003328,SS/NEisSlc,male,91 days,6,,CMO:0000012,body weight,,,,343.8,g,10.05,24.6174,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (8 %) (for 42 days) then candesartan (1 mg/kg/d) (for 42 days),100700,controlled sodium content diet (8 %) (for 42 days),,,candesartan (1 mg/kg/d) (for 42 days),,,,, 2520,"Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4.",body mass,,RS:0004500,SD-Nfe2l2em1Mcwi+/+,male,12 days to 10 days,4,,CMO:0000012,body weight,,,,290,g,11.1,22.2,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 70 and 84 days),100731,controlled sodium content diet (0.4 %) (between 70 and 84 days),,,,,,,, 2520,"Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4.",body mass,,RS:0004501,SD-Nfe2l2em1Mcwi-/-,male,12 days to 10 days,4,,CMO:0000012,body weight,,,,287,g,26.7,53.4,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 70 and 84 days),100732,controlled sodium content diet (0.4 %) (between 70 and 84 days),,,,,,,, 2520,"Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4.",body mass,,RS:0004500,SD-Nfe2l2em1Mcwi+/+,male,11 days to 9 days,8,,CMO:0000012,body weight,,,,281,g,17.7,50.0632,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days),100733,controlled sodium content diet (0.4 %) (between 70 and 84 days),,,controlled sodium content diet (4 %) (for 6 days),,,vehicle control condition (for 3 days),, 2520,"Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4.",body mass,,RS:0004501,SD-Nfe2l2em1Mcwi-/-,male,11 days to 9 days,4,,CMO:0000012,body weight,,,,299,g,22.2,44.4,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days),100734,controlled sodium content diet (0.4 %) (between 70 and 84 days),,,controlled sodium content diet (4 %) (for 6 days),,,vehicle control condition (for 3 days),, 2520,"Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4.",body mass,,RS:0004500,SD-Nfe2l2em1Mcwi+/+,male,11 days to 9 days,6,,CMO:0000012,body weight,,,,291,g,11.6,28.4141,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days),100735,controlled sodium content diet (0.4 %) (between 70 and 84 days),,,controlled sodium content diet (4 %) (for 6 days),,,angiotensin II (100 ng/kg/min) (for 3 days),, 2520,"Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4.",body mass,,RS:0004501,SD-Nfe2l2em1Mcwi-/-,male,11 days to 9 days,6,,CMO:0000012,body weight,,,,307,g,11.5,28.1691,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days),100736,controlled sodium content diet (0.4 %) (between 70 and 84 days),,,controlled sodium content diet (4 %) (for 6 days),,,angiotensin II (100 ng/kg/min) (for 3 days),, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,6,,CMO:0000012,body weight,,,,258.7,g,11.0,26.9444,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days),100799,right nephrectomy (for 56 days),,,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,276.6,g,7.4,23.4009,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) ,100800,right nephrectomy (for 56 days),,,reserpine (5 mg/l) ,hydralazine (80 mg/l) ,controlled hydralazine content drinking water (25 mg/l) ,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,287.2,g,5.4,17.0763,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then captopril (30 mg/kg/d) ,100801,right nephrectomy (for 56 days),,,captopril (30 mg/kg/d) ,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,9,,CMO:0000012,body weight,,,,280.5,g,1.1,3.3,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then enalapril (20 mg/kg/d) ,100802,right nephrectomy (for 56 days),,,enalapril (20 mg/kg/d) ,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,282.7,g,5.1,16.1276,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then lisinopril (10 mg/kg/d) ,100803,right nephrectomy (for 56 days),,,lisinopril (10 mg/kg/d) ,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,7,,CMO:0000012,body weight,,,,254.9,g,14.1,37.3051,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then angiotensin II receptor antagonist (20 mg/l) ,100804,right nephrectomy (for 56 days),,,angiotensin II receptor antagonist (20 mg/l) ,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,5,,CMO:0000012,body weight,,,,257,g,6.1,13.64,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then angiotensin II receptor antagonist (80 mg/l) ,100805,right nephrectomy (for 56 days),,,angiotensin II receptor antagonist (80 mg/l) ,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,6,,CMO:0000012,body weight,,,,294,g,8.2,20.0858,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days),100806,right nephrectomy (for 84 days),,,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,276.6,g,7.4,23.4009,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then reserpine (5 mg/l) (for 28 days) and hydralazine (80 mg/l) (for 28 days) and controlled hydralazine content drinking water (25 mg/l) (for 28 days),100807,right nephrectomy (for 84 days),,,reserpine (5 mg/l) (for 28 days),hydralazine (80 mg/l) (for 28 days),controlled hydralazine content drinking water (25 mg/l) (for 28 days),,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,290.8,g,8.0,25.2982,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then captopril (30 mg/kg/d) (for 28 days),100822,right nephrectomy (for 84 days),,,captopril (30 mg/kg/d) (for 28 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,9,,CMO:0000012,body weight,,,,299.6,g,11.7,35.1,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then enalapril (20 mg/kg/d) (for 28 days),100823,right nephrectomy (for 84 days),,,enalapril (20 mg/kg/d) (for 28 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,293.5,g,5.4,17.0763,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then lisinopril (10 mg/kg/d) (for 28 days),100824,right nephrectomy (for 84 days),,,lisinopril (10 mg/kg/d) (for 28 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,7,,CMO:0000012,body weight,,,,284.7,g,7.2,19.0494,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then angiotensin II receptor antagonist (20 mg/l) (for 28 days),100825,right nephrectomy (for 84 days),,,angiotensin II receptor antagonist (20 mg/l) (for 28 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,5,,CMO:0000012,body weight,,,,276.4,g,4.9,10.9567,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then angiotensin II receptor antagonist (80 mg/l) (for 28 days),100826,right nephrectomy (for 84 days),,,angiotensin II receptor antagonist (80 mg/l) (for 28 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,6,,CMO:0000012,body weight,,,,283.2,g,19.9,48.7448,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days),100827,right nephrectomy (for 112 days),,,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,244.3,g,17.2,54.3912,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days),100828,right nephrectomy (for 112 days),,,reserpine (5 mg/l) (for 56 days),hydralazine (80 mg/l) (for 56 days),controlled hydralazine content drinking water (25 mg/l) (for 56 days),,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,320.6,g,15.0,47.4342,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days),100829,right nephrectomy (for 112 days),,,captopril (30 mg/kg/d) (for 56 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,9,,CMO:0000012,body weight,,,,313.8,g,15.0,45.0,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days),100830,right nephrectomy (for 112 days),,,enalapril (20 mg/kg/d) (for 56 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,10,,CMO:0000012,body weight,,,,293,g,14.2,44.9043,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days),100831,right nephrectomy (for 112 days),,,lisinopril (10 mg/kg/d) (for 56 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,7,,CMO:0000012,body weight,,,,289,g,13.6,35.9822,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days),100832,right nephrectomy (for 112 days),,,angiotensin II receptor antagonist (20 mg/l) (for 56 days),,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",body mass,,RS:0000592,MW,male,0 days,5,,CMO:0000012,body weight,,,,271,g,14.1,31.5286,MMO:0000016,body weighing method,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days),100833,right nephrectomy (for 112 days),,,angiotensin II receptor antagonist (80 mg/l) (for 56 days),,,,, 2541,"Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9.",body mass,,RS:0003240,MWF/ZtmRrrc,male,126 days,8,,CMO:0000012,body weight,,,,378,g,10.6066,30.0,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,100901,vehicle control condition,,,,,,,, 2541,"Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9.",body mass,,RS:0003240,MWF/ZtmRrrc,male,126 days,10,,CMO:0000012,body weight,,,,376,g,5.6921,18.0,MMO:0000016,body weighing method,,0.0,,,,,enalapril (50 mg/l) (for 60 days),100902,enalapril (50 mg/l) (for 60 days),,,,,,,, 2541,"Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9.",body mass,,RS:0003240,MWF/ZtmRrrc,male,126 days,7,,CMO:0000012,body weight,,,,385,g,11.3389,30.0,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,100903,vehicle control condition,,,,,,,, 2541,"Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9.",body mass,,RS:0003240,MWF/ZtmRrrc,male,126 days,8,,CMO:0000012,body weight,,,,373,g,4.5962,13.0,MMO:0000016,body weighing method,,0.0,,,,,enalapril (50 mg/l) (for 60 days),100904,enalapril (50 mg/l) (for 60 days),,,,,,,, 2541,"Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9.",body mass,,RS:0003240,MWF/ZtmRrrc,male,246 days,8,,CMO:0000012,body weight,,,,433,g,9.1924,26.0,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,100905,vehicle control condition,,,,,,,, 2541,"Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9.",body mass,,RS:0003240,MWF/ZtmRrrc,male,246 days,6,,CMO:0000012,body weight,,,,442,g,7.3485,18.0,MMO:0000016,body weighing method,,0.0,,,,,enalapril (50 mg/l) (for 182 days),100906,enalapril (50 mg/l) (for 182 days),,,,,,,, 2561,"Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000.",body mass,,RS:0000592,MW,male,0 days,8,,CMO:0000012,body weight,,,,250,g,3.0,8.4853,MMO:0000016,body weighing method,,0.0,,5/6 nephrectomy,28,days,nephrectomy (for 28 days) then control condition,100983,nephrectomy (for 28 days),,,control condition,,,,, 2561,"Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000.",body mass,,RS:0000592,MW,male,0 days,8,,CMO:0000012,body weight,,,,248,g,4.0,11.3137,MMO:0000016,body weighing method,,0.0,,5/6 nephrectomy,28,days,nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days),100984,nephrectomy (for 28 days),,,enalapril (50 mg/l) (for 21 days),,,,, 2561,"Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000.",body mass,,RS:0000592,MW,male,0 days,8,,CMO:0000012,body weight,,,,233,g,4.0,11.3137,MMO:0000016,body weighing method,,0.0,,5/6 nephrectomy,28,days,nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days),100985,nephrectomy (for 28 days),,,reserpine (5 mg/l) (for 21 days),hydralazine (80 mg/l) (for 21 days),controlled hydralazine content drinking water (25 mg/l) (for 21 days),,, 2563,"Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10.",body mass,,RS:0001013,WI,male,1 days,21,,CMO:0000012,body weight,,,,8.4,g,0.8,3.6661,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days),101051,controlled in utero environment (for 21 days),standard diet (100 % of calories) (for 21 days),,,,,,, 2563,"Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10.",body mass,,RS:0001013,WI,male,1 days,35,,CMO:0000012,body weight,,,,4.7,g,0.07,0.4141,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days),101052,controlled in utero environment (for 21 days),standard diet (50 % of calories) (for 21 days),,,,,,, 2563,"Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10.",body mass,,RS:0001013,WI,male,68 days,21,,CMO:0000012,body weight,,,,284.6,g,11.24,51.5082,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days),101053,controlled in utero environment (for 21 days),standard diet (100 % of calories) (for 21 days),,,,,,, 2563,"Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10.",body mass,,RS:0001013,WI,male,68 days,35,,CMO:0000012,body weight,,,,303.6,g,6.5,38.4545,MMO:0000016,body weighing method,,0.0,,,,,controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days),101054,controlled in utero environment (for 21 days),standard diet (50 % of calories) (for 21 days),,,,,,, 2564,"Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7.",body mass,,RS:0000681,SD,male,77 days,6,,CMO:0000012,body weight,,,,403.2,g,7.4,18.1262,MMO:0000016,body weighing method,,0.0,,lad occlusion,28,days,left anterior descending coronary artery occlusion (for 28 days),101075,left anterior descending coronary artery occlusion (for 28 days),,,,,,,, 2564,"Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7.",body mass,,RS:0000681,SD,male,77 days,6,,CMO:0000012,body weight,,,,378.1,g,12.1,29.6388,MMO:0000016,body weighing method,,0.0,,sham lad occlusion,28,days,sham surgical control condition (for 28 days),101076,sham surgical control condition (for 28 days),,,,,,,, 2564,"Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7.",body mass,,RS:0000681,SD,male,189 days,10,,CMO:0000012,body weight,,,,568.3,g,34.1,107.8337,MMO:0000016,body weighing method,,0.0,,lad occlusion,140,days,left anterior descending coronary artery occlusion (for 140 days),101077,left anterior descending coronary artery occlusion (for 140 days),,,,,,,, 2564,"Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7.",body mass,,RS:0000681,SD,male,189 days,6,,CMO:0000012,body weight,,,,532.2,g,20.4,49.9696,MMO:0000016,body weighing method,,0.0,,sham lad occlusion,140,days,sham surgical control condition (for 140 days),101078,sham surgical control condition (for 140 days),,,,,,,, 2582,"Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80.",body mass,,RS:0000681,SD,male,90 days,9,,CMO:0000012,body weight,,,,396,g,7.6,22.8,MMO:0000016,body weighing method,,0.0,,,,,control condition,101214,control condition,,,,,,,, 2582,"Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80.",body mass,,RS:0000681,SD,male,450 days to 420 days,9,,CMO:0000012,body weight,,,,572,g,14.4,43.2,MMO:0000016,body weighing method,,0.0,,,,,control condition,101215,control condition,,,,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000012,body weight,,,,197,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,acf,4,days,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days),101294,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days),,,artificial aortocaval fistula (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000012,body weight,,,,193,g,3.0,6.7082,MMO:0000016,body weighing method,,0.0,,sham acf,4,days,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days),101301,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days),,,sham surgical control condition (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000012,body weight,,,,186,g,2.0,5.2915,MMO:0000016,body weighing method,,0.0,,acf,4,days,vehicle control condition then artificial aortocaval fistula (for 4 days),101302,vehicle control condition,,,artificial aortocaval fistula (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000012,body weight,,,,188,g,1.0,2.2361,MMO:0000016,body weighing method,,0.0,,,4,days,vehicle control condition then sham surgical control condition (for 4 days),101303,vehicle control condition,,,sham surgical control condition (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000012,body weight,,,,181,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,acf,7,days,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days),101304,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days),,,artificial aortocaval fistula (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000012,body weight,,,,186,g,1.0,2.2361,MMO:0000016,body weighing method,,0.0,,sham acf,7,days,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days),101305,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days),,,sham surgical control condition (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000012,body weight,,,,184,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,acf,7,days,vehicle control condition then artificial aortocaval fistula (for 7 days),101306,vehicle control condition,,,artificial aortocaval fistula (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000012,body weight,,,,180,g,2.0,4.4721,MMO:0000016,body weighing method,,0.0,,,7,days,vehicle control condition then sham surgical control condition (for 7 days),101307,vehicle control condition,,,sham surgical control condition (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000012,body weight,,,,176,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,acf,9,days,controlled ramipril content drinking water (3 mg/kg/d) (for 10 days) then artificial aortocaval fistula (for 9 days),101308,controlled ramipril content drinking water (3 mg/kg/d) (for 10 days),,,artificial aortocaval fistula (for 9 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000012,body weight,,,,180,g,2.0,5.2915,MMO:0000016,body weighing method,,0.0,,acf,9,days,vehicle control condition then artificial aortocaval fistula (for 9 days),101309,vehicle control condition,,,artificial aortocaval fistula (for 9 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,8,,CMO:0000012,body weight,,,,189,g,2.0,5.6569,MMO:0000016,body weighing method,,0.0,,acf,2,days,controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days),101310,controlled losartan content drinking water (10 mg/kg/d) (for 3 days),,,artificial aortocaval fistula (for 2 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000012,body weight,,,,190,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,sham acf,2,days,controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days),101311,controlled losartan content drinking water (10 mg/kg/d) (for 3 days),,,sham surgical control condition (for 2 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,8,,CMO:0000012,body weight,,,,202,g,3.0,8.4853,MMO:0000016,body weighing method,,0.0,,acf,2,days,vehicle control condition then artificial aortocaval fistula (for 2 days),101312,vehicle control condition,,,artificial aortocaval fistula (for 2 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000012,body weight,,,,200,g,2.0,4.899,MMO:0000016,body weighing method,,0.0,,,2,days,vehicle control condition then sham surgical control condition (for 2 days),101313,vehicle control condition,,,sham surgical control condition (for 2 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,8,,CMO:0000012,body weight,,,,187,g,1.0,2.8284,MMO:0000016,body weighing method,,0.0,,acf,4,days,controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days),101314,controlled losartan content drinking water (10 mg/kg/d) (for 5 days),,,artificial aortocaval fistula (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000012,body weight,,,,184,g,2.0,4.899,MMO:0000016,body weighing method,,0.0,,sham acf,4,days,controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days),101315,controlled losartan content drinking water (10 mg/kg/d) (for 5 days),,,sham surgical control condition (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,8,,CMO:0000012,body weight,,,,194,g,3.0,8.4853,MMO:0000016,body weighing method,,0.0,,acf,4,days,vehicle control condition then artificial aortocaval fistula (for 4 days),101316,vehicle control condition,,,artificial aortocaval fistula (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000012,body weight,,,,192,g,3.0,6.7082,MMO:0000016,body weighing method,,0.0,,,4,days,vehicle control condition then sham surgical control condition (for 4 days),101317,vehicle control condition,,,sham surgical control condition (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000012,body weight,,,,203,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,acf,7,days,controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days),101318,controlled losartan content drinking water (10 mg/kg/d) (for 8 days),,,artificial aortocaval fistula (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000012,body weight,,,,204,g,2.0,4.899,MMO:0000016,body weighing method,,0.0,,sham acf,7,days,controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days),101319,controlled losartan content drinking water (10 mg/kg/d) (for 8 days),,,sham surgical control condition (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,8,,CMO:0000012,body weight,,,,193,g,2.0,5.6569,MMO:0000016,body weighing method,,0.0,,acf,7,days,vehicle control condition then artificial aortocaval fistula (for 7 days),101320,vehicle control condition,,,artificial aortocaval fistula (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000012,body weight,,,,201,g,3.0,7.3485,MMO:0000016,body weighing method,,0.0,,,7,days,vehicle control condition then sham surgical control condition (for 7 days),101321,vehicle control condition,,,sham surgical control condition (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000420,body weight gain,,change from surgery weight,,-4,g,2.0,5.2915,MMO:0000016,body weighing method,,0.0,,acf,4,days,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days),101322,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days),,,artificial aortocaval fistula (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000420,body weight gain,,change from surgery weight,,20,g,2.0,4.4721,MMO:0000016,body weighing method,,0.0,,sham acf,4,days,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days),101323,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days),,,sham surgical control condition (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000420,body weight gain,,change from surgery weight,,-10,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,acf,4,days,vehicle control condition then artificial aortocaval fistula (for 4 days),101324,vehicle control condition,,,artificial aortocaval fistula (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000420,body weight gain,,change from surgery weight,,18,g,1.0,2.2361,MMO:0000016,body weighing method,,0.0,,,4,days,vehicle control condition then sham surgical control condition (for 4 days),101325,vehicle control condition,,,sham surgical control condition (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000420,body weight gain,,change from surgery weight,,4,g,1.0,2.6458,MMO:0000016,body weighing method,,0.0,,acf,7,days,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days),101326,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days),,,artificial aortocaval fistula (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000420,body weight gain,,change from surgery weight,,30,g,2.0,4.4721,MMO:0000016,body weighing method,,0.0,,sham acf,7,days,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days),101327,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days),,,sham surgical control condition (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000420,body weight gain,,change from surgery weight,,12,g,3.0,6.7082,MMO:0000016,body weighing method,,0.0,,acf,7,days,vehicle control condition then artificial aortocaval fistula (for 7 days),101328,vehicle control condition,,,artificial aortocaval fistula (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000420,body weight gain,,change from surgery weight,,34,g,2.0,4.4721,MMO:0000016,body weighing method,,0.0,,,7,days,vehicle control condition then sham surgical control condition (for 7 days),101329,vehicle control condition,,,sham surgical control condition (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000420,body weight gain,,change from surgery weight,,21,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,acf,9,days,controlled ramipril content drinking water (3 mg/kg/d) (for 10 days) then artificial aortocaval fistula (for 9 days),101330,controlled ramipril content drinking water (3 mg/kg/d) (for 10 days),,,artificial aortocaval fistula (for 9 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000420,body weight gain,,change from surgery weight,,29,g,3.0,7.9373,MMO:0000016,body weighing method,,0.0,,acf,9,days,vehicle control condition then artificial aortocaval fistula (for 9 days),101331,vehicle control condition,,,artificial aortocaval fistula (for 9 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,8,,CMO:0000420,body weight gain,,change from surgery weight,,-12,g,2.0,5.6569,MMO:0000016,body weighing method,,0.0,,acf,2,days,controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days),101332,controlled losartan content drinking water (10 mg/kg/d) (for 3 days),,,artificial aortocaval fistula (for 2 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000420,body weight gain,,change from surgery weight,,-5,g,2.0,4.899,MMO:0000016,body weighing method,,0.0,,sham acf,2,days,controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days),101333,controlled losartan content drinking water (10 mg/kg/d) (for 3 days),,,sham surgical control condition (for 2 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000420,body weight gain,,change from surgery weight,,-14,g,2.0,5.2915,MMO:0000016,body weighing method,,0.0,,acf,2,days,vehicle control condition then artificial aortocaval fistula (for 2 days),101334,vehicle control condition,,,artificial aortocaval fistula (for 2 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000420,body weight gain,,change from surgery weight,,-6,g,1.0,2.4495,MMO:0000016,body weighing method,,0.0,,sham acf,2,days,vehicle control condition then sham surgical control condition (for 2 days),101335,vehicle control condition,,,sham surgical control condition (for 2 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,8,,CMO:0000420,body weight gain,,change from surgery weight,,-5,g,2.0,5.6569,MMO:0000016,body weighing method,,0.0,,acf,4,days,controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days),101336,controlled losartan content drinking water (10 mg/kg/d) (for 5 days),,,artificial aortocaval fistula (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000420,body weight gain,,change from surgery weight,,-1,g,1.0,2.4495,MMO:0000016,body weighing method,,0.0,,sham acf,4,days,controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days),101337,controlled losartan content drinking water (10 mg/kg/d) (for 5 days),,,sham surgical control condition (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000420,body weight gain,,change from surgery weight,,-5,g,2.0,5.2915,MMO:0000016,body weighing method,,0.0,,acf,4,days,vehicle control condition then artificial aortocaval fistula (for 4 days),101338,vehicle control condition,,,artificial aortocaval fistula (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000420,body weight gain,,change from surgery weight,,6,g,1.0,2.2361,MMO:0000016,body weighing method,,0.0,,sham acf,4,days,vehicle control condition then sham surgical control condition (for 4 days),101339,vehicle control condition,,,sham surgical control condition (for 4 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000420,body weight gain,,change from surgery weight,,3,g,6.0,15.8745,MMO:0000016,body weighing method,,0.0,,acf,7,days,controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days),101340,controlled losartan content drinking water (10 mg/kg/d) (for 8 days),,,artificial aortocaval fistula (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000420,body weight gain,,change from surgery weight,,8,g,2.0,4.899,MMO:0000016,body weighing method,,0.0,,sham acf,7,days,controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days),101341,controlled losartan content drinking water (10 mg/kg/d) (for 8 days),,,sham surgical control condition (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000420,body weight gain,,change from surgery weight,,8,g,2.0,4.899,MMO:0000016,body weighing method,,0.0,,acf,7,days,vehicle control condition then artificial aortocaval fistula (for 7 days),101342,vehicle control condition,,,artificial aortocaval fistula (for 7 days),,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",body mass,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000420,body weight gain,,change from surgery weight,,23,g,3.0,6.7082,MMO:0000016,body weighing method,,0.0,,sham acf,7,days,vehicle control condition then sham surgical control condition (for 7 days),101343,vehicle control condition,,,sham surgical control condition (for 7 days),,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,336,g,6.532,16.0,MMO:0000016,body weighing method,,0.0,,sham unx,13,days,sham surgical control condition (between 12 and 14 days),101535,sham surgical control condition (between 12 and 14 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,11,,CMO:0000012,body weight,,,,277,g,8.1408,27.0,MMO:0000016,body weighing method,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days),101536,unilateral nephrectomy (between 12 and 14 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,5,,CMO:0000012,body weight,,,,285,g,6.7082,15.0,MMO:0000016,body weighing method,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days),101537,unilateral nephrectomy (between 12 and 14 days),,,enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days),,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,5,,CMO:0000012,body weight,,,,302,g,6.261,14.0,MMO:0000016,body weighing method,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days),101538,unilateral nephrectomy (between 12 and 14 days),,,enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days),aldosterone (30-40 mg/kg/d) (between 12 and 14 days),,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0002045,change in body weight,,change from surgery weight,,84,g,4.899,12.0,MMO:0000016,body weighing method,,0.0,,sham unx,13,days,sham surgical control condition (between 12 and 14 days),101539,sham surgical control condition (between 12 and 14 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,11,,CMO:0002045,change in body weight,,change from surgery weight,,66,g,7.8393,26.0,MMO:0000016,body weighing method,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days),101540,unilateral nephrectomy (between 12 and 14 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,5,,CMO:0002045,change in body weight,,change from surgery weight,,74,g,7.6026,17.0,MMO:0000016,body weighing method,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days),101541,unilateral nephrectomy (between 12 and 14 days),,,enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days),,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,5,,CMO:0002045,change in body weight,,change from surgery weight,,66,g,4.9193,11.0,MMO:0000016,body weighing method,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days),101542,unilateral nephrectomy (between 12 and 14 days),,,enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days),aldosterone (30-40 mg/kg/d) (between 12 and 14 days),,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,347,g,7.3485,18.0,MMO:0000016,body weighing method,,0.0,,sham unx,28,days,sham surgical control condition (for 28 days),101571,sham surgical control condition (for 28 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,309,g,18.8982,50.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days),101572,unilateral nephrectomy (for 28 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0000012,body weight,,,,307,g,36.6626,25.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days),101573,unilateral nephrectomy (for 28 days),,,enalapril (50 mg/l) (for 28 days),losartan (180 mg/l) (for 28 days),,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0000012,body weight,,,,312,g,9.798,24.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days),101574,unilateral nephrectomy (for 28 days),,,enalapril (50 mg/l) (for 28 days),losartan (180 mg/l) (for 28 days),aldosterone (35 mg/kg/d) (for 28 days),,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0002045,change in body weight,,change from surgery weight,,99,g,6.532,16.0,MMO:0000016,body weighing method,,0.0,,sham unx,28,days,sham surgical control condition (for 28 days),101575,sham surgical control condition (for 28 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0002045,change in body weight,,change from surgery weight,,96,g,15.1186,40.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days),101576,unilateral nephrectomy (for 28 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,7,,CMO:0002045,change in body weight,,change from surgery weight,,97,g,7.5593,20.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days),101577,unilateral nephrectomy (for 28 days),,,enalapril (50 mg/l) (for 28 days),losartan (180 mg/l) (for 28 days),,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,6,,CMO:0002045,change in body weight,,change from surgery weight,,106,g,10.6145,26.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days),101578,unilateral nephrectomy (for 28 days),,,enalapril (50 mg/l) (for 28 days),losartan (180 mg/l) (for 28 days),aldosterone (35 mg/kg/d) (for 28 days),,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0000012,body weight,,,,315,g,9.5459,27.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days),101607,unilateral nephrectomy (for 28 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0000012,body weight,,,,300,g,10.9602,31.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days),101608,unilateral nephrectomy (for 28 days),,,spironolactone (5.56 mg/kg/d) (for 28 days),,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0002045,change in body weight,,change from surgery weight,,59,g,10.9602,31.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days),101609,unilateral nephrectomy (for 28 days),,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",body mass,,RS:0000681,SD,male,0 days,8,,CMO:0002045,change in body weight,,change from surgery weight,,48,g,10.9602,31.0,MMO:0000016,body weighing method,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days),101610,unilateral nephrectomy (for 28 days),,,spironolactone (5.56 mg/kg/d) (for 28 days),,,,, 2622,"Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23.",body mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,female,91 days,9,,CMO:0000012,body weight,,,,294,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,ovariectomy,42,days,bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days),101661,bilateral ovariectomy (for 42 days),,,vehicle control condition (for 35 days),,,,, 2622,"Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23.",body mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,female,91 days,12,,CMO:0000012,body weight,,,,220,g,4.0,13.8564,MMO:0000016,body weighing method,,0.0,,ovariectomy,42,days,bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days),101662,bilateral ovariectomy (for 42 days),,,17 beta-estradiol (0.5 mg) (for 35 days),,,,, 2622,"Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23.",body mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,female,91 days,8,,CMO:0000012,body weight,,,,393,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,ovariectomy,42,days,bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days),101663,bilateral ovariectomy (for 42 days),,,vehicle control condition (for 35 days),,,,, 2622,"Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23.",body mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,female,91 days,7,,CMO:0000012,body weight,,,,339,g,13.0,34.3948,MMO:0000016,body weighing method,,0.0,,ovariectomy,42,days,bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days),101664,bilateral ovariectomy (for 42 days),,,17 beta-estradiol (0.5 mg) (for 35 days),,,,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",body mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000012,body weight,,,,443.75,g,21.62,52.958,MMO:0000016,body weighing method,,0.0,,,,,control condition,101885,control condition,,,,,,,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",body mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000012,body weight,,,,536.92,g,6.98,18.4673,MMO:0000016,body weighing method,,0.0,,,,,control condition,101886,control condition,,,,,,,, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001454,SR/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,212,g,4.4,,MMO:0000016,body weighing method,,0.0,,,,,control condition,102181,control condition,,,,,,,, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001481,SS/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,235,g,3.6,,MMO:0000016,body weighing method,,0.0,,,,,control condition,102182,control condition,,,,,,,, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001454,SR/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,226,g,4.7,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.4 %) (for 14 days) then sham surgical control condition then peanut oil (0.2 ml) (for 14 days),102183,controlled sodium chloride content diet (0.4 %) (for 14 days),,,sham surgical control condition,,,peanut oil (0.2 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001454,SR/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,232,g,4.1,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (4 %) (for 14 days) then sham surgical control condition then peanut oil (0.2 ml) (for 14 days),102184,controlled sodium chloride content diet (4 %) (for 14 days),,,sham surgical control condition,,,peanut oil (0.2 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001454,SR/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,276,g,11.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.4 %) (for 14 days) then bilateral ovariectomy then peanut oil (0.2 ml) (for 14 days),102185,controlled sodium chloride content diet (0.4 %) (for 14 days),,,bilateral ovariectomy,,,peanut oil (0.2 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001454,SR/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,269,g,7.3,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (4 %) (for 14 days) then bilateral ovariectomy then peanut oil (0.2 ml) (for 14 days),102186,controlled sodium chloride content diet (4 %) (for 14 days),,,bilateral ovariectomy,,,peanut oil (0.2 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001454,SR/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,200,g,2.5,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.4 %) (for 14 days) then bilateral ovariectomy then 17 beta-estradiol (10 ug/d) (for 14 days),102187,controlled sodium chloride content diet (0.4 %) (for 14 days),,,bilateral ovariectomy,,,17 beta-estradiol (10 ug/d) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001454,SR/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,213,g,2.2,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (4 %) (for 14 days) then bilateral ovariectomy then 17 beta-estradiol (10 ml) (for 14 days),102188,controlled sodium chloride content diet (4 %) (for 14 days),,,bilateral ovariectomy,,,17 beta-estradiol (10 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001481,SS/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,252,g,3.8,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.4 %) (for 14 days) then sham surgical control condition then peanut oil (0.2 ml) (for 14 days),102189,controlled sodium chloride content diet (0.4 %) (for 14 days),,,sham surgical control condition,,,peanut oil (0.2 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001481,SS/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,235,g,13.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (4 %) (for 14 days) then sham surgical control condition then peanut oil (0.2 ml) (for 14 days),102190,controlled sodium chloride content diet (4 %) (for 14 days),,,sham surgical control condition,,,peanut oil (0.2 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001481,SS/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,294,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.4 %) (for 14 days) then bilateral ovariectomy then peanut oil (0.2 ml) (for 14 days),102191,controlled sodium chloride content diet (0.4 %) (for 14 days),,,bilateral ovariectomy,,,peanut oil (0.2 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001481,SS/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,297,g,5.1,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (4 %) (for 14 days) then bilateral ovariectomy then peanut oil (0.2 ml) (for 14 days),102192,controlled sodium chloride content diet (4 %) (for 14 days),,,bilateral ovariectomy,,,peanut oil (0.2 ml) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001481,SS/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,211,g,4.6,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.4 %) (for 14 days) then bilateral ovariectomy then 17 beta-estradiol (10 ug/d) (for 14 days),102193,controlled sodium chloride content diet (0.4 %) (for 14 days),,,bilateral ovariectomy,,,17 beta-estradiol (10 ug/d) (for 14 days),, 2681,"Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1.",body mass,,RS:0001481,SS/JrHsd,female,0 days,N/A,,CMO:0000012,body weight,,,,228,g,6.1,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (4 %) (for 14 days) then bilateral ovariectomy then 17 beta-estradiol (10 ml) (for 14 days),102194,controlled sodium chloride content diet (4 %) (for 14 days),,,bilateral ovariectomy,,,17 beta-estradiol (10 ml) (for 14 days),, 2683,"Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19.",body mass,,RS:0000789,SS,male,49 days,8,,CMO:0000012,body weight,,,,208,g,2.7224,7.7,MMO:0000016,body weighing method,,0.0,,,,,standard diet,102270,standard diet,,,,,,,, 2683,"Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19.",body mass,,RS:0000785,SR/Hsd,male,49 days,8,,CMO:0000012,body weight,,,,213,g,2.4042,6.8,MMO:0000016,body weighing method,,0.0,,,,,standard diet,102271,standard diet,,,,,,,, 2683,"Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19.",body mass,,RS:0000789,SS,male,91 days,8,,CMO:0000012,body weight,,,,309,g,6.364,18.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 42 days),102272,controlled sodium chloride content diet (8 %) (for 42 days),,,,,,,, 2683,"Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19.",body mass,,RS:0000785,SR/Hsd,male,91 days,8,,CMO:0000012,body weight,,,,308,g,10.6066,30.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 42 days),102273,controlled sodium chloride content diet (8 %) (for 42 days),,,,,,,, 2684,"Ishikawa M, et al., Int Heart J. 2013;54(2):98-106.",body mass,,RS:0003329,SR/NEisSlc,male,126 days,8,,CMO:0000012,body weight,,,,449,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days),102310,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 77 days),,,,, 2684,"Ishikawa M, et al., Int Heart J. 2013;54(2):98-106.",body mass,,RS:0003328,SS/NEisSlc,male,126 days,8,,CMO:0000012,body weight,,,,361,g,9.0,25.4558,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days),102311,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 77 days),,,vehicle control condition (for 49 days),, 2684,"Ishikawa M, et al., Int Heart J. 2013;54(2):98-106.",body mass,,RS:0003328,SS/NEisSlc,male,126 days,8,,CMO:0000012,body weight,,,,386,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days),102312,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 77 days),,,tolvaptan (0.05 %) (for 49 days),, 2686,"Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13.",body mass,,RS:0001481,SS/JrHsd,female,112 days,6,,CMO:0000012,body weight,,,,281.5,g,4.1,10.0429,MMO:0000016,body weighing method,,0.0,,sham ovx,63,days,controlled sodium content diet (0.1 %) (for 112 days) then sham surgical control condition (between 56 and 63 days),102340,controlled sodium content diet (0.1 %) (for 112 days),,,sham surgical control condition (between 56 and 63 days),,,,, 2686,"Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13.",body mass,,RS:0001481,SS/JrHsd,female,112 days,6,,CMO:0000012,body weight,,,,350.5,g,11.3,27.6792,MMO:0000016,body weighing method,,0.0,,ovx,63,days,controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days),102341,controlled sodium content diet (0.1 %) (for 112 days),,,bilateral ovariectomy (between 56 and 63 days),,,,, 2686,"Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13.",body mass,,RS:0001481,SS/JrHsd,female,112 days,6,,CMO:0000012,body weight,,,,241.6,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,ovx,63,days,controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) and 17 beta-estradiol (5 mg) (between 56 and 63 days),102342,controlled sodium content diet (0.1 %) (for 112 days),,,bilateral ovariectomy (between 56 and 63 days),17 beta-estradiol (5 mg) (between 56 and 63 days),,,, 2686,"Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13.",body mass,,RS:0001454,SR/JrHsd,female,112 days,6,,CMO:0000012,body weight,,,,253.5,g,4.9,12.0025,MMO:0000016,body weighing method,,0.0,,sham ovx,63,days,controlled sodium content diet (0.1 %) (for 112 days) then sham surgical control condition (between 56 and 63 days),102343,controlled sodium content diet (0.1 %) (for 112 days),,,sham surgical control condition (between 56 and 63 days),,,,, 2686,"Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13.",body mass,,RS:0001454,SR/JrHsd,female,112 days,6,,CMO:0000012,body weight,,,,309.7,g,13.4,32.8232,MMO:0000016,body weighing method,,0.0,,ovx,63,days,controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days),102344,controlled sodium content diet (0.1 %) (for 112 days),,,bilateral ovariectomy (between 56 and 63 days),,,,, 2686,"Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13.",body mass,,RS:0001454,SR/JrHsd,female,112 days,6,,CMO:0000012,body weight,,,,209.5,g,5.3,12.9823,MMO:0000016,body weighing method,,0.0,,ovx,63,days,controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) and 17 beta-estradiol (5 mg) (between 56 and 63 days),102345,controlled sodium content diet (0.1 %) (for 112 days),,,bilateral ovariectomy (between 56 and 63 days),17 beta-estradiol (5 mg) (between 56 and 63 days),,,, 2688,"Hojnż S, et al., Physiol Res. 2005;54(2):201-6.",body mass,,RS:0000787,SR/JrIpcv,male,0 days,N/A,,CMO:0000012,body weight,,,,218,g,9.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) ,102389,controlled sodium content diet (0.3 %) ,,,,,,,, 2688,"Hojnż S, et al., Physiol Res. 2005;54(2):201-6.",body mass,,RS:0000923,SS/JrIpcv,male,0 days,N/A,,CMO:0000012,body weight,,,,271,g,10.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) ,102390,controlled sodium content diet (0.3 %) ,,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003329,SR/NEisSlc,male,63 days,7,,CMO:0000012,body weight,,,,286,g,6.0474,16.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 7 days),102405,controlled sodium chloride content diet (8 %) (for 7 days),,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003328,SS/NEisSlc,male,63 days,8,,CMO:0000012,body weight,,,,292,g,3.182,9.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 7 days),102406,controlled sodium chloride content diet (8 %) (for 7 days),,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003329,SR/NEisSlc,male,70 days,8,,CMO:0000012,body weight,,,,309,g,3.8891,11.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 14 days),102407,controlled sodium chloride content diet (8 %) (for 14 days),,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003328,SS/NEisSlc,male,70 days,7,,CMO:0000012,body weight,,,,297,g,5.2915,14.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 14 days),102408,controlled sodium chloride content diet (8 %) (for 14 days),,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003329,SR/NEisSlc,male,77 days,7,,CMO:0000012,body weight,,,,371,g,4.5356,12.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days),102409,controlled sodium chloride content diet (8 %) (for 21 days),,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003328,SS/NEisSlc,male,77 days,8,,CMO:0000012,body weight,,,,342,g,4.2426,12.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days),102410,controlled sodium chloride content diet (8 %) (for 21 days),,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003329,SR/NEisSlc,male,77 days,19,,CMO:0000012,body weight,,,,370,g,2.5236,11.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days) then 0.9% sodium chloride solution (for 21 days),102453,controlled sodium chloride content diet (8 %) (for 21 days),,,0.9% sodium chloride solution (for 21 days),,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003328,SS/NEisSlc,male,77 days,14,,CMO:0000012,body weight,,,,348,g,4.0089,15.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days) then 0.9% sodium chloride solution (for 21 days),102454,controlled sodium chloride content diet (8 %) (for 21 days),,,0.9% sodium chloride solution (for 21 days),,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",body mass,,RS:0003328,SS/NEisSlc,male,77 days,14,,CMO:0000012,body weight,,,,350,g,3.7417,14.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days) then adrenomedulin (400 ng/hr) (for 21 days),102455,controlled sodium chloride content diet (8 %) (for 21 days),,,adrenomedulin (400 ng/hr) (for 21 days),,,,, 2690,"Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35.",body mass,,RS:0003329,SR/NEisSlc,male,77 days,10,,CMO:0000012,body weight,,,,356,g,3.4785,11.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days),102480,controlled sodium chloride content diet (0.3 %) (for 42 days),,,controlled sodium chloride content diet (8 %) (for 35 days),,,,, 2690,"Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35.",body mass,,RS:0003329,SR/NEisSlc,male,126 days,10,,CMO:0000012,body weight,,,,483,g,5.6921,18.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 84 days),102481,controlled sodium chloride content diet (0.3 %) (for 42 days),,,controlled sodium chloride content diet (8 %) (for 84 days),,,,, 2690,"Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35.",body mass,,RS:0003328,SS/NEisSlc,male,77 days,10,,CMO:0000012,body weight,,,,344,g,8.2219,26.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days),102482,controlled sodium chloride content diet (0.3 %) (for 42 days),,,controlled sodium chloride content diet (8 %) (for 35 days),,,,, 2690,"Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35.",body mass,,RS:0003328,SS/NEisSlc,male,126 days,10,,CMO:0000012,body weight,,,,298,g,4.4272,14.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 84 days),102483,controlled sodium chloride content diet (0.3 %) (for 42 days),,,controlled sodium chloride content diet (8 %) (for 84 days),,,,, 2691,"Fenton RA, et al., Am J Physiol Renal Physiol. 2003 Jul;285(1):F143-51. Epub 2003 Apr 8.",body mass,,RS:0001454,SR/JrHsd,male,0 days,6,,CMO:0000012,body weight,,,,118,g,0.58,1.4207,MMO:0000016,body weighing method,,0.0,,osmotic pump implant,0,days,gelled diet (200 g/kg/d) (for 8 days) then distilled water,102540,gelled diet (200 g/kg/d) (for 8 days),,,distilled water,,,,, 2691,"Fenton RA, et al., Am J Physiol Renal Physiol. 2003 Jul;285(1):F143-51. Epub 2003 Apr 8.",body mass,,RS:0001454,SR/JrHsd,male,0 days,6,,CMO:0000012,body weight,,,,130,g,0.63,1.5432,MMO:0000016,body weighing method,,0.0,,osmotic pump implant,6,days,gelled diet (200 g/kg/d) (for 8 days) then distilled water (for 6 days),102541,gelled diet (200 g/kg/d) (for 8 days),,,distilled water (for 6 days),,,,, 2691,"Fenton RA, et al., Am J Physiol Renal Physiol. 2003 Jul;285(1):F143-51. Epub 2003 Apr 8.",body mass,,RS:0001481,SS/JrHsd,male,0 days,6,,CMO:0000012,body weight,,,,131,g,2.5,6.1237,MMO:0000016,body weighing method,,0.0,,osmotic pump implant,0,days,gelled diet (200 g/kg/d) (for 8 days) then distilled water,102542,gelled diet (200 g/kg/d) (for 8 days),,,distilled water,,,,, 2691,"Fenton RA, et al., Am J Physiol Renal Physiol. 2003 Jul;285(1):F143-51. Epub 2003 Apr 8.",body mass,,RS:0001481,SS/JrHsd,male,0 days,6,,CMO:0000012,body weight,,,,140,g,3.1,7.5934,MMO:0000016,body weighing method,,0.0,,osmotic pump implant,6,days,gelled diet (200 g/kg/d) (for 8 days) then distilled water (for 6 days),102543,gelled diet (200 g/kg/d) (for 8 days),,,distilled water (for 6 days),,,,, 2691,"Fenton RA, et al., Am J Physiol Renal Physiol. 2003 Jul;285(1):F143-51. Epub 2003 Apr 8.",body mass,,RS:0001481,SS/JrHsd,male,0 days,6,,CMO:0000012,body weight,,,,128,g,2.9,7.1035,MMO:0000016,body weighing method,,0.0,,osmotic pump implant,0,days,gelled diet (200 g/kg/d) (for 8 days) then carbenoxolone (100 mg/kg/d) ,102544,gelled diet (200 g/kg/d) (for 8 days),,,carbenoxolone (100 mg/kg/d) ,,,,, 2691,"Fenton RA, et al., Am J Physiol Renal Physiol. 2003 Jul;285(1):F143-51. Epub 2003 Apr 8.",body mass,,RS:0001481,SS/JrHsd,male,0 days,6,,CMO:0000012,body weight,,,,139,g,2.8,6.8586,MMO:0000016,body weighing method,,0.0,,osmotic pump implant,6,days,gelled diet (200 g/kg/d) (for 8 days) then carbenoxolone (100 mg/kg/d) (for 6 days),102545,gelled diet (200 g/kg/d) (for 8 days),,,carbenoxolone (100 mg/kg/d) (for 6 days),,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",body mass,,RS:0004090,LH/MavRrrcAek,male,126 days to 21 days,N/A,,CMO:0002806,body weight area under curve (AUC),body weight X week = growth AUC,growth auc,,41351184,g x min,396144.0,,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow (for 98 days) then controlled sodium chloride content diet (4 %) (for 21 days),102617,standard rat chow (for 98 days),,,controlled sodium chloride content diet (4 %) (for 21 days),,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",body mass,,RS:0004091,LN/MavRrrcAek,male,126 days to 21 days,N/A,,CMO:0002806,body weight area under curve (AUC),body weight X week = growth AUC,growth auc,,28740096,g x min,358848.0,,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow (for 98 days) then controlled sodium chloride content diet (4 %) (for 21 days),102618,standard rat chow (for 98 days),,,controlled sodium chloride content diet (4 %) (for 21 days),,,,, 2703,"Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3.",body mass,,RS:0001366,LL/Mav,male,56 days to 49 days,13,,CMO:0000012,body weight,,,,219,g,5.0,18.0278,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,102641,vehicle control condition,,,,,,,, 2703,"Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3.",body mass,,RS:0000556,LH/Mav,male,56 days to 49 days,8,,CMO:0000012,body weight,,,,232,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,102642,vehicle control condition,,,,,,,, 2703,"Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3.",body mass,,RS:0000556,LH/Mav,male,56 days to 49 days,37,,CMO:0000012,body weight,,,,233,g,4.0,24.3311,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (75 mg/kg) ,102643,streptozotocin (75 mg/kg) ,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",body mass,,RS:0001366,LL/Mav,male,56 days,9,,CMO:0000012,body weight,,,,231,g,4.0,12.0,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,102698,vehicle control condition,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",body mass,,RS:0001366,LL/Mav,male,56 days,18,,CMO:0000012,body weight,,,,215,g,3.0,12.7279,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (100 mg/kg) ,102699,streptozotocin (100 mg/kg) ,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",body mass,,RS:0000556,LH/Mav,male,56 days,11,,CMO:0000012,body weight,,,,246,g,4.0,13.2665,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,102700,vehicle control condition,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",body mass,,RS:0000556,LH/Mav,male,56 days,14,,CMO:0000012,body weight,,,,248,g,4.0,14.9666,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (75 mg/kg) ,102701,streptozotocin (75 mg/kg) ,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",body mass,,RS:0001366,LL/Mav,male,112 days,9,,CMO:0000012,body weight,,,,364,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,102722,vehicle control condition,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",body mass,,RS:0001366,LL/Mav,male,112 days,18,,CMO:0000012,body weight,,,,331,g,3.0,12.7279,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (100 mg/kg) ,102723,streptozotocin (100 mg/kg) ,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",body mass,,RS:0000556,LH/Mav,male,112 days,11,,CMO:0000012,body weight,,,,384,g,9.0,29.8496,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,102724,vehicle control condition,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",body mass,,RS:0000556,LH/Mav,male,112 days,14,,CMO:0000012,body weight,,,,388,g,5.0,18.7083,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (75 mg/kg) ,102725,streptozotocin (75 mg/kg) ,,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,112 days,8,,CMO:0000012,body weight,,,,391,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,control condition,102787,control condition,,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,112 days,8,,CMO:0000012,body weight,,,,394,g,4.0,11.3137,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.04 mg/kg/d) (for 98 days),102788,perindopril (0.04 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,112 days,8,,CMO:0000012,body weight,,,,404,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.1 mg/kg/d) (for 98 days),102789,perindopril (0.1 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,112 days,8,,CMO:0000012,body weight,,,,405,g,7.0,19.799,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.4 mg/kg/d) (for 98 days),102790,perindopril (0.4 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,112 days,4,,CMO:0000012,body weight,,,,374,g,6.0,12.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,102791,control condition,,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,112 days,6,,CMO:0000012,body weight,,,,391,g,8.0,19.5959,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.01 mg/kg/d) (for 98 days),102792,perindopril (0.01 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,112 days,6,,CMO:0000012,body weight,,,,372,g,9.0,22.0454,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.04 mg/kg/d) (for 98 days),102793,perindopril (0.04 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,161 days,8,,CMO:0000012,body weight,,,,442,g,8.0,22.6274,MMO:0000016,body weighing method,,0.0,,,,,control condition,102801,control condition,,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,161 days,8,,CMO:0000012,body weight,,,,442,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.04 mg/kg/d) (for 98 days),102802,perindopril (0.04 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,161 days,8,,CMO:0000012,body weight,,,,452,g,5.0,14.1421,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.1 mg/kg/d) (for 98 days),102803,perindopril (0.1 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,161 days,8,,CMO:0000012,body weight,,,,459,g,10.0,28.2843,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.4 mg/kg/d) (for 98 days),102804,perindopril (0.4 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,161 days,4,,CMO:0000012,body weight,,,,431,g,8.0,16.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,102805,control condition,,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,161 days,6,,CMO:0000012,body weight,,,,460,g,14.0,34.2929,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.01 mg/kg/d) (for 98 days),102806,perindopril (0.01 mg/kg/d) (for 98 days),,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",body mass,,RS:0000556,LH/Mav,male,161 days,6,,CMO:0000012,body weight,,,,457,g,11.0,26.9444,MMO:0000016,body weighing method,,0.0,,,,,perindopril (0.04 mg/kg/d) (for 98 days),102807,perindopril (0.04 mg/kg/d) (for 98 days),,,,,,,, 2782,"Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.",body mass,,RS:0001833,Crl:WI(Han),female,87 days,6,,CMO:0000012,body weight,,,,292,g,13.0,31.8434,MMO:0000016,body weighing method,,0.0,,,,,sham surgical control condition (for 24 days),102930,sham surgical control condition (for 24 days),,,,,,,, 2782,"Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.",body mass,,RS:0001833,Crl:WI(Han),female,87 days,6,,CMO:0000012,body weight,,,,351,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,,,,bilateral ovariectomy (for 24 days),102931,bilateral ovariectomy (for 24 days),,,,,,,, 2784,"Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1.",body mass,,RS:0001840,Crlj:WI,male,16 days,6,,CMO:0000012,body weight,,,,322,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,,,,air oxygen content (21 %) (for 28 days),102999,air oxygen content (21 %) (for 28 days),,,,,,,, 2784,"Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1.",body mass,,RS:0001840,Crlj:WI,male,16 days,7,,CMO:0000012,body weight,,,,300,g,5.0,13.2288,MMO:0000016,body weighing method,,0.0,,,,,air oxygen content (5 %) (for 28 days),103000,air oxygen content (5 %) (for 28 days),,,,,,,, 2784,"Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1.",body mass,,RS:0001299,GK,male,16 days,5,,CMO:0000012,body weight,,,,379,g,2.0,4.4721,MMO:0000016,body weighing method,,0.0,,,,,air oxygen content (21 %) (for 28 days),103001,air oxygen content (21 %) (for 28 days),,,,,,,, 2784,"Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1.",body mass,,RS:0001299,GK,male,16 days,7,,CMO:0000012,body weight,,,,333,g,6.0,15.8745,MMO:0000016,body weighing method,,0.0,,,,,air oxygen content (5 %) (for 28 days),103002,air oxygen content (5 %) (for 28 days),,,,,,,, 2785,"Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8.",body mass,,RS:0004409,Jcl:WI,male,84 days,8,,CMO:0000012,body weight,,,,432,g,10.253,29.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,103055,standard diet,,,,,,,, 2785,"Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8.",body mass,,RS:0004409,Jcl:WI,male,84 days,8,,CMO:0000012,body weight,,,,429,g,6.0104,17.0,MMO:0000016,body weighing method,,0.0,,,,,Omacor (400 mg/kg/d) (for 56 days),103056,Omacor (400 mg/kg/d) (for 56 days),,,,,,,, 2785,"Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8.",body mass,,RS:0004580,GK/Jcl,male,84 days,8,,CMO:0000012,body weight,,,,353,g,7.0711,20.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,103057,standard diet,,,,,,,, 2785,"Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8.",body mass,,RS:0004580,GK/Jcl,male,84 days,8,,CMO:0000012,body weight,,,,342,g,4.9497,14.0,MMO:0000016,body weighing method,,0.0,,,,,Omacor (400 mg/kg/d) (for 56 days),103058,Omacor (400 mg/kg/d) (for 56 days),,,,,,,, 2786,"Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013.",body mass,,RS:0001011,Crl:WI,male,168 days,4,,CMO:0000012,body weight,,,,491.67,g,4.625,9.25,MMO:0000016,body weighing method,,0.0,,,,,control condition,103087,control condition,,,,,,,, 2786,"Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013.",body mass,,RS:0001995,GK/CskCrljCrl,male,168 days,4,,CMO:0000012,body weight,,,,334.17,g,8.89,17.78,MMO:0000016,body weighing method,,0.0,,,,,control condition,103088,control condition,,,,,,,, 2787,"Sobajima M, et al., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2214-20. doi: 10.1152/ajpheart.00615.2010. Epub 2011 Mar 18.",body mass,,RS:0000817,SS/Jr,not specified,84 days,5,,CMO:0000012,body weight,,,,332,g,22.3607,50.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 21 days) then controlled sodium chloride content diet (8 %) (for 42 days),103141,controlled sodium chloride content diet (0.3 %) (for 21 days),,,controlled sodium chloride content diet (8 %) (for 42 days),,,,, 2787,"Sobajima M, et al., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2214-20. doi: 10.1152/ajpheart.00615.2010. Epub 2011 Mar 18.",body mass,,RS:0000786,SR/Jr,not specified,84 days,5,,CMO:0000012,body weight,,,,349,g,10.2859,23.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 21 days) then controlled sodium chloride content diet (8 %) (for 42 days),103142,controlled sodium chloride content diet (0.3 %) (for 21 days),,,controlled sodium chloride content diet (8 %) (for 42 days),,,,, 2801,"Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30.",body mass,,RS:0000785,SR/Hsd,male,61 days to 52 days,N/A,,CMO:0000420,body weight gain,,change from surgery weight (2wks),,65,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days),103214,artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days),,,,,,,, 2801,"Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30.",body mass,,RS:0000922,SS/Hsd,male,61 days to 52 days,N/A,,CMO:0000420,body weight gain,,change from surgery weight (2wks),,58,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days),103216,artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days),,,,,,,, 2801,"Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30.",body mass,,RS:0000922,SS/Hsd,male,61 days to 52 days,N/A,,CMO:0000420,body weight gain,,change from surgery weight (2wks),,61,g,6.0,,MMO:0000016,body weighing method,,0.0,,,,,aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days),103217,aldosterone (22.5 ng/hr) (for 14 days),artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days),,,,,,, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",body mass,,RS:0000786,SR/Jr,male,63 days,16,,CMO:0000012,body weight,,,,218,g,9.0,36.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 35 days),103234,controlled sodium chloride content diet (0.3 %) (for 35 days),,,,,,,, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",body mass,,RS:0000786,SR/Jr,male,63 days,13,,CMO:0000012,body weight,,,,225,g,8.0,28.8444,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 35 days),103235,controlled sodium chloride content diet (8 %) (for 35 days),,,,,,,, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",body mass,,RS:0000817,SS/Jr,male,63 days,15,,CMO:0000012,body weight,,,,271,g,10.0,38.7298,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 35 days),103236,controlled sodium chloride content diet (0.3 %) (for 35 days),,,,,,,, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",body mass,,RS:0000817,SS/Jr,male,63 days,10,,CMO:0000012,body weight,,,,201,g,20.0,63.2456,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 35 days),103237,controlled sodium chloride content diet (8 %) (for 35 days),,,,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",body mass,,RS:0000789,SS,male,42 days,5,,CMO:0000012,body weight,,,,195,g,3.5777,8.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days),103296,controlled sodium content diet (0.3 %) (for 42 days),,,,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",body mass,,RS:0000784,SR,male,42 days,5,,CMO:0000012,body weight,,,,185,g,7.1554,16.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days),103297,controlled sodium content diet (0.3 %) (for 42 days),,,,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",body mass,,RS:0000789,SS,male,84 days,7,,CMO:0000012,body weight,,,,287,g,9.4491,25.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days),103298,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 42 days),,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",body mass,,RS:0000784,SR,male,84 days,6,,CMO:0000012,body weight,,,,352,g,8.165,20.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days),103299,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 42 days),,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",body mass,,RS:0000789,SS,male,126 days,6,,CMO:0000012,body weight,,,,323,g,5.7155,14.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days),103300,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 84 days),,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",body mass,,RS:0000784,SR,male,126 days,6,,CMO:0000012,body weight,,,,445,g,11.8392,29.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days),103301,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 84 days),,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",body mass,,RS:0000784,SR,male,70 days to 63 days,7,,CMO:0000012,body weight,,,,303,g,10.961,29.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (6 %) (between 21 and 28 days),103344,controlled sodium content diet (6 %) (between 21 and 28 days),,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",body mass,,RS:0000784,SR,male,91 days to 77 days,7,,CMO:0000012,body weight,,,,360,g,9.8271,26.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (6 %) (between 35 and 49 days),103345,controlled sodium content diet (6 %) (between 35 and 49 days),,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",body mass,,RS:0000784,SR,male,132 days to 98 days,7,,CMO:0000012,body weight,,,,405,g,15.4965,41.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (6 %) (between 56 and 70 days),103346,controlled sodium content diet (6 %) (between 56 and 70 days),,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",body mass,,RS:0000789,SS,male,70 days to 63 days,7,,CMO:0000012,body weight,,,,312,g,11.7169,31.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (6 %) (between 21 and 28 days),103347,controlled sodium content diet (6 %) (between 21 and 28 days),,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",body mass,,RS:0000789,SS,male,91 days to 77 days,7,,CMO:0000012,body weight,,,,336,g,9.0711,24.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (6 %) (between 35 and 49 days),103348,controlled sodium content diet (6 %) (between 35 and 49 days),,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",body mass,,RS:0000789,SS,male,132 days to 98 days,7,,CMO:0000012,body weight,,,,417,g,31.749,84.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (6 %) (between 56 and 70 days),103349,controlled sodium content diet (6 %) (between 56 and 70 days),,,,,,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",body mass,,RS:0000556,LH/Mav,male,119 days,7,,CMO:0000012,body weight,,,,407,g,9.0,23.8118,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (2 %) (for 8 days),103404,controlled sodium chloride content drinking water (2 %) (for 8 days),,,,,,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",body mass,,RS:0000556,LH/Mav,male,119 days,8,,CMO:0000012,body weight,,,,393,g,7.0,19.799,MMO:0000016,body weighing method,,0.0,,,,,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days),103405,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),,,controlled sodium chloride content drinking water (2 %) (for 8 days),,,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",body mass,,RS:0000556,LH/Mav,male,119 days,8,,CMO:0000012,body weight,,,,380,g,10.0,28.2843,MMO:0000016,body weighing method,,0.0,,,,,controlled perindopril content drinking water (1.5 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days),103406,controlled perindopril content drinking water (1.5 mg/kg/d) (for 63 days),,,controlled sodium chloride content drinking water (2 %) (for 8 days),,,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",body mass,,RS:0000556,LH/Mav,male,119 days,6,,CMO:0000012,body weight,,,,362,g,8.0,19.5959,MMO:0000016,body weighing method,,0.0,,,,,controlled hydralazine content drinking water (75 mg/kg/d) (for 63 days) and controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days),103407,controlled hydralazine content drinking water (75 mg/kg/d) (for 63 days),controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days),,controlled sodium chloride content drinking water (2 %) (for 8 days),,,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",body mass,,RS:0000556,LH/Mav,male,119 days,7,,CMO:0000012,body weight,,,,383,g,7.0,18.5203,MMO:0000016,body weighing method,,0.0,,,,,controlled hydralazine content drinking water (75 mg/kg/d) (for 63 days) and controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and controlled reserpine content drinking water (0.75 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days),103408,controlled hydralazine content drinking water (75 mg/kg/d) (for 63 days),controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days),controlled reserpine content drinking water (0.75 mg/kg/d) (for 63 days),controlled sodium chloride content drinking water (2 %) (for 8 days),,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",body mass,,RS:0000556,LH/Mav,male,84 days,12,,CMO:0000012,body weight,,,,353,g,8.0,27.7128,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 84 days),103424,control condition (for 84 days),,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",body mass,,RS:0000556,LH/Mav,male,84 days,13,,CMO:0000012,body weight,,,,340,g,5.0,18.0278,MMO:0000016,body weighing method,,0.0,,,,,controlled losartan content drinking water (10 mg/kg/d) (for 63 days),103425,controlled losartan content drinking water (10 mg/kg/d) (for 63 days),,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",body mass,,RS:0000556,LH/Mav,male,84 days,13,,CMO:0000012,body weight,,,,327,g,7.0,25.2389,MMO:0000016,body weighing method,,0.0,,,,,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),103426,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",body mass,,RS:0000556,LH/Mav,male,84 days,12,,CMO:0000012,body weight,,,,318,g,8.0,27.7128,MMO:0000016,body weighing method,,0.0,,,,,controlled perindopril content drinking water (3 mg/kg/d) (for 63 days),103427,controlled perindopril content drinking water (3 mg/kg/d) (for 63 days),,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",body mass,,RS:0000556,LH/Mav,male,154 days to 147 days,6,,CMO:0000012,body weight,,,,433,g,7.0,17.1464,MMO:0000016,body weighing method,,0.0,,,,,control condition (between 147 and 154 days),103428,control condition (between 147 and 154 days),,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",body mass,,RS:0000556,LH/Mav,male,154 days to 147 days,5,,CMO:0000012,body weight,,,,432,g,11.0,24.5967,MMO:0000016,body weighing method,,0.0,,,,,controlled losartan content drinking water (10 mg/kg/d) (for 63 days),103429,controlled losartan content drinking water (10 mg/kg/d) (for 63 days),,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",body mass,,RS:0000556,LH/Mav,male,154 days to 147 days,6,,CMO:0000012,body weight,,,,428,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,,,,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),103430,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",body mass,,RS:0000556,LH/Mav,male,154 days to 147 days,6,,CMO:0000012,body weight,,,,436,g,8.0,19.5959,MMO:0000016,body weighing method,,0.0,,,,,controlled perindopril content drinking water (3 mg/kg/d) (for 63 days),103431,controlled perindopril content drinking water (3 mg/kg/d) (for 63 days),,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",body mass,,RS:0004585,SD-Tg(Ren2)27-/-,male,84 days,6,,CMO:0000012,body weight,,,,405,g,31.0,75.9342,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),103474,control condition (for 0 hours),,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",body mass,,RS:0000687,SD-Tg(Ren2)27,male,84 days,6,,CMO:0000012,body weight,,,,326,g,11.0,26.9444,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),103475,control condition (for 0 hours),,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",body mass,,RS:0000742,WKY,male,84 days,5,,CMO:0000012,body weight,,,,260,g,7.0,15.6525,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),103476,control condition (for 0 hours),,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",body mass,,RS:0000015,SHR,male,84 days,5,,CMO:0000012,body weight,,,,276,g,10.0,22.3607,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),103477,control condition (for 0 hours),,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",body mass,,RS:0001366,LL/Mav,male,84 days,5,,CMO:0000012,body weight,,,,332,g,8.0,17.8885,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),103478,control condition (for 0 hours),,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",body mass,,RS:0000556,LH/Mav,male,84 days,5,,CMO:0000012,body weight,,,,360,g,6.0,13.4164,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),103479,control condition (for 0 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",body mass,,RS:0000731,WKY/NCrl,male,140 days,6,,CMO:0000012,body weight,,,,436,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,,,,control condition,103486,control condition,,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",body mass,,RS:0000731,WKY/NCrl,male,140 days,6,,CMO:0000012,body weight,,,,437,g,3.0,7.3485,MMO:0000016,body weighing method,,0.0,,,,,control condition,103487,control condition,,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",body mass,,RS:0001299,GK,male,140 days,6,,CMO:0000012,body weight,,,,366,g,8.0,19.5959,MMO:0000016,body weighing method,,0.0,,,,,control condition,103488,control condition,,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",body mass,,RS:0001299,GK,male,140 days,6,,CMO:0000012,body weight,,,,359,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,,,,control condition,103489,control condition,,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",body mass,,RS:0000731,WKY/NCrl,male,168 days,6,,CMO:0000012,body weight,,,,463,g,7.0,17.1464,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 28 days),103490,vehicle control condition (for 28 days),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",body mass,,RS:0000731,WKY/NCrl,male,168 days,6,,CMO:0000012,body weight,,,,462,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,,,,salidroside (40 mg/kg) (for 28 days),103491,salidroside (40 mg/kg) (for 28 days),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",body mass,,RS:0001299,GK,male,168 days,6,,CMO:0000012,body weight,,,,380,g,7.0,17.1464,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 28 days),103492,vehicle control condition (for 28 days),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",body mass,,RS:0001299,GK,male,168 days,6,,CMO:0000012,body weight,,,,367,g,7.0,17.1464,MMO:0000016,body weighing method,,0.0,,,,,salidroside (40 mg/kg) (for 28 days),103493,salidroside (40 mg/kg) (for 28 days),,,,,,,, 2782,"Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.",body mass,,RS:0001299,GK,female,87 days,6,,CMO:0000012,body weight,,,,229,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,,,,sham surgical control condition (for 24 days),103755,sham surgical control condition (for 24 days),,,,,,,, 2782,"Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.",body mass,,RS:0001299,GK,female,87 days,6,,CMO:0000012,body weight,,,,314,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,,,,bilateral ovariectomy (for 24 days),103756,bilateral ovariectomy (for 24 days),,,,,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",body mass,,RS:0004409,Jcl:WI,male,24 days,6,,CMO:0000012,body weight,,,,53.56,g,0.98,2.4005,MMO:0000016,body weighing method,,0.0,,,,,control condition,103904,control condition,,,,,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",body mass,,RS:0004580,GK/Jcl,male,24 days,6,,CMO:0000012,body weight,,,,53.67,g,1.48,3.6252,MMO:0000016,body weighing method,,0.0,,,,,control condition,103905,control condition,,,,,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",body mass,,RS:0004580,GK/Jcl,male,24 days,6,,CMO:0000012,body weight,,,,52.98,g,1.45,3.5518,MMO:0000016,body weighing method,,0.0,,,,,controlled hesperidin content diet (1 %) ,103906,controlled hesperidin content diet (1 %) ,,,,,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",body mass,,RS:0004580,GK/Jcl,male,24 days,6,,CMO:0000012,body weight,,,,52.81,g,1.57,3.8457,MMO:0000016,body weighing method,,0.0,,,,,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) ,103907,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) ,,,,,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",body mass,,RS:0004409,Jcl:WI,male,52 days,6,,CMO:0000012,body weight,,,,190.46,g,14.37,35.1992,MMO:0000016,body weighing method,,0.0,,,,,control condition,103908,control condition,,,,,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",body mass,,RS:0004580,GK/Jcl,male,24 days,6,,CMO:0000012,body weight,,,,179.97,g,1.82,4.4581,MMO:0000016,body weighing method,,0.0,,,,,control condition,103909,control condition,,,,,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",body mass,,RS:0004580,GK/Jcl,male,24 days,6,,CMO:0000012,body weight,,,,172.3,g,5.83,14.2805,MMO:0000016,body weighing method,,0.0,,,,,controlled hesperidin content diet (1 %) ,103910,controlled hesperidin content diet (1 %) ,,,,,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",body mass,,RS:0004580,GK/Jcl,male,24 days,6,,CMO:0000012,body weight,,,,166.41,g,2.36,5.7808,MMO:0000016,body weighing method,,0.0,,,,,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) ,103911,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) ,,,,,,,, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001011,Crl:WI,male,147 days,6,,CMO:0000012,body weight,,,,525,g,15.0,36.7423,MMO:0000016,body weighing method,,0.0,,,,,control condition,103978,control condition,,,,,,,, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001011,Crl:WI,male,147 days,6,,CMO:0000012,body weight,,,,499,g,15.0,36.7423,MMO:0000016,body weighing method,,0.0,,,,,running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours),103979,running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours),,,running on treadmill (15 m/min) (for 0.5 hours),,,running on treadmill (15 m/min) (for 0.8 hours),, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001011,Crl:WI,male,147 days,6,,CMO:0000012,body weight,,,,553,g,23.0,56.3383,MMO:0000016,body weighing method,,0.0,,,,,control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days),103980,control condition,,,controlled saxagliptin content diet (10 mg/kg/d) (for 12 days),,,,, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001317,GK/MolTac,male,147 days,6,,CMO:0000012,body weight,,,,382,g,13.0,31.8434,MMO:0000016,body weighing method,,0.0,,,,,control condition,103981,control condition,,,,,,,, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001317,GK/MolTac,male,147 days,6,,CMO:0000012,body weight,,,,373,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,,,,running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours),103982,running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours),,,running on treadmill (15 m/min) (for 0.5 hours),,,running on treadmill (15 m/min) (for 0.8 hours),, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001317,GK/MolTac,male,147 days,N/A,,CMO:0000012,body weight,,,,389,g,7.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition,103983,control condition,,,,,,,, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001317,GK/MolTac,male,147 days,N/A,,CMO:0000012,body weight,,,,374,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours),103984,running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours),,,running on treadmill (15 m/min) (for 0.5 hours),,,running on treadmill (15 m/min) (for 0.8 hours),, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001317,GK/MolTac,male,147 days,N/A,,CMO:0000012,body weight,,,,389,g,7.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days),103985,control condition,,,controlled saxagliptin content diet (10 mg/kg/d) (for 12 days),,,,, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",body mass,,RS:0001317,GK/MolTac,male,147 days,N/A,,CMO:0000012,body weight,,,,366,g,6.0,,MMO:0000016,body weighing method,,0.0,,,,,running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours),103986,running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours),,,controlled saxagliptin content diet (10 mg/kg/d) (for 12 days),,,running on treadmill (15 m/min) (for 0.5 hours),,running on treadmill (15 m/min) (for 0.8 hours) 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000580,MNS,male,84 days,9,,CMO:0000012,body weight,,,,336,g,8.3333,25.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,104061,control condition,,,,,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000577,MHS,male,84 days,9,,CMO:0000012,body weight,,,,339,g,10.6667,32.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,104062,control condition,,,,,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0001011,Crl:WI,male,84 days,8,,CMO:0000012,body weight,,,,330,g,6.364,18.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,104063,control condition,,,,,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000580,MNS,male,168 days,8,,CMO:0000012,body weight,,,,470,g,10.253,29.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,104064,control condition,,,,,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000580,MNS,male,168 days,8,,CMO:0000012,body weight,,,,370,g,13.7886,39.0,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days),104065,streptozotocin (55 mg/kg) ,,,insulin (4 IU/kg) (for 84 days),,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000577,MHS,male,168 days,8,,CMO:0000012,body weight,,,,473,g,17.6777,50.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,104066,control condition,,,,,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000577,MHS,male,168 days,9,,CMO:0000012,body weight,,,,364,g,13.6667,41.0,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days),104067,streptozotocin (55 mg/kg) ,,,insulin (4 IU/kg) (for 84 days),,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000580,MNS,male,252 days,14,,CMO:0000012,body weight,,,,552,g,6.4143,24.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,104068,control condition,,,,,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000580,MNS,male,252 days,12,,CMO:0000012,body weight,,,,345,g,15.0111,52.0,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days),104069,streptozotocin (55 mg/kg) ,,,insulin (4 IU/kg) (for 168 days),,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000577,MHS,male,252 days,14,,CMO:0000012,body weight,,,,558,g,7.4833,28.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,104070,control condition,,,,,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0000577,MHS,male,252 days,14,,CMO:0000012,body weight,,,,337,g,12.5613,47.0,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days),104071,streptozotocin (55 mg/kg) ,,,insulin (4 IU/kg) (for 168 days),,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0001011,Crl:WI,male,252 days,10,,CMO:0000012,body weight,,,,558,g,24.6658,78.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,104072,control condition,,,,,,,, 2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",body mass,,RS:0001011,Crl:WI,male,252 days,14,,CMO:0000012,body weight,,,,354,g,10.6904,40.0,MMO:0000016,body weighing method,,0.0,,,,,streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days),104073,streptozotocin (55 mg/kg) ,,,insulin (4 IU/kg) (for 168 days),,,,, 2926,"Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1.",body mass,,RS:0000580,MNS,not specified,25 days to 23 days,11,,CMO:0000012,body weight,,,,71,g,2.6,8.6232,MMO:0000016,body weighing method,,0.0,,,,,control condition,104154,control condition,,,,,,,, 2926,"Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1.",body mass,,RS:0000577,MHS,not specified,25 days to 23 days,11,,CMO:0000012,body weight,,,,72,g,2.1,6.9649,MMO:0000016,body weighing method,,0.0,,,,,control condition,104155,control condition,,,,,,,, 2927,"Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92.",body mass,,RS:0000580,MNS,male,63 days,10,,CMO:0000012,body weight,,,,270.8,g,4.3007,13.6,MMO:0000016,body weighing method,,0.0,,,,,standard diet,104192,standard diet,,,,,,,, 2927,"Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92.",body mass,,RS:0000577,MHS,male,63 days,10,,CMO:0000012,body weight,,,,245.4,g,3.9845,12.6,MMO:0000016,body weighing method,,0.0,,,,,standard diet,104193,standard diet,,,,,,,, 2927,"Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92.",body mass,,RS:0000577,MHS,male,63 days,10,,CMO:0000012,body weight,,,,235,g,1.8657,5.9,MMO:0000016,body weighing method,,0.0,,,,,standard diet,104194,standard diet,,,,,,,, 2927,"Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92.",body mass,,RS:0000580,MNS,male,270 days,10,,CMO:0000012,body weight,,,,565.2,g,8.0638,25.5,MMO:0000016,body weighing method,,0.0,,,,,standard diet,104195,standard diet,,,,,,,, 2927,"Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92.",body mass,,RS:0000577,MHS,male,270 days,10,,CMO:0000012,body weight,,,,538.6,g,6.7673,21.4,MMO:0000016,body weighing method,,0.0,,,,,standard diet,104196,standard diet,,,,,,,, 2927,"Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92.",body mass,,RS:0000577,MHS,male,63 days,10,,CMO:0000012,body weight,,,,544.4,g,11.4474,36.2,MMO:0000016,body weighing method,,0.0,,,,,standard diet,104197,standard diet,,,,,,,, 2948,"Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10.",body mass,,RS:0004609,SS-Kcnj1em1Kasu+/+,male,13 days,6,,CMO:0000012,body weight,,,,29.5,g,0.4,0.9798,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 13 days),104415,control condition (for 13 days),,,,,,,, 2948,"Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10.",body mass,,RS:0004613,SS-Kcnj1em1Kasu+/-,male,13 days,6,,CMO:0000012,body weight,,,,26.6,g,1.4,3.4293,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 13 days),104416,control condition (for 13 days),,,,,,,, 2948,"Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10.",body mass,,RS:0004614,SS-Kcnj1em1Kasu-/-,male,13 days,5,,CMO:0000012,body weight,,,,14.3,g,0.2,0.4472,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 13 days),104417,control condition (for 13 days),,,,,,,, 3008,"Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15.",body mass,,RS:0004653,F344-Hsd11b2em1Jmul-/-,male,98 days,7,,CMO:0000012,body weight,,,,276.7,g,4.1,10.8476,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow,104989,standard rat chow,,,,,,,, 3008,"Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15.",body mass,,RS:0004656,F344-Hsd11b2em1Jmul+/+,male,98 days,9,,CMO:0000012,body weight,,,,319.8,g,6.1,18.3,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow,104990,standard rat chow,,,,,,,, 3008,"Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15.",body mass,,RS:0004653,F344-Hsd11b2em1Jmul-/-,female,98 days,5,,CMO:0000012,body weight,,,,166.2,g,2.6,5.8138,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow,104991,standard rat chow,,,,,,,, 3008,"Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15.",body mass,,RS:0004656,F344-Hsd11b2em1Jmul+/+,female,98 days,4,,CMO:0000012,body weight,,,,190.5,g,2.5,5.0,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow,104992,standard rat chow,,,,,,,, 3017,"Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13.",body mass,,RS:0001011,Crl:WI,male,140 days to 70 days,8,,CMO:0000012,body weight,,,,511,g,45.0,127.2792,MMO:0000016,body weighing method,,0.0,,,,,control condition,105506,control condition,,,,,,,, 3017,"Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13.",body mass,,RS:0004673,WI-Mc4rm1Hubr,male,140 days to 70 days,8,,CMO:0000012,body weight,,,,793,g,95.0,268.7006,MMO:0000016,body weighing method,,0.0,,,,,control condition,105507,control condition,,,,,,,, 3022,"Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18.",body mass,,RS:0003089,SS-Plekha7em4Mcwi+/+,male,63 days,10,,CMO:0000012,body weight,,,,250,g,8.0,25.2982,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 42 days),105736,controlled sodium content diet (0.4 %) (for 42 days),,,,,,,, 3022,"Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18.",body mass,,RS:0003088,SS-Plekha7em4Mcwi-/-,male,63 days,10,,CMO:0000012,body weight,,,,264,g,9.0,28.4605,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (0.4 %) (for 42 days),105737,controlled sodium content diet (0.4 %) (for 42 days),,,,,,,, 3022,"Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18.",body mass,,RS:0003089,SS-Plekha7em4Mcwi+/+,male,91 days,10,,CMO:0000012,body weight,,,,371,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days),105742,controlled sodium content diet (8 %) (for 28 days),,,,,,,, 3022,"Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18.",body mass,,RS:0003088,SS-Plekha7em4Mcwi-/-,male,91 days,10,,CMO:0000012,body weight,,,,279,g,4.0,12.6491,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days),105743,controlled sodium content diet (8 %) (for 28 days),,,,,,,, 3025,"Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13.",body mass,,RS:0000698,Hsd:SD,male,84 days,5,,CMO:0000012,body weight,,,,386.2,g,20.4,45.6158,MMO:0000016,body weighing method,,,,,,,control condition (for 84 days),106438,control condition (for 84 days),,,,,,,, 3025,"Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13.",body mass,,RS:0004674,SD-Ahrem2Sage,male,84 days,5,,CMO:0000012,body weight,,,,380.5,g,12.6,28.1745,MMO:0000016,body weighing method,,,,,,,control condition (for 84 days),106439,control condition (for 84 days),,,,,,,, 3025,"Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13.",body mass,,RS:0000698,Hsd:SD,female,84 days,5,,CMO:0000012,body weight,,,,257.6,g,27.2,60.821,MMO:0000016,body weighing method,,,,,,,control condition (for 84 days),106440,control condition (for 84 days),,,,,,,, 3025,"Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13.",body mass,,RS:0004674,SD-Ahrem2Sage,female,84 days,5,,CMO:0000012,body weight,,,,252.7,g,18.8,42.0381,MMO:0000016,body weighing method,,,,,,,control condition (for 84 days),106441,control condition (for 84 days),,,,,,,, 3032,"Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5.",body mass,,RS:0000811,SS/JrHsdMcwi,male,56 days,7,,CMO:0000012,body weight,,,,261,g,6.0,15.8745,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,106550,vehicle control condition,,,,,,,, 3032,"Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5.",body mass,,RS:0001480,SS-Sod3m1Mcwi,male,56 days,10,,CMO:0000012,body weight,,,,259,g,2.8,8.8544,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition,106551,vehicle control condition,,,,,,,, 3032,"Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5.",body mass,,RS:0000811,SS/JrHsdMcwi,male,56 days,11,,CMO:0000012,body weight,,,,208,g,4.1,13.5982,MMO:0000016,body weighing method,,0.0,,,,,monocrotaline (40 mg/kg) ,106552,monocrotaline (40 mg/kg) ,,,,,,,, 3032,"Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5.",body mass,,RS:0001480,SS-Sod3m1Mcwi,male,56 days,15,,CMO:0000012,body weight,,,,205,g,4.6,17.8157,MMO:0000016,body weighing method,,0.0,,,,,monocrotaline (40 mg/kg) ,106553,monocrotaline (40 mg/kg) ,,,,,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,328,g,5.4,15.2735,MMO:0000016,body weighing method,,0.0,,,,,sham surgical control condition (for 56 days) and water (for 56 days) and standard rat chow (for 56 days),106640,sham surgical control condition (for 56 days),water (for 56 days),standard rat chow (for 56 days),,,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,319,g,5.0,14.1421,MMO:0000016,body weighing method,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days),106641,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),,,,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,345,g,6.9,19.5161,MMO:0000016,body weighing method,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and darusentan (50 mg/kg/d) (for 56 days),106642,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),darusentan (50 mg/kg/d) (for 56 days),,,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000677,SBH/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,359,g,3.1,8.7681,MMO:0000016,body weighing method,,0.0,,,,,sham surgical control condition (for 56 days) and water (for 56 days) and standard rat chow (for 56 days),106643,sham surgical control condition (for 56 days),water (for 56 days),standard rat chow (for 56 days),,,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000677,SBH/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,340,g,8.9,25.173,MMO:0000016,body weighing method,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days),106644,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),,,,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,377,g,7.4,20.9304,MMO:0000016,body weighing method,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and darusentan (50 mg/kg/d) (for 56 days),106645,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),darusentan (50 mg/kg/d) (for 56 days),,,,,, 3038,"Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.",body mass,,RS:0000677,SBH/Ygl,male,98 days,7,,CMO:0000012,body weight,,,,295,g,10.0,26.4575,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.65 %) (for 98 days),106700,controlled sodium chloride content diet (0.65 %) (for 98 days),,,,,,,, 3038,"Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.",body mass,,RS:0000677,SBH/Ygl,male,98 days,7,,CMO:0000012,body weight,,,,270,g,7.0,18.5203,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 42 days),106701,controlled sodium chloride content diet (8 %) (for 42 days),,,,,,,, 3038,"Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.",body mass,,RS:0000677,SBH/Ygl,male,98 days,7,,CMO:0000012,body weight,,,,223,g,15.0,39.6863,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days),106702,controlled sodium chloride content diet (0.65 %) (for 98 days),,,streptozotocin (60 mg/kg) ,,,insulin (10 ul) (for 42 days),, 3038,"Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.",body mass,,RS:0000677,SBH/Ygl,male,98 days,7,,CMO:0000012,body weight,,,,216,g,13.0,34.3948,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days),106703,controlled sodium chloride content diet (8 %) (for 42 days),,,streptozotocin (60 mg/kg) ,,,insulin (10 ul) (for 42 days),, 3070,"Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.",body mass,,RS:0004817,GK/CskCrlj,male,238 days to 224 days,10,,CMO:0000012,body weight,,,,412.9,g,10.8,34.1526,MMO:0000016,body weighing method,,0.0,,,,,control condition,106889,control condition,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",body mass,body weight,RS:0001317,GK/MolTac,female,60 days,6,,CMO:0000012,body weight,,,,209,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,,,,control condition,106893,control condition,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",body mass,body weight,RS:0001317,GK/MolTac,female,240 days,11,,CMO:0000012,body weight,,,,280,g,6.0,19.8997,MMO:0000016,body weighing method,,0.0,,,,,control condition,106894,control condition,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",body mass,body weight,RS:0001317,GK/MolTac,female,420 days,11,,CMO:0000012,body weight,,,,292,g,6.0,19.8997,MMO:0000016,body weighing method,,0.0,,,,,control condition,106895,control condition,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",body mass,body weight,RS:0001602,WKY/NMolTac,female,60 days,6,,CMO:0000012,body weight,,,,178,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,,,,control condition,106896,control condition,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",body mass,body weight,RS:0001602,WKY/NMolTac,female,240 days,9,,CMO:0000012,body weight,,,,253,g,4.0,12.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,106897,control condition,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",body mass,body weight,RS:0001602,WKY/NMolTac,female,420 days,9,,CMO:0000012,body weight,,,,268,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,106898,control condition,,,,,,,, 3070,"Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.",body mass,,RS:0004403,Slc:ZUC-Leprfa-/-,male,105 days to 84 days,44,,CMO:0000012,body weight,,slc:zuc-leprfa-/-,,499.6,g,7.3,48.4227,MMO:0000016,body weighing method,,0.0,,,,,control condition,106935,control condition,,,,,,,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",body mass,,RS:0002538,SHRSP/A3NCrl,male,141 days to 134 days,8,,CMO:0000012,body weight,,normal diet,,332,g,3.0,8.4853,MMO:0000016,body weighing method,,0.0,normal diet,,,,control condition,106957,control condition,,,,,,,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",body mass,,RS:0002538,SHRSP/A3NCrl,male,141 days to 134 days,11,,CMO:0000012,body weight,,high salt/fat diet HSFD,,315,g,7.0,23.2164,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days),106958,controlled sodium chloride content drinking water (1 %) (for 49 days),controlled fat content diet (24.5 %) (for 49 days),,,,,,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",body mass,,RS:0002538,SHRSP/A3NCrl,male,141 days to 134 days,6,,CMO:0000012,body weight,,HSFD +0.1 mg/kg/day GSK2181236A,,331,g,16.0,39.1918,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled GSK2181236A content diet (0.1 mg/kg/d) (for 42 days),106959,controlled sodium chloride content drinking water (1 %) (for 49 days),controlled fat content diet (24.5 %) (for 49 days),,controlled GSK2181236A content diet (0.1 mg/kg/d) (for 42 days),,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,female,63 days,2,,CMO:0000012,body weight,,,,152,g,0.0,5.7,MMO:0000016,body weighing method,,0.0,,,,,control condition,106960,control condition,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,female,0 days to 98 days,2,,CMO:0000012,body weight,,,,224,g,0.0,9.2,MMO:0000016,body weighing method,,0.0,,,,,control condition,106961,control condition,,,,,,,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",body mass,,RS:0002538,SHRSP/A3NCrl,male,141 days to 134 days,10,,CMO:0000012,body weight,,HSFD +1.0 mg/kg/day GSK2181236A,,338,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled GSK2181236A content diet (1 mg/kg/d) (for 42 days),106962,controlled sodium chloride content drinking water (1 %) (for 49 days),controlled fat content diet (24.5 %) (for 49 days),,controlled GSK2181236A content diet (1 mg/kg/d) (for 42 days),,,,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",body mass,,RS:0002538,SHRSP/A3NCrl,male,141 days to 134 days,9,,CMO:0000012,body weight,,HSFD +0.3 mg/kg/day BAY 60-4552,,328,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled BAY60-4552 content diet (0.3 mg/kg/d) (for 42 days),106963,controlled sodium chloride content drinking water (1 %) (for 49 days),controlled fat content diet (24.5 %) (for 49 days),,controlled BAY60-4552 content diet (0.3 mg/kg/d) (for 42 days),,,,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",body mass,,RS:0002538,SHRSP/A3NCrl,male,141 days to 134 days,10,,CMO:0000012,body weight,,HSFD +3.0 mg/kg/day BAY 60-4552,,345,g,14.0,44.2719,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled BAY60-4552 content diet (3 mg/kg/d) (for 42 days),106964,controlled sodium chloride content drinking water (1 %) (for 49 days),controlled fat content diet (24.5 %) (for 49 days),,controlled BAY60-4552 content diet (3 mg/kg/d) (for 42 days),,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,female,84 days,2,,CMO:0000012,body weight,,,,207,g,0.0,15.6,MMO:0000016,body weighing method,,0.0,,,,,control condition,106977,control condition,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,female,0 days to 119 days,2,,CMO:0000012,body weight,,,,241,g,7.9903,11.3,MMO:0000016,body weighing method,,0.0,,,,,control condition,106978,control condition,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,female,63 days,2,,CMO:0000012,body weight,,,,148,g,1.9799,2.8,MMO:0000016,body weighing method,,0.0,,,,,control condition,106979,control condition,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,female,0 days to 98 days,2,,CMO:0000012,body weight,,,,211,g,4.5255,6.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,106980,control condition,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,female,63 days,2,,CMO:0000012,body weight,,,,173,g,7.4953,10.6,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (0.4 ml) ,106981,0.9% sodium chloride solution (0.4 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,male,63 days,2,,CMO:0000012,body weight,,,,233,g,26.5165,37.5,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (0.4 ml) ,106982,0.9% sodium chloride solution (0.4 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,female,56 days,2,,CMO:0000012,body weight,,,,135,g,0.0,0.0,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (0.4 ml) ,106983,0.9% sodium chloride solution (0.4 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,male,56 days,2,,CMO:0000012,body weight,,,,200,g,6.0104,8.5,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (0.4 ml) ,106984,0.9% sodium chloride solution (0.4 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,female,56 days,2,,CMO:0000012,body weight,,,,126,g,4.0305,5.7,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (0.4 ml) ,106985,0.9% sodium chloride solution (0.4 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,male,56 days,2,,CMO:0000012,body weight,,,,178,g,5.0205,7.1,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (0.4 ml) ,106986,0.9% sodium chloride solution (0.4 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,female,84 days,8,,CMO:0000012,body weight,,,,206,g,3.182,9.0,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106987,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,female,63 days,8,,CMO:0000012,body weight,,,,161,g,2.3688,6.7,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106988,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,female,63 days,8,,CMO:0000012,body weight,,,,146,g,2.4395,6.9,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106989,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,female,63 days,4,,CMO:0000012,body weight,,,,180,g,2.35,4.7,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106990,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,male,63 days,4,,CMO:0000012,body weight,,,,237,g,4.65,9.3,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106991,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,female,56 days,4,,CMO:0000012,body weight,,,,140,g,6.8,13.6,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106992,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,male,56 days,4,,CMO:0000012,body weight,,,,197,g,5.15,10.3,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106993,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,female,56 days,4,,CMO:0000012,body weight,,,,126,g,3.9,7.8,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106994,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,male,56 days,4,,CMO:0000012,body weight,,,,203,g,4.9,9.8,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,106995,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,female,0 days to 119 days,8,,CMO:0000012,body weight,,,,232,g,3.1466,8.9,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107002,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,female,0 days to 98 days,8,,CMO:0000012,body weight,,,,198,g,2.7577,7.8,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107003,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,female,0 days to 98 days,8,,CMO:0000012,body weight,,,,224,g,3.1113,8.8,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107004,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,female,0 days to 98 days,4,,CMO:0000012,body weight,,,,210,g,3.05,6.1,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107005,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,male,0 days to 98 days,4,,CMO:0000012,body weight,,,,361,g,8.8,17.6,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107006,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,female,0 days to 91 days,4,,CMO:0000012,body weight,,,,222,g,8.9,17.8,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107007,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,male,0 days to 91 days,4,,CMO:0000012,body weight,,,,386,g,8.35,16.7,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107008,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,female,0 days to 91 days,4,,CMO:0000012,body weight,,,,195,g,6.25,12.5,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107009,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,male,0 days to 91 days,4,,CMO:0000012,body weight,,,,327,g,10.0,20.0,MMO:0000016,body weighing method,,0.0,,,,,Azoxymethane (15 mg/kg) ,107010,Azoxymethane (15 mg/kg) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,female,0 days to 98 days,2,,CMO:0000012,body weight,,,,231,g,7.4953,10.6,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (1 ml) ,107011,0.9% sodium chloride solution (1 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000093,BDIX/Orl,male,0 days to 98 days,2,,CMO:0000012,body weight,,,,358,g,23.4759,33.2,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (1 ml) ,107012,0.9% sodium chloride solution (1 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,female,0 days to 91 days,2,,CMO:0000012,body weight,,,,232,g,4.5255,6.4,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (1 ml) ,107013,0.9% sodium chloride solution (1 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000363,F344/NHsd,male,0 days to 91 days,2,,CMO:0000012,body weight,,,,417,g,17.4655,24.7,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (1 ml) ,107014,0.9% sodium chloride solution (1 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,female,0 days to 91 days,2,,CMO:0000012,body weight,,,,200,g,6.0104,8.5,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (1 ml) ,107015,0.9% sodium chloride solution (1 ml) ,,,,,,,, 3074,"Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7.",body mass,body weight,RS:0000969,WAG/Rij,male,0 days to 91 days,2,,CMO:0000012,body weight,,,,326,g,18.0312,25.5,MMO:0000016,body weighing method,,0.0,,,,,0.9% sodium chloride solution (1 ml) ,107016,0.9% sodium chloride solution (1 ml) ,,,,,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",body mass,,RS:0000775,SHRSP/A3N,male,224 days to 203 days,10,,CMO:0000012,body weight,,high salt high fat diet +carvedilol,,367,g,10.0,31.6228,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107103,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",body mass,,RS:0000775,SHRSP/A3N,male,224 days to 203 days,10,,CMO:0000012,body weight,,high salt high fat diet,,329,g,6.0,18.9737,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days),107104,controlled sodium chloride content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),,,,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",body mass,,RS:0000775,SHRSP/A3N,male,224 days to 203 days,10,,CMO:0000012,body weight,,standard rat chow,,341,g,4.0,12.6491,MMO:0000016,body weighing method,,0.0,,,,,standard condition (for 126 days),107106,standard condition (for 126 days),,,,,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",body mass,,RS:0000731,WKY/NCrl,male,224 days to 203 days,10,,CMO:0000012,body weight,,standard rat chow,,409,g,7.0,22.1359,MMO:0000016,body weighing method,,0.0,,,,,standard condition (for 126 days),107108,standard condition (for 126 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000021,ACI/Eur,male,95 days to 89 days,9,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.1,%,0.9,2.7,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107171,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0001805,BN/HsdMcwiCrl,male,95 days to 89 days,11,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,1.5,%,0.6,1.99,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107172,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.9,%,1.0,3.1623,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107173,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000363,F344/NHsd,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,5.7,%,0.9,2.846,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107176,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000521,LEW/NHsd,male,95 days to 89 days,9,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,5,%,0.7,2.1,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107178,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000645,PVG/OlaHsd,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,5.9,%,1.0,3.1623,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107180,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000785,SR/Hsd,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,2.2,%,0.7,2.2136,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107181,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0002215,SS/HsdMcwiCrl,male,95 days to 89 days,8,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.6,%,0.8,2.2627,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107182,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000239,DA/Bkl,male,95 days to 89 days,9,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,4.7,%,1.0,3.0,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107183,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000754,SHR/NHsd,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,4.5,%,0.8,2.5298,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107184,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000134,BN/Crl,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.6,%,0.7,2.2136,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107185,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000695,Crl:SD,male,95 days to 89 days,11,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.3,%,0.6,1.99,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107186,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000178,FHH/EurMcwiCrl,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,6.4,%,0.5,1.5811,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107187,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000593,MWF/Hsd,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,5.1,%,0.8,2.5298,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107188,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0001789,BDIX/CrCrl,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.1,%,0.6,1.8974,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107189,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0002075,NBL/CrCrl,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,2.7,%,0.1,0.3162,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107190,arterial catheter implantation (for 1 days),,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0001789,BDIX/CrCrl,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,331,g,9.0,28.4605,MMO:0000016,body weighing method,,0.0,,,,,control condition,107345,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000134,BN/Crl,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,259,g,6.0,18.9737,MMO:0000016,body weighing method,,0.0,,,,,control condition,107346,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0001805,BN/HsdMcwiCrl,male,94 days to 88 days,11,,CMO:0000012,body weight,,,,276,g,4.0,13.2665,MMO:0000016,body weighing method,,0.0,,,,,control condition,107347,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0002215,SS/HsdMcwiCrl,male,94 days to 88 days,8,,CMO:0000012,body weight,,,,341,g,16.0,45.2548,MMO:0000016,body weighing method,,0.0,,,,,control condition,107348,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000178,FHH/EurMcwiCrl,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,361,g,7.0,22.1359,MMO:0000016,body weighing method,,0.0,,,,,control condition,107349,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0002075,NBL/CrCrl,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,317,g,10.0,31.6228,MMO:0000016,body weighing method,,0.0,,,,,control condition,107350,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000695,Crl:SD,male,94 days to 88 days,11,,CMO:0000012,body weight,,,,448,g,8.0,26.533,MMO:0000016,body weighing method,,0.0,,,,,control condition,107351,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0003549,ACI/EurMcwi,male,94 days to 88 days,9,,CMO:0000012,body weight,,,,230,g,4.0,12.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,107352,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000185,COP/CrCrl,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,250,g,3.0,9.4868,MMO:0000016,body weighing method,,0.0,,,,,control condition,107353,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000244,DA/OlaHsd,male,94 days to 88 days,9,,CMO:0000012,body weight,,,,258,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,107354,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000363,F344/NHsd,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,283,g,8.0,25.2982,MMO:0000016,body weighing method,,0.0,,,,,control condition,107355,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000521,LEW/NHsd,male,94 days to 88 days,9,,CMO:0000012,body weight,,,,302,g,6.0,18.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,107356,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000593,MWF/Hsd,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,276,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,,,,control condition,107357,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000645,PVG/OlaHsd,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,261,g,4.0,12.6491,MMO:0000016,body weighing method,,0.0,,,,,control condition,107358,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000754,SHR/NHsd,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,323,g,4.0,12.6491,MMO:0000016,body weighing method,,0.0,,,,,control condition,107359,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000785,SR/Hsd,male,94 days to 88 days,10,,CMO:0000012,body weight,,,,316,g,8.0,25.2982,MMO:0000016,body weighing method,,0.0,,,,,control condition,107360,control condition,,,,,,,, 3083,"Lenhard SC, etal., J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. doi: 10.1124/jpet.103.057398. Epub 2003 Oct 15.",body mass,,RS:0002538,SHRSP/A3NCrl,male,175 days to 161 days,8,,CMO:0000012,body weight,,,,310,g,7.0,19.799,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 91 days) and controlled fat content diet (24.5 %) (for 91 days) then controlled SB-239063 content diet (1200 ppm) (for 35 days),107381,controlled sodium chloride content drinking water (1 %) (for 91 days),controlled fat content diet (24.5 %) (for 91 days),,controlled SB-239063 content diet (1200 ppm) (for 35 days),,,,, 3083,"Lenhard SC, etal., J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. doi: 10.1124/jpet.103.057398. Epub 2003 Oct 15.",body mass,,RS:0002538,SHRSP/A3NCrl,male,175 days to 161 days,6,,CMO:0000012,body weight,,,,307,g,8.0,19.5959,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 91 days) and controlled fat content diet (24.5 %) (for 91 days) then vehicle control condition (for 35 days),107382,controlled sodium chloride content drinking water (1 %) (for 91 days),controlled fat content diet (24.5 %) (for 91 days),,vehicle control condition (for 35 days),,,,, 3083,"Lenhard SC, etal., J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. doi: 10.1124/jpet.103.057398. Epub 2003 Oct 15.",body mass,,RS:0002538,SHRSP/A3NCrl,male,175 days to 161 days,7,,CMO:0000012,body weight,,,,311,g,4.0,10.583,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 91 days),107383,control condition (for 91 days),,,,,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",body mass,,RS:0004090,LH/MavRrrcAek,male,84 days,N/A,,CMO:0002804,body weight to body length (nose to rump) ratio,,,,15.9,g/cm,0.21,,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow (for 84 days),107398,standard rat chow (for 84 days),,,,,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",body mass,,RS:0004091,LN/MavRrrcAek,male,84 days,N/A,,CMO:0002804,body weight to body length (nose to rump) ratio,,,,11.9,g/cm,0.12,,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow (for 84 days),107399,standard rat chow (for 84 days),,,,,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",body mass,,RS:0004090,LH/MavRrrcAek,male,112 days,N/A,,CMO:0002804,body weight to body length (nose to rump) ratio,,,,17,g/cm,0.21,,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow (for 98 days) then controlled sodium chloride content diet (4 %) (for 14 days),107400,standard rat chow (for 98 days),,,controlled sodium chloride content diet (4 %) (for 14 days),,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",body mass,,RS:0004091,LN/MavRrrcAek,male,112 days,N/A,,CMO:0002804,body weight to body length (nose to rump) ratio,,,,13.2,g/cm,0.22,,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow (for 98 days) then controlled sodium chloride content diet (4 %) (for 14 days),107401,standard rat chow (for 98 days),,,controlled sodium chloride content diet (4 %) (for 14 days),,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",body mass,,RS:0004090,LH/MavRrrcAek,male,126 days to 21 days,N/A,,CMO:0003452,maximum slope of body weight growth curve,y=mx + c,maximum slope of body weight growth curve (CMO:0003452),,45.1,g/week,0.74,,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow (for 98 days) then controlled sodium chloride content diet (4 %) (for 21 days),107402,standard rat chow (for 98 days),,,controlled sodium chloride content diet (4 %) (for 21 days),,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",body mass,,RS:0004091,LN/MavRrrcAek,male,126 days to 21 days,N/A,,CMO:0003452,maximum slope of body weight growth curve,y=mx+c,maximum slope of body weight growth curve (CMO:0003452),,35.2,g/week,0.52,,MMO:0000016,body weighing method,,0.0,,,,,standard rat chow (for 98 days) then controlled sodium chloride content diet (4 %) (for 21 days),107403,standard rat chow (for 98 days),,,controlled sodium chloride content diet (4 %) (for 21 days),,,,, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,11,,CMO:0000012,body weight,,,,408,g,10.0,33.1662,MMO:0000016,body weighing method,,0.0,,unx,150,days,unilateral nephrectomy (for 150 days) then vehicle control condition,107445,unilateral nephrectomy (for 150 days),,,vehicle control condition,,,,, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,17,,CMO:0000012,body weight,,,,256,g,5.0,20.6155,MMO:0000016,body weighing method,,0.0,,unx,150,days,unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition,107446,unilateral nephrectomy (for 150 days),,,streptozotocin (35 mg/kg) ,,,vehicle control condition,, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,17,,CMO:0000012,body weight,,,,274,g,6.0,24.7386,MMO:0000016,body weighing method,,0.0,,unx,150,days,unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days),107447,unilateral nephrectomy (for 150 days),,,streptozotocin (35 mg/kg) ,,,bosentan (100 mg/kg/d) (for 136 days),, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,16,,CMO:0000012,body weight,,,,261,g,7.0,28.0,MMO:0000016,body weighing method,,0.0,,unx,150,days,unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days),107448,unilateral nephrectomy (for 150 days),,,streptozotocin (35 mg/kg) ,,,enalapril (10 mg/kg/d) (for 136 days),, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",body mass,,RS:0000742,WKY,male,0 days,16,,CMO:0000012,body weight,,,,267,g,9.0,36.0,MMO:0000016,body weighing method,,0.0,,unx,150,days,unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days),107449,unilateral nephrectomy (for 150 days),,,streptozotocin (35 mg/kg) ,,,enalapril (10 mg/kg/d) (for 136 days),bosentan (100 mg/kg/d) (for 136 days), 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",body mass,,RS:0000714,WKY/N,male,147 days to 126 days,N/A,,CMO:0000012,body weight,,,,309,g,8.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 42 days),107525,control condition (for 42 days),,,,,,,, 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",body mass,,RS:0000775,SHRSP/A3N,male,147 days to 126 days,N/A,,CMO:0000012,body weight,,,,293,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 42 days),107526,control condition (for 42 days),,,,,,,, 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",body mass,,RS:0000775,SHRSP/A3N,male,147 days to 126 days,N/A,,CMO:0000012,body weight,,,,254,g,7.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 42 days) and controlled fat content diet (24.5 %) (for 42 days) and vehicle control condition (for 42 days),107527,controlled sodium chloride content drinking water (1 %) (for 42 days),controlled fat content diet (24.5 %) (for 42 days),vehicle control condition (for 42 days),,,,,, 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",body mass,,RS:0000775,SHRSP/A3N,male,147 days to 126 days,N/A,,CMO:0000012,body weight,,,,298,g,2.0,,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 42 days) and controlled fat content diet (24.5 %) (for 42 days) and eprosartan (60 mg/kg/d) (for 42 days),107528,controlled sodium chloride content drinking water (1 %) (for 42 days),controlled fat content diet (24.5 %) (for 42 days),eprosartan (60 mg/kg/d) (for 42 days),,,,,, 3093,"Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665.",body mass,,RS:0000775,SHRSP/A3N,male,140 days to 120 days,24,,CMO:0000012,body weight,,,,316,g,9.0,44.0908,MMO:0000016,body weighing method,,0.0,,,,,control condition,107572,control condition,,,,,,,, 3093,"Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665.",body mass,,RS:0000775,SHRSP/A3N,male,140 days to 120 days,10,,CMO:0000012,body weight,,,,254,g,11.0,34.7851,MMO:0000016,body weighing method,,0.0,,,,,reproduction condition,107573,reproduction condition,,,,,,,, 3093,"Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665.",body mass,,RS:0000775,SHRSP/A3N,female,140 days to 120 days,24,,CMO:0000012,body weight,,,,207,g,4.0,19.5959,MMO:0000016,body weighing method,,0.0,,,,,control condition,107574,control condition,,,,,,,, 3093,"Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665.",body mass,,RS:0000775,SHRSP/A3N,female,140 days to 120 days,15,,CMO:0000012,body weight,,,,158,g,14.0,54.2218,MMO:0000016,body weighing method,,0.0,,,,,reproduction condition,107575,reproduction condition,,,,,,,, 3098,"Pross M, et al., Surg Endosc. 2001 Aug;15(8):882-5. doi: 10.1007/s004640090029. Epub 2001 May 2.",body mass,,RS:0000967,WAG,male,0 days,16,,CMO:0000012,body weight,,,,263,g,2.2,8.8,MMO:0000016,body weighing method,,0.0,,,,,control condition,107870,control condition,,,,,,,, 3098,"Pross M, et al., Surg Endosc. 2001 Aug;15(8):882-5. doi: 10.1007/s004640090029. Epub 2001 May 2.",body mass,,RS:0000967,WAG,male,0 days,16,,CMO:0000012,body weight,,,,271.9,g,1.775,7.1,MMO:0000016,body weighing method,,0.0,,,,,control condition,107871,control condition,,,,,,,, 3098,"Pross M, et al., Surg Endosc. 2001 Aug;15(8):882-5. doi: 10.1007/s004640090029. Epub 2001 May 2.",body mass,,RS:0000967,WAG,male,0 days,16,,CMO:0000012,body weight,,,,272.4,g,3.35,13.4,MMO:0000016,body weighing method,,0.0,cells and vehicle injected,IP injection,21,days,CC531 cells (5 X 10E6) (for 21 days) then vehicle control condition (1 ml) (for 21 days),107872,CC531 cells (5 X 10E6) (for 21 days),,,vehicle control condition (1 ml) (for 21 days),,,,, 3098,"Pross M, et al., Surg Endosc. 2001 Aug;15(8):882-5. doi: 10.1007/s004640090029. Epub 2001 May 2.",body mass,,RS:0000967,WAG,male,0 days,16,,CMO:0000012,body weight,,,,281.87,g,1.9775,7.91,MMO:0000016,body weighing method,,0.0,cells and vehicle injected,IP injection,21,days,CC531 cells (5 X 10E6) (for 21 days) then phosphoramidon (250 mg) (for 21 days),107873,CC531 cells (5 X 10E6) (for 21 days),,,phosphoramidon (250 mg) (for 21 days),,,,, 3104,"Echevarria-Uraga JJ, et al., Int J Nanomedicine. 2012;7:2399-410. doi: 10.2147/IJN.S31302. Epub 2012 May 9.",body mass,,RS:0002249,WAG/RijCrl,male,148 days,23,,CMO:0000012,body weight,,,,288,g,7.2355,34.7,MMO:0000016,body weighing method,,0.0,,CC531 injection,28,days,CC531 cells (25 X 10E3) (for 28 days),107971,CC531 cells (25 X 10E3) (for 28 days),,,,,,,, 3104,"Echevarria-Uraga JJ, et al., Int J Nanomedicine. 2012;7:2399-410. doi: 10.2147/IJN.S31302. Epub 2012 May 9.",body mass,,RS:0002249,WAG/RijCrl,male,148 days,19,,CMO:0000012,body weight,,,,292,g,8.8096,38.4,MMO:0000016,body weighing method,,0.0,,CC531 injection,28,days,CC531 cells (25 X 10E3) (for 28 days) then iron oxide nanoparticles (2.6 mg) (for 0.1 hours),107972,CC531 cells (25 X 10E3) (for 28 days),,,iron oxide nanoparticles (2.6 mg) (for 0.1 hours),,,,, 3106,"Wakuta M, etal., Invest Ophthalmol Vis Sci. 2007 Feb;48(2):590-6. doi: 10.1167/iovs.05-1168.",body mass,,RS:0001995,GK/CskCrljCrl,male,105 days to 91 days,6,,CMO:0000012,body weight,,,,347,g,6.9402,17.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,107991,control condition,,,,,,,, 3106,"Wakuta M, etal., Invest Ophthalmol Vis Sci. 2007 Feb;48(2):590-6. doi: 10.1167/iovs.05-1168.",body mass,,RS:0001840,Crlj:WI,male,105 days to 91 days,5,,CMO:0000012,body weight,,,,474,g,13.8636,31.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,107992,control condition,,,,,,,, 3108,"Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1.",body mass,,RS:0004852,W/Jpe,male,540 days to 450 days,20,,CMO:0000420,body weight gain,,wistar,,2.4,g,0.8,3.5777,MMO:0000016,body weighing method,,0.0,,,,,control condition,107999,control condition,,,,,,,, 3108,"Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1.",body mass,,RS:0004851,GK/Jpe,male,540 days to 450 days,20,,CMO:0000420,body weight gain,,,,1.5,g,0.7,3.1305,MMO:0000016,body weighing method,,0.0,,,,,control condition,108000,control condition,,,,,,,, 3108,"Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1.",body mass,,RS:0004851,GK/Jpe,male,540 days to 450 days,10,,CMO:0000420,body weight gain,,,,7.6,g,2.6,8.2219,MMO:0000016,body weighing method,,0.0,,,,,controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days),108001,controlled cholesterol content diet (1.25 %) (for 90 days),controlled cocoa butter content diet (7.5 %) (for 90 days),,,,,,, 3108,"Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1.",body mass,,RS:0004851,GK/Jpe,male,540 days to 450 days,10,,CMO:0000420,body weight gain,,,,50.1,g,6.4,20.2386,MMO:0000016,body weighing method,,0.0,,,,,controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then soybean oil (2 ml/kg) (for 90 days),108002,controlled cholesterol content diet (1.25 %) (for 90 days),controlled cocoa butter content diet (7.5 %) (for 90 days),,soybean oil (2 ml/kg) (for 90 days),,,,, 3108,"Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1.",body mass,,RS:0004851,GK/Jpe,male,540 days to 450 days,10,,CMO:0000420,body weight gain,,,,11.9,g,3.7,11.7004,MMO:0000016,body weighing method,,0.0,,,,,controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then alpha-lipoic acid (50 mg/kg) (for 90 days),108003,controlled cholesterol content diet (1.25 %) (for 90 days),controlled cocoa butter content diet (7.5 %) (for 90 days),,alpha-lipoic acid (50 mg/kg) (for 90 days),,,,, 3109,"Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11.",body mass,,RS:0001592,HanTac:WH,male,112 days,N/A,,CMO:0000012,body weight,,,,375,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108024,control condition,,,,,,,, 3109,"Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11.",body mass,,RS:0001317,GK/MolTac,male,112 days,N/A,,CMO:0000012,body weight,,,,351,g,5.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108025,control condition,,,,,,,, 3109,"Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11.",body mass,,RS:0001592,HanTac:WH,male,154 days,N/A,,CMO:0000012,body weight,,,,452,g,13.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108026,control condition,,,,,,,, 3109,"Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11.",body mass,,RS:0001317,GK/MolTac,male,154 days,N/A,,CMO:0000012,body weight,,,,419,g,7.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108027,control condition,,,,,,,, 3110,"Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6.",body mass,,RS:0000963,W/Kyo,male,63 days,6,,CMO:0000012,body weight,,,,219,g,2.0,4.899,MMO:0000016,body weighing method,,0.0,,,,,control condition,108038,control condition,,,,,,,, 3110,"Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6.",body mass,,RS:0000963,W/Kyo,male,63 days,6,,CMO:0000012,body weight,,,,194,g,3.0,7.3485,MMO:0000016,body weighing method,,0.0,,,,,running on treadmill (15 m/min) (for 1 hours),108039,running on treadmill (15 m/min) (for 1 hours),,,,,,,, 3110,"Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6.",body mass,,RS:0001299,GK,male,63 days,6,,CMO:0000012,body weight,,,,240,g,6.0,14.6969,MMO:0000016,body weighing method,,0.0,,,,,control condition,108040,control condition,,,,,,,, 3110,"Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6.",body mass,,RS:0001299,GK,male,63 days,6,,CMO:0000012,body weight,,,,223,g,5.0,12.2474,MMO:0000016,body weighing method,,0.0,,,,,running on treadmill (15 m/min) (for 1 hours),108041,running on treadmill (15 m/min) (for 1 hours),,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0000596,MWF/FubRkb,not specified,-6 days,N/A,,CMO:0002080,fetal body weight,,,,0.236,g,0.004,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108067,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0000596,MWF/FubRkb,not specified,-4 days,N/A,,CMO:0002080,fetal body weight,,,,0.619,g,0.014,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108068,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0000596,MWF/FubRkb,not specified,-2 days,N/A,,CMO:0002080,fetal body weight,,,,2.03,g,0.05,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108069,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0001014,Hsd:WI,not specified,-6 days,N/A,,CMO:0002080,fetal body weight,,,,0.312,g,0.004,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108070,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0001014,Hsd:WI,not specified,-4 days,N/A,,CMO:0002080,fetal body weight,,,,0.868,g,0.013,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108071,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0001014,Hsd:WI,not specified,-2 days,N/A,,CMO:0002080,fetal body weight,,,,2.26,g,0.03,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108072,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0001014,Hsd:WI,not specified,1 days,N/A,,CMO:0002079,neonatal body weight,,,,6.58,g,0.16,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108076,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0000596,MWF/FubRkb,not specified,1 days,N/A,,CMO:0002079,neonatal body weight,,,,6.12,g,0.8,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108077,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0001014,Hsd:WI,not specified,7 days,N/A,,CMO:0002079,neonatal body weight,,,,14.3,g,0.2,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108078,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0000596,MWF/FubRkb,not specified,7 days,N/A,,CMO:0002079,neonatal body weight,,,,13.4,g,0.2,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108079,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0001014,Hsd:WI,not specified,12 days,N/A,,CMO:0002079,neonatal body weight,,,,22.8,g,0.4,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108080,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0000596,MWF/FubRkb,not specified,12 days,N/A,,CMO:0002079,neonatal body weight,,,,21.6,g,0.6,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108081,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0001014,Hsd:WI,not specified,100 days,N/A,,CMO:0000012,body weight,,,,376,g,8.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108082,control condition,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",body mass,,RS:0000596,MWF/FubRkb,not specified,100 days,N/A,,CMO:0000012,body weight,,,,334,g,6.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition,108083,control condition,,,,,,,, 3070,"Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.",body mass,,RS:0001036,WKY/NCrlCrlj,male,238 days to 224 days,5,,CMO:0000012,body weight,,,,622.7,g,31.7,70.8834,MMO:0000016,body weighing method,,0.0,,,,,control condition,108091,control condition,,,,,,,, 3070,"Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.",body mass,,RS:0005130,Slc:ZUC-Leprfa+,male,105 days to 84 days,9,,CMO:0000012,body weight,,slc:zuc-leprfa+,,342.7,g,2.9,8.7,MMO:0000016,body weighing method,,0.0,,,,,control condition,108663,control condition,,,,,,,, 3130,"Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19.",body mass,,RS:0000593,MWF/Hsd,male,84 days,5,,CMO:0000012,body weight,,,,249,g,14.0,31.305,MMO:0000016,body weighing method,,0.0,,,,,control condition,108752,control condition,,,,,,,, 3130,"Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19.",body mass,,RS:0004793,HsdCpb:WU,male,84 days,5,,CMO:0000012,body weight,,,,386,g,7.0,15.6525,MMO:0000016,body weighing method,,0.0,,,,,control condition,108753,control condition,,,,,,,, 3130,"Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19.",body mass,,RS:0004793,HsdCpb:WU,male,175 days,6,,CMO:0000012,body weight,,,,466,g,14.0,34.2929,MMO:0000016,body weighing method,,0.0,,,,,left anterior descending coronary artery occlusion,108786,left anterior descending coronary artery occlusion,,,,,,,, 3130,"Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19.",body mass,,RS:0004793,HsdCpb:WU,male,175 days,10,,CMO:0000012,body weight,,,,482,g,11.0,34.7851,MMO:0000016,body weighing method,,0.0,,,,,sham surgical control condition,108787,sham surgical control condition,,,,,,,, 3130,"Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19.",body mass,,RS:0000593,MWF/Hsd,male,175 days,9,,CMO:0000012,body weight,,,,340,g,9.0,27.0,MMO:0000016,body weighing method,,0.0,,,,,sham surgical control condition,108788,sham surgical control condition,,,,,,,, 3130,"Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19.",body mass,,RS:0000593,MWF/Hsd,male,175 days,10,,CMO:0000012,body weight,,,,342,g,8.0,25.2982,MMO:0000016,body weighing method,,0.0,,,,,left anterior descending coronary artery occlusion,108789,left anterior descending coronary artery occlusion,,,,,,,, 3133,"Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22.",body mass,,RS:0000744,SHR/FubRkb,male,168 days,10,,CMO:0000012,body weight,,,,377.5,g,4.4,13.914,MMO:0000016,body weighing method,,0.0,,,,,control condition,108916,control condition,,,,,,,, 3133,"Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22.",body mass,,RS:0000744,SHR/FubRkb,female,168 days,10,,CMO:0000012,body weight,,,,208,g,5.5,17.3925,MMO:0000016,body weighing method,,0.0,,,,,control condition,108917,control condition,,,,,,,, 3133,"Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22.",body mass,,RS:0002073,MWF-Chr 8SHR/Rkb,male,168 days,20,,CMO:0000012,body weight,,,,351.1,g,6.8,30.4105,MMO:0000016,body weighing method,,0.0,,,,,control condition,108918,control condition,,,,,,,, 3133,"Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22.",body mass,,RS:0002073,MWF-Chr 8SHR/Rkb,female,168 days,20,,CMO:0000012,body weight,,,,204.4,g,2.4,10.7331,MMO:0000016,body weighing method,,0.0,,,,,control condition,108919,control condition,,,,,,,, 3133,"Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22.",body mass,,RS:0000596,MWF/FubRkb,male,168 days,18,,CMO:0000012,body weight,,,,363.9,g,11.3,47.9418,MMO:0000016,body weighing method,,0.0,,,,,control condition,108920,control condition,,,,,,,, 3133,"Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22.",body mass,,RS:0000596,MWF/FubRkb,female,168 days,18,,CMO:0000012,body weight,,,,207.2,g,1.2,5.0912,MMO:0000016,body weighing method,,0.0,,,,,control condition,108921,control condition,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",body mass,,RS:0000519,LEW/Mol,female,104 days,8,,CMO:0000012,body weight,,,,193,g,2.6,7.3539,MMO:0000016,body weighing method,,0.0,,,,,standard diet,108996,standard diet,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",body mass,,RS:0000519,LEW/Mol,male,104 days,8,,CMO:0000012,body weight,,,,280,g,8.5,24.0416,MMO:0000016,body weighing method,,0.0,,,,,standard diet,108997,standard diet,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",body mass,,RS:0000519,LEW/Mol,female,104 days,8,,CMO:0000012,body weight,,,,195,g,1.7,4.8083,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 56 days),108998,controlled sodium chloride content diet (8 %) (for 56 days),,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",body mass,,RS:0000519,LEW/Mol,male,104 days,8,,CMO:0000012,body weight,,,,287,g,3.6,10.1823,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 56 days),108999,controlled sodium chloride content diet (8 %) (for 56 days),,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",body mass,,RS:0000595,MWF/Fub,female,104 days,8,,CMO:0000012,body weight,,,,193,g,2.8,7.9196,MMO:0000016,body weighing method,,0.0,,,,,standard diet,109000,standard diet,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",body mass,,RS:0000595,MWF/Fub,male,104 days,8,,CMO:0000012,body weight,,,,319,g,7.1,20.0818,MMO:0000016,body weighing method,,0.0,,,,,standard diet,109001,standard diet,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",body mass,,RS:0000595,MWF/Fub,female,104 days,8,,CMO:0000012,body weight,,,,188,g,1.6,4.5255,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 56 days),109002,controlled sodium chloride content diet (8 %) (for 56 days),,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",body mass,,RS:0000595,MWF/Fub,male,104 days,8,,CMO:0000012,body weight,,,,310,g,3.9,11.0309,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content diet (8 %) (for 56 days),109003,controlled sodium content diet (8 %) (for 56 days),,,,,,,, 3116,"Schulz A, etal., Physiol Genomics. 2010 Jun.",body mass,,RS:0000744,SHR/FubRkb,male,84 days,N/A,,CMO:0000012,body weight,,,,248,g,8.5,,MMO:0000016,body weighing method,,0.0,,,,,control condition,109034,control condition,,,,,,,, 3116,"Schulz A, etal., Physiol Genomics. 2010 Jun.",body mass,,RS:0000744,SHR/FubRkb,male,84 days,N/A,,CMO:0000012,body weight,,,,263.5,g,9.8,,MMO:0000016,body weighing method,,0.0,,,,,controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days),109035,controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days),,,,,,,, 3116,"Schulz A, etal., Physiol Genomics. 2010 Jun.",body mass,,RS:0002404,SHR-Chr 6MWF/Rkb,male,84 days,N/A,,CMO:0000012,body weight,,,,280.5,g,15.3,,MMO:0000016,body weighing method,,0.0,,,,,control condition,109036,control condition,,,,,,,, 3116,"Schulz A, etal., Physiol Genomics. 2010 Jun.",body mass,,RS:0002404,SHR-Chr 6MWF/Rkb,male,84 days,N/A,,CMO:0000012,body weight,,,,277.5,g,17.9,,MMO:0000016,body weighing method,,0.0,,,,,controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days),109038,controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days),,,,,,,, 3116,"Schulz A, etal., Physiol Genomics. 2010 Jun.",body mass,,RS:0000596,MWF/FubRkb,male,84 days,N/A,,CMO:0000012,body weight,,,,279.3,g,5.5,,MMO:0000016,body weighing method,,0.0,,,,,control condition,109039,control condition,,,,,,,, 3116,"Schulz A, etal., Physiol Genomics. 2010 Jun.",body mass,,RS:0000596,MWF/FubRkb,male,84 days,N/A,,CMO:0000012,body weight,,,,270.7,g,4.9,,MMO:0000016,body weighing method,,0.0,,,,,controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days),109040,controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days),,,,,,,, 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",body mass,,RS:0001299,GK,male,77 days,10,,CMO:0000012,body weight,,,,315.12,g,4.1299,13.06,MMO:0000016,body weighing method,,0.0,,,,,control condition,109066,control condition,,,,,,,, 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",body mass,,RS:0001299,GK,male,77 days,10,,CMO:0000012,body weight,,,,319.82,g,3.956,12.51,MMO:0000016,body weighing method,,0.0,,,,,control condition,109070,control condition,,,,,,,, 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",body mass,,RS:0001299,GK,male,77 days,10,,CMO:0000012,body weight,,,,301.31,g,6.9886,22.1,MMO:0000016,body weighing method,,0.0,,,,,control condition,109071,control condition,,,,,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000032,ACI/SegHsd,male,95 days to 89 days,9,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,56.9,%,0.5,1.5,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (between 1 and 1.2 days) then controlled hemorrhage (between 1 and 6 hours),109123,arterial catheter implantation (between 1 and 1.2 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0001805,BN/HsdMcwiCrl,male,95 days to 89 days,11,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,,,56.8,%,0.4,1.3266,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109124,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,,,57.1,%,0.4,1.2649,MMO:0000016,body weighing method,,,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109125,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000363,F344/NHsd,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,57.8,%,0.4,1.2649,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109126,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000521,LEW/NHsd,male,95 days to 89 days,9,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,57.2,%,1.1,3.3,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109127,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000645,PVG/OlaHsd,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,58.3,%,0.5,1.5811,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109128,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000785,SR/Hsd,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,56,%,0.4,1.2649,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109129,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0002215,SS/HsdMcwiCrl,male,95 days to 89 days,8,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,56.5,%,0.6,1.6971,MMO:0000016,body weighing method,,,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109130,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000244,DA/OlaHsd,male,95 days to 89 days,9,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,57.3,%,0.4,1.2,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109131,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000754,SHR/NHsd,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,57.4,%,0.7,2.2136,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109132,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000134,BN/Crl,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,56.5,%,0.6,1.8974,MMO:0000016,body weighing method,,,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109133,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000695,Crl:SD,male,95 days to 89 days,11,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,56.8,%,0.2,0.6633,MMO:0000016,body weighing method,,,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109134,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000178,FHH/EurMcwiCrl,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,58,%,0.5,1.5811,MMO:0000016,body weighing method,,,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109135,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000593,MWF/Hsd,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,57.5,%,0.4,1.2649,MMO:0000016,body weighing method,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109136,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0001789,BDIX/CrCrl,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,56.9,%,0.3,0.9487,MMO:0000016,body weighing method,,,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109137,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0002075,NBL/CrCrl,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663),,56.7,%,0.6,1.8974,MMO:0000016,body weighing method,,,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109138,arterial catheter implantation (for 1 days),,,controlled hemorrhage (between 1 and 6 hours),,,,, 3138,"Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206.",body mass,,RS:0004778,MWF/Ztm,male,147 days to 105 days,8,,CMO:0000012,body weight,,,,317,g,18.7383,53.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,109197,standard diet,,,,,,,, 3138,"Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206.",body mass,,RS:0004778,MWF/Ztm,female,153 days to 126 days,8,,CMO:0000012,body weight,,,,218,g,3.8891,11.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,109198,standard diet,,,,,,,, 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",body mass,,RS:0000731,WKY/NCrl,male,84 days,10,,CMO:0000012,body weight,,,,282.4,g,4.9,15.4952,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),109272,control condition (for 0 hours),,,,,,,, 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",body mass,,RS:0000744,SHR/FubRkb,male,84 days,10,,CMO:0000012,body weight,,,,287.2,g,9.3,29.4092,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),109273,control condition (for 0 hours),,,,,,,, 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",body mass,,RS:0000596,MWF/FubRkb,male,84 days,10,,CMO:0000012,body weight,,,,302.6,g,4.3,13.5978,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 0 hours),109274,control condition (for 0 hours),,,,,,,, 3144,"van Hoesel QG, etal., J Natl Cancer Inst. 1986 Feb;76(2):299-307.",body mass,,RS:0000566,LOU/M,male,84 days,43,,CMO:0000012,body weight,,,,259,g,3.2025,21.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,109289,control condition,,,,,,,, 3144,"van Hoesel QG, etal., J Natl Cancer Inst. 1986 Feb;76(2):299-307.",body mass,,RS:0000566,LOU/M,female,84 days,43,,CMO:0000012,body weight,,,,162,g,1.83,12.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,109290,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0004778,MWF/Ztm,male,10 days,5,,CMO:0000012,body weight,,,,16.2,g,0.246,0.55,MMO:0000016,body weighing method,,0.0,,,,,control condition,109294,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0004778,MWF/Ztm,male,20 days,5,,CMO:0000012,body weight,,,,34.7,g,0.9078,2.03,MMO:0000016,body weighing method,,0.0,,,,,control condition,109295,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0004778,MWF/Ztm,male,45 days,5,,CMO:0000012,body weight,,,,170,g,2.576,5.76,MMO:0000016,body weighing method,,0.0,,,,,control condition,109296,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0004778,MWF/Ztm,male,60 days,5,,CMO:0000012,body weight,,,,229.9,g,4.3961,9.83,MMO:0000016,body weighing method,,0.0,,,,,control condition,109297,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0004778,MWF/Ztm,male,100 days,5,,CMO:0000012,body weight,,,,311.7,g,18.0227,40.3,MMO:0000016,body weighing method,,0.0,,,,,control condition,109298,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0004778,MWF/Ztm,male,150 days,5,,CMO:0000012,body weight,,,,420.5,g,6.4399,14.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,109299,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0000533,LEW/Ztm,male,10 days,5,,CMO:0000012,body weight,,,,20.1,g,0.3801,0.85,MMO:0000016,body weighing method,,0.0,,,,,control condition,109300,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0000533,LEW/Ztm,male,20 days,5,,CMO:0000012,body weight,,,,36,g,0.8005,1.79,MMO:0000016,body weighing method,,0.0,,,,,control condition,109301,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0000533,LEW/Ztm,male,45 days,5,,CMO:0000012,body weight,,,,178.9,g,5.8585,13.1,MMO:0000016,body weighing method,,0.0,,,,,control condition,109302,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0000533,LEW/Ztm,male,60 days,5,,CMO:0000012,body weight,,,,249.7,g,7.2001,16.1,MMO:0000016,body weighing method,,0.0,,,,,control condition,109303,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0000533,LEW/Ztm,male,100 days,5,,CMO:0000012,body weight,,,,338.1,g,3.5777,8.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,109304,control condition,,,,,,,, 3137,"Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882.",body mass,,RS:0000533,LEW/Ztm,male,150 days,5,,CMO:0000012,body weight,,,,365.9,g,17.2177,38.5,MMO:0000016,body weighing method,,0.0,,,,,control condition,109305,control condition,,,,,,,, 3140,"Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.",body mass,,RS:0001011,Crl:WI,male,112 days,10,,CMO:0000012,body weight,,,,391.8,g,17.2,54.3912,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 28 days),109387,vehicle control condition (for 28 days),,,,,,,, 3140,"Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.",body mass,,RS:0001011,Crl:WI,male,112 days,10,,CMO:0000012,body weight,,,,392.5,g,12.7,40.1609,MMO:0000016,body weighing method,,0.0,,,,,finerenone (10 mg/kg/d) (for 28 days),109388,finerenone (10 mg/kg/d) (for 28 days),,,,,,,, 3140,"Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.",body mass,,RS:0000596,MWF/FubRkb,male,112 days,10,,CMO:0000012,body weight,,,,362.8,g,12.8,40.4772,MMO:0000016,body weighing method,,0.0,,,,,vehicle control condition (for 28 days),109389,vehicle control condition (for 28 days),,,,,,,, 3140,"Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.",body mass,,RS:0000596,MWF/FubRkb,male,112 days,10,,CMO:0000012,body weight,,,,350.3,g,9.0,28.4605,MMO:0000016,body weighing method,,0.0,,,,,finerenone (10 mg/kg/d) (for 28 days),109390,finerenone (10 mg/kg/d) (for 28 days),,,,,,,, 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0000596,MWF/FubRkb,not specified,-6 days,11,,CMO:0002080,fetal body weight,,,,0.26,g,0.0096,0.032,MMO:0000016,body weighing method,,0.0,,,,,control condition,109501,control condition,,,,,,,, 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0000744,SHR/FubRkb,not specified,-6 days,10,,CMO:0002080,fetal body weight,,,,0.181,g,0.0089,0.028,MMO:0000016,body weighing method,,0.0,,,,,control condition,109502,control condition,,,,,,,, 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0000744,SHR/FubRkb,not specified,-5 days,10,,CMO:0002080,fetal body weight,,,,0.249,g,0.0082,0.026,MMO:0000016,body weighing method,,0.0,,,,,control condition,109503,control condition,,,,,,,, 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,-6 days,12,,CMO:0002080,fetal body weight,,,,0.27,g,0.0061,0.021,MMO:0000016,body weighing method,,0.0,,,,,control condition,109505,control condition,,,,,,,, 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,-6 days,12,,CMO:0002080,fetal body weight,,,,0.265,g,0.0049,0.017,MMO:0000016,body weighing method,,0.0,,,,,control condition,109506,control condition,,,,,,,, 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0000744,SHR/FubRkb,not specified,-5 days,10,,CMO:0002080,fetal body weight,,,,0.24,g,0.007,0.022,MMO:0000016,body weighing method,,0.0,,,,,control condition,109507,control condition,,,,,,,, 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0000596,MWF/FubRkb,not specified,-6 days,11,,CMO:0002080,fetal body weight,,,,0.258,g,0.0084,0.028,MMO:0000016,body weighing method,,0.0,,,,,control condition,109508,control condition,,,,,,,, 3148,"Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22.",body mass,,RS:0000744,SHR/FubRkb,male,168 days,9,,CMO:0000012,body weight,,,,329.2,g,8.2,24.6,MMO:0000016,body weighing method,,0.0,,,,,sham surgical control condition (for 126 days),109549,sham surgical control condition (for 126 days),,,,,,,, 3148,"Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22.",body mass,,RS:0000744,SHR/FubRkb,male,168 days,15,,CMO:0000012,body weight,,,,330.4,g,6.0,23.2379,MMO:0000016,body weighing method,,0.0,,,,,unilateral nephrectomy (for 126 days),109550,unilateral nephrectomy (for 126 days),,,,,,,, 3148,"Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22.",body mass,,RS:0003207,SHR-Chr 8MWF/Rkb,male,168 days,9,,CMO:0000012,body weight,,,,345,g,7.8,23.4,MMO:0000016,body weighing method,,0.0,,,,,sham surgical control condition (for 126 days),109551,sham surgical control condition (for 126 days),,,,,,,, 3148,"Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22.",body mass,,RS:0003207,SHR-Chr 8MWF/Rkb,male,168 days,15,,CMO:0000012,body weight,,,,336.5,g,6.7,25.949,MMO:0000016,body weighing method,,0.0,,,,,unilateral nephrectomy (for 126 days),109552,unilateral nephrectomy (for 126 days),,,,,,,, 3150,"van Hoesel QG, etal., Cancer Res. 1984 Sep;44(9):3698-705.",body mass,,RS:0004900,LOU/MWsl,male,115 days to 105 days,6,,CMO:0002218,change in body weight to initial body weight ratio,,,,-8.1,%,,,MMO:0000016,body weighing method,,0.0,,,,,rat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 10 days),109575,rat IgM immunocytoma cells (1 x 10E4 cells) ,,,doxorubicin (1 mg/kg) (for 10 days),,,,, 3150,"van Hoesel QG, etal., Cancer Res. 1984 Sep;44(9):3698-705.",body mass,,RS:0004900,LOU/MWsl,male,115 days to 105 days,6,,CMO:0002218,change in body weight to initial body weight ratio,,,,-4.1,%,,,MMO:0000016,body weighing method,,0.0,,,,,rat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days),109576,rat IgM immunocytoma cells (1 x 10E4 cells) ,,,negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days),,,,, 3150,"van Hoesel QG, etal., Cancer Res. 1984 Sep;44(9):3698-705.",body mass,,RS:0004900,LOU/MWsl,male,115 days to 105 days,6,,CMO:0002218,change in body weight to initial body weight ratio,,,,-3.2,%,,,MMO:0000016,body weighing method,,0.0,,,,,rat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days),109577,rat IgM immunocytoma cells (1 x 10E4 cells) ,,,positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days),,,,, 3150,"van Hoesel QG, etal., Cancer Res. 1984 Sep;44(9):3698-705.",body mass,,RS:0004900,LOU/MWsl,male,133 days to 105 days,6,,CMO:0002218,change in body weight to initial body weight ratio,,,,10,%,,,MMO:0000016,body weighing method,,0.0,,,,,rat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 28 days),109578,rat IgM immunocytoma cells (1 x 10E4 cells) ,,,negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 28 days),,,,, 3150,"van Hoesel QG, etal., Cancer Res. 1984 Sep;44(9):3698-705.",body mass,,RS:0004900,LOU/MWsl,male,119 days to 105 days,6,,CMO:0002218,change in body weight to initial body weight ratio,,,,-40,%,,,MMO:0000016,body weighing method,,0.0,,,,,rat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (2 mg/kg) (for 14 days),109579,rat IgM immunocytoma cells (1 x 10E4 cells) ,,,doxorubicin (2 mg/kg) (for 14 days),,,,, 3150,"van Hoesel QG, etal., Cancer Res. 1984 Sep;44(9):3698-705.",body mass,,RS:0004900,LOU/MWsl,male,119 days to 105 days,6,,CMO:0002218,change in body weight to initial body weight ratio,,,,-10,%,,,MMO:0000016,body weighing method,,0.0,,,,,rat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 14 days),109580,rat IgM immunocytoma cells (1 x 10E4 cells) ,,,negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 14 days),,,,, 3152,"Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16.",body mass,,RS:0000596,MWF/FubRkb,male,30 days,5,,CMO:0000012,body weight,,,,98.42,g,0.8765,1.96,MMO:0000016,body weighing method,,0.0,,,,,control condition,109703,control condition,,,,,,,, 3152,"Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16.",body mass,,RS:0000596,MWF/FubRkb,female,30 days,5,,CMO:0000012,body weight,,,,80.61,g,3.7163,8.31,MMO:0000016,body weighing method,,0.0,,,,,control condition,109704,control condition,,,,,,,, 3152,"Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16.",body mass,,RS:0000596,MWF/FubRkb,male,44 days,5,,CMO:0000012,body weight,,,,203.06,g,10.2859,23.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,109705,control condition,,,,,,,, 3152,"Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16.",body mass,,RS:0000596,MWF/FubRkb,female,44 days,5,,CMO:0000012,body weight,,,,145.2,g,2.4373,5.45,MMO:0000016,body weighing method,,0.0,,,,,control condition,109706,control condition,,,,,,,, 3152,"Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16.",body mass,,RS:0000596,MWF/FubRkb,male,58 days,5,,CMO:0000012,body weight,,,,241.28,g,4.4721,10.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,109707,control condition,,,,,,,, 3152,"Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16.",body mass,,RS:0000596,MWF/FubRkb,female,58 days,5,,CMO:0000012,body weight,,,,164.3,g,5.5633,12.44,MMO:0000016,body weighing method,,0.0,,,,,control condition,109708,control condition,,,,,,,, 3153,"Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5.",body mass,,RS:0000531,LEW/SsNHsd,male,182 days,12,,CMO:0000012,body weight,,,,415,g,6.0,20.7846,MMO:0000016,body weighing method,,0.0,,,,,control condition,109752,control condition,,,,,,,, 3155,"van Hoesel QG, etal., J Natl Cancer Inst. 1984 May;72(5):1141-50.",body mass,,RS:0004900,LOU/MWsl,male,144 days,5,,CMO:0002218,change in body weight to initial body weight ratio,,,,-15,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,,,42,days,doxorubicin (1 mg/kg) (for 42 days),109753,doxorubicin (1 mg/kg) (for 42 days),,,,,,,, 3155,"van Hoesel QG, etal., J Natl Cancer Inst. 1984 May;72(5):1141-50.",body mass,,RS:0004900,LOU/MWsl,male,109 days,5,,CMO:0002218,change in body weight to initial body weight ratio,,,,-24,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,,,7,days,doxorubicin (2 mg/kg) (for 7 days),109754,doxorubicin (2 mg/kg) (for 7 days),,,,,,,, 3153,"Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5.",body mass,,RS:0000178,FHH/EurMcwiCrl,male,182 days,14,,CMO:0000012,body weight,,,,375,g,4.0,14.9666,MMO:0000016,body weighing method,,0.0,,,,,control condition,109755,control condition,,,,,,,, 3153,"Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5.",body mass,,RS:0000593,MWF/Hsd,male,182 days,12,,CMO:0000012,body weight,,,,375,g,7.0,24.2487,MMO:0000016,body weighing method,,0.0,,,,,control condition,109756,control condition,,,,,,,, 3156,"Kreutz R, etal., J Hypertens. 2007 Nov;25(11):2308-16. doi: 10.1097/HJH.0b013e3282ef8611.",body mass,,RS:0000595,MWF/Fub,male,112 days,8,,CMO:0000012,body weight,,,,372.8,g,12.1269,34.3,MMO:0000016,body weighing method,,0.0,,,,,control condition,109846,control condition,,,,,,,, 3156,"Kreutz R, etal., J Hypertens. 2007 Nov;25(11):2308-16. doi: 10.1097/HJH.0b013e3282ef8611.",body mass,,RS:0001011,Crl:WI,male,112 days,8,,CMO:0000012,body weight,,,,455.7,g,12.8693,36.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,109847,control condition,,,,,,,, 3159,"Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105.",body mass,,RS:0001011,Crl:WI,female,300 days to 270 days,11,,CMO:0000012,body weight,,,,289.4,g,6.6,21.8897,MMO:0000016,body weighing method,,0.0,,,,,control condition,109873,control condition,,,,,,,, 3159,"Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105.",body mass,,RS:0004579,GK/Par,female,300 days to 270 days,14,,CMO:0000012,body weight,,,,284.6,g,4.4,16.4633,MMO:0000016,body weighing method,,0.0,,,,,control condition,109874,control condition,,,,,,,, 3159,"Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105.",body mass,,RS:0004579,GK/Par,female,300 days to 270 days,9,,CMO:0000012,body weight,,,,267.5,g,5.7,17.1,MMO:0000016,body weighing method,,0.0,,,,,controlled ethanol content drinking water used as vehicle (1 %) (for 56 days),109875,controlled ethanol content drinking water used as vehicle (1 %) (for 56 days),,,,,,,, 3159,"Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105.",body mass,,RS:0004579,GK/Par,female,300 days to 270 days,8,,CMO:0000012,body weight,,,,269.7,g,6.4,18.1019,MMO:0000016,body weighing method,,0.0,56 days in drinking water,,,,controlled resveratrol content drinking water (1 mg/kg/d) (for 56 days),109876,controlled resveratrol content drinking water (1 mg/kg/d) (for 56 days),,,,,,,, 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",body mass,,RS:0001299,GK,male,0 days,20,,CMO:0000012,body weight,,,,338,g,3.7,16.5469,MMO:0000016,body weighing method,,0.0,,,,,resting (for 42 days),109895,resting (for 42 days),,,,,,,, 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",body mass,,RS:0001299,GK,male,0 days,20,,CMO:0000012,body weight,,,,314,g,2.7,12.0748,MMO:0000016,body weighing method,,0.0,,,,,running (3.91 km/d) (for 42 days),109896,running (3.91 km/d) (for 42 days),,,,,,,, 3162,"Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9.",body mass,,RS:0004778,MWF/Ztm,male,210 days,10,,CMO:0000012,body weight,,,,423,g,5.3759,17.0,MMO:0000016,body weighing method,,0.0,,,,,standard diet,109975,standard diet,,,,,,,, 3162,"Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9.",body mass,,RS:0004778,MWF/Ztm,male,210 days,7,,CMO:0000012,body weight,,,,417,g,12.8508,34.0,MMO:0000016,body weighing method,,0.0,,,,,controlled lisinopril content drinking water (50 mg/l) (for 70 days),109976,controlled lisinopril content drinking water (50 mg/l) (for 70 days),,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",body mass,,RS:0000594,MWF,male,146 days to 132 days,7,,CMO:0000012,body weight,,,,374,g,13.6067,36.0,MMO:0000016,body weighing method,,0.0,,,,,castor oil (for 7 days),109994,castor oil (for 7 days),,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",body mass,,RS:0000594,MWF,male,146 days to 132 days,6,,CMO:0000012,body weight,,,,376,g,8.9815,22.0,MMO:0000016,body weighing method,,0.0,,,,,cyclosporine A (50 mg/kg/d) (for 7 days),110001,cyclosporine A (50 mg/kg/d) (for 7 days),,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",body mass,,RS:0000594,MWF,male,146 days to 132 days,7,,CMO:0000012,body weight,,,,381,g,5.6695,15.0,MMO:0000016,body weighing method,,0.0,,,,,cyclosporine A (50 mg/kg/d) (for 7 days) and lacidipine (1 mg/kg/d) (for 7 days),110002,cyclosporine A (50 mg/kg/d) (for 7 days),lacidipine (1 mg/kg/d) (for 7 days),,,,,,, 3164,"Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14.",body mass,,RS:0000580,MNS,not specified,87 days to 85 days,11,,CMO:0000012,body weight,,,,350,g,6.0,19.8997,MMO:0000016,body weighing method,,0.0,,,,,control condition,110138,control condition,,,,,,,, 3164,"Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14.",body mass,,RS:0000577,MHS,not specified,87 days to 85 days,11,,CMO:0000012,body weight,,,,364,g,5.0,16.5831,MMO:0000016,body weighing method,,0.0,,,,,control condition,110139,control condition,,,,,,,, 3166,"Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904.",body mass,,RS:0000681,SD,female,121 days to 96 days,7,,CMO:0000012,body weight,,,,201,g,4.9135,13.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,110176,control condition,,,,,,,, 3166,"Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904.",body mass,,RS:0000594,MWF,female,121 days to 96 days,10,,CMO:0000012,body weight,,,,190,g,2.2136,7.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,110177,control condition,,,,,,,, 3166,"Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904.",body mass,,RS:0000681,SD,female,121 days to 96 days,7,,CMO:0000012,body weight,,,,192,g,2.6458,7.0,MMO:0000016,body weighing method,,0.0,,,,,doxorubicin (5 mg/kg) (between 6 and 7 days),110178,doxorubicin (5 mg/kg) (between 6 and 7 days),,,,,,,, 3166,"Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904.",body mass,,RS:0000594,MWF,female,121 days to 96 days,11,,CMO:0000012,body weight,,,,182,g,4.8242,16.0,MMO:0000016,body weighing method,,0.0,,,,,doxorubicin (5 mg/kg) (between 6 and 7 days),110179,doxorubicin (5 mg/kg) (between 6 and 7 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001592,HanTac:WH,female,56 days,8,,CMO:0000012,body weight,,,,173,g,6.0,16.9706,MMO:0000016,body weighing method,,0.0,,,,,control condition,110241,control condition,,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001592,HanTac:WH,female,56 days,8,,CMO:0000012,body weight,,,,178,g,4.0,11.3137,MMO:0000016,body weighing method,,0.0,,,,,control condition,110242,control condition,,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001317,GK/MolTac,female,56 days,9,,CMO:0000012,body weight,,,,188,g,3.0,9.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,110243,control condition,,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001317,GK/MolTac,female,56 days,10,,CMO:0000012,body weight,,,,191,g,3.0,9.4868,MMO:0000016,body weighing method,,0.0,,,,,control condition,110244,control condition,,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001592,HanTac:WH,female,70 days,8,,CMO:0000012,body weight,,,,203,g,7.0,19.799,MMO:0000016,body weighing method,,0.0,,,,,control IgG monoclonal antibody (1 mg) (for 14 days),110245,control IgG monoclonal antibody (1 mg) (for 14 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001592,HanTac:WH,female,70 days,8,,CMO:0000012,body weight,,,,208,g,4.0,11.3137,MMO:0000016,body weighing method,,0.0,,,,,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 14 days),110246,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 14 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001317,GK/MolTac,female,70 days,9,,CMO:0000012,body weight,,,,207,g,5.0,15.0,MMO:0000016,body weighing method,,0.0,,,,,control IgG monoclonal antibody (1 mg) (for 14 days),110247,control IgG monoclonal antibody (1 mg) (for 14 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001317,GK/MolTac,female,70 days,10,,CMO:0000012,body weight,,,,212,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,,,,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 14 days),110248,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 14 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001592,HanTac:WH,female,84 days,8,,CMO:0000012,body weight,,,,219,g,7.0,19.799,MMO:0000016,body weighing method,,0.0,,,,,control IgG monoclonal antibody (1 mg) (for 28 days),110249,control IgG monoclonal antibody (1 mg) (for 28 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001592,HanTac:WH,female,84 days,8,,CMO:0000012,body weight,,,,230,g,4.0,11.3137,MMO:0000016,body weighing method,,0.0,,,,,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 28 days),110250,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 28 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001317,GK/MolTac,female,84 days,9,,CMO:0000012,body weight,,,,230,g,4.0,12.0,MMO:0000016,body weighing method,,0.0,,,,,control IgG monoclonal antibody (1 mg) (for 28 days),110251,control IgG monoclonal antibody (1 mg) (for 28 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001317,GK/MolTac,female,84 days,10,,CMO:0000012,body weight,,,,235,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,,,,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 28 days),110252,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 28 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001592,HanTac:WH,female,98 days,8,,CMO:0000012,body weight,,,,227,g,7.0,19.799,MMO:0000016,body weighing method,,0.0,,,,,control IgG monoclonal antibody (1 mg) (for 42 days),110253,control IgG monoclonal antibody (1 mg) (for 42 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001592,HanTac:WH,female,98 days,8,,CMO:0000012,body weight,,,,234,g,5.0,14.1421,MMO:0000016,body weighing method,,0.0,,,,,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days),110254,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001317,GK/MolTac,female,98 days,9,,CMO:0000012,body weight,,,,237,g,4.0,12.0,MMO:0000016,body weighing method,,0.0,,,,,control IgG monoclonal antibody (1 mg) (for 42 days),110255,control IgG monoclonal antibody (1 mg) (for 42 days),,,,,,,, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",body mass,,RS:0001317,GK/MolTac,female,98 days,10,,CMO:0000012,body weight,,,,241,g,5.0,15.8114,MMO:0000016,body weighing method,,0.0,,,,,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days),110256,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days),,,,,,,, 3174,"El-Omar MM, et al., Basic Res Cardiol. 2004 Mar;99(2):133-41. doi: 10.1007/s00395-004-0440-4. Epub 2003 Oct 7.",body mass,,RS:0001011,Crl:WI,male,240 days to 150 days,6,,CMO:0000012,body weight,,at least 6 animals,,559.5,g,18.5,45.3156,MMO:0000016,body weighing method,,0.0,,,,,control condition,110439,control condition,,,,,,,, 3174,"El-Omar MM, et al., Basic Res Cardiol. 2004 Mar;99(2):133-41. doi: 10.1007/s00395-004-0440-4. Epub 2003 Oct 7.",body mass,,RS:0004950,GK/Wnsm,male,240 days to 150 days,6,,CMO:0000012,body weight,,at least 6 animals,,379.6,g,16.0,39.1918,MMO:0000016,body weighing method,,0.0,,,,,control condition,110440,control condition,,,,,,,, 3177,"Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42.",body mass,,RS:0000145,BN/NHsdMcwi,male,180 days,6,,CMO:0000012,body weight,,n=6-27,,340,g,18.0,44.0908,MMO:0000016,body weighing method,,0.0,,,,,control condition,110590,control condition,,,,,,,, 3177,"Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42.",body mass,,RS:0004036,GK/FarMcwi,male,180 days,6,,CMO:0000012,body weight,,n=6-27,,351,g,13.0,31.8434,MMO:0000016,body weighing method,,0.0,,,,,control condition,110591,control condition,,,,,,,, 3177,"Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42.",body mass,,RS:0001576,T2DN/Mcwi,male,180 days,6,,CMO:0000012,body weight,,n=6-27,,375,g,15.0,36.7423,MMO:0000016,body weighing method,,0.0,,,,,control condition,110592,control condition,,,,,,,, 3177,"Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42.",body mass,,RS:0000145,BN/NHsdMcwi,male,365 days,6,,CMO:0000012,body weight,,n=6-27,,432,g,18.0,44.0908,MMO:0000016,body weighing method,,0.0,,,,,control condition,110593,control condition,,,,,,,, 3177,"Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42.",body mass,,RS:0004036,GK/FarMcwi,male,365 days,6,,CMO:0000012,body weight,,n=6-27,,421,g,20.0,48.9898,MMO:0000016,body weighing method,,0.0,,,,,control condition,110594,control condition,,,,,,,, 3177,"Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42.",body mass,,RS:0001576,T2DN/Mcwi,male,365 days,6,,CMO:0000012,body weight,,n=6-27,,424,g,17.0,41.6413,MMO:0000016,body weighing method,,0.0,,,,,control condition,110595,control condition,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",body mass,,RS:0001334,ISIAH,male,7 days,13,,CMO:0000012,body weight,,,,11.4,g,1.0,3.6056,MMO:0000016,body weighing method,,0.0,,,,,control condition,110671,control condition,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",body mass,,RS:0003766,WAG/Nov,male,7 days,15,,CMO:0000012,body weight,,,,11.9,g,7.2,27.8855,MMO:0000016,body weighing method,,0.0,,,,,control condition,110672,control condition,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",body mass,,RS:0001334,ISIAH,male,14 days,13,,CMO:0000012,body weight,,,,21,g,1.8,6.49,MMO:0000016,body weighing method,,0.0,,,,,control condition,110673,control condition,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",body mass,,RS:0003766,WAG/Nov,male,14 days,15,,CMO:0000012,body weight,,,,21.2,g,1.6,6.1968,MMO:0000016,body weighing method,,0.0,,,,,control condition,110674,control condition,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",body mass,,RS:0001334,ISIAH,male,25 days,13,,CMO:0000012,body weight,,,,51.1,g,11.3,40.7427,MMO:0000016,body weighing method,,0.0,,,,,control condition,110675,control condition,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",body mass,,RS:0003766,WAG/Nov,male,25 days,15,,CMO:0000012,body weight,,,,40.6,g,5.3,20.5268,MMO:0000016,body weighing method,,0.0,,,,,control condition,110676,control condition,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",body mass,,RS:0001334,ISIAH,male,98 days to 84 days,13,,CMO:0000012,body weight,,,,324.85,g,5.86,21.1285,MMO:0000016,body weighing method,,0.0,,,,,control condition,110685,control condition,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",body mass,,RS:0003766,WAG/Nov,male,98 days to 84 days,6,,CMO:0000012,body weight,,,,282.1,g,13.71,33.5825,MMO:0000016,body weighing method,,0.0,,,,,control condition,110686,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,105 days,8,,CMO:0000012,body weight,,,,325.4,g,9.2,26.0215,MMO:0000016,body weighing method,,0.0,,,,,control condition,110729,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,105 days,10,,CMO:0000012,body weight,,,,335.6,g,5.2,16.4438,MMO:0000016,body weighing method,,0.0,,,,,control condition,110730,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,105 days,9,,CMO:0000012,body weight,,,,337.3,g,7.8,23.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,110731,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,112 days,8,,CMO:0000012,body weight,,,,337.1,g,9.3,26.3044,MMO:0000016,body weighing method,,0.0,,,,,control condition,110732,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,112 days,10,,CMO:0000012,body weight,,,,352.4,g,6.5,20.5548,MMO:0000016,body weighing method,,0.0,,,,,control condition,110733,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,112 days,9,,CMO:0000012,body weight,,,,345.8,g,8.4,25.2,MMO:0000016,body weighing method,,0.0,,,,,control condition,110734,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,119 days,8,,CMO:0000012,body weight,,,,343,g,9.0,25.4558,MMO:0000016,body weighing method,,0.0,,,,,control condition,110735,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,119 days,10,,CMO:0000012,body weight,,,,350.1,g,7.7,24.3495,MMO:0000016,body weighing method,,0.0,,,,,control condition,110736,control condition,,,,,,,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",body mass,,RS:0001317,GK/MolTac,male,119 days,9,,CMO:0000012,body weight,,,,350.8,g,9.8,29.4,MMO:0000016,body weighing method,,0.0,,,,,control condition,110737,control condition,,,,,,,, 3185,"Ohta T, et al., Br J Pharmacol. 1999 Apr;126(7):1674-80. doi: 10.1038/sj.bjp.0702481.",body mass,,RS:0001840,Crlj:WI,male,56 days,5,,CMO:0000012,body weight,,,,238,g,2.5,5.5902,MMO:0000016,body weighing method,,0.0,,,,,fasting (for 16 hours),110766,fasting (for 16 hours),,,,,,,, 3185,"Ohta T, et al., Br J Pharmacol. 1999 Apr;126(7):1674-80. doi: 10.1038/sj.bjp.0702481.",body mass,,RS:0004817,GK/CskCrlj,male,56 days,5,,CMO:0000012,body weight,,,,204.4,g,1.9,4.2485,MMO:0000016,body weighing method,,0.0,,,,,fasting (for 16 hours),110767,fasting (for 16 hours),,,,,,,, 3192,"Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17.",body mass,,RS:0004946,SD-Myh7bem1Blar+/-,not specified,84 days,N/A,,CMO:0000012,body weight,,,,292.65,g,16.8,,MMO:0000016,body weighing method,,0.0,,,,,control condition,110825,control condition,,,,,,,, 3192,"Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17.",body mass,,RS:0004947,SD-Myh7bem1Blar-/-,not specified,84 days,N/A,,CMO:0000012,body weight,,,,244.6,g,28.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition,110826,control condition,,,,,,,, 3192,"Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17.",body mass,,RS:0005005,SD-Myh7bem1Blar+/+,not specified,84 days,N/A,,CMO:0000012,body weight,,SD-Myh7bem1Blar+/+ (RS:0005005),,307.6,g,16.5,,MMO:0000016,body weighing method,,0.0,,,,,control condition,110827,control condition,,,,,,,, 3193,"Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706.",body mass,,RS:0004852,W/Jpe,male,540 days,7,,CMO:0000012,body weight,,,,559.7,g,28.8,76.1976,MMO:0000016,body weighing method,,0.0,,,,,control condition,110845,control condition,,,,,,,, 3193,"Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706.",body mass,,RS:0004851,GK/Jpe,male,540 days,7,,CMO:0000012,body weight,,,,358.5,g,8.7,23.018,MMO:0000016,body weighing method,,0.0,,,,,control condition,110847,control condition,,,,,,,, 3193,"Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706.",body mass,,RS:0004851,GK/Jpe,male,540 days,7,,CMO:0000012,body weight,,,,428.8,g,12.0,31.749,MMO:0000016,body weighing method,,0.0,,,,,controlled cocoa butter content diet (7.5 null) (for 90 days) and controlled cholesterol content diet (1.25 null) (for 90 days) and soybean oil (2 ml/kg) (for 90 days),110848,controlled cocoa butter content diet (7.5 null) (for 90 days),controlled cholesterol content diet (1.25 null) (for 90 days),soybean oil (2 ml/kg) (for 90 days),,,,,, 3193,"Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706.",body mass,,RS:0004851,GK/Jpe,male,540 days,7,,CMO:0000012,body weight,,,,433.9,g,10.9,28.8387,MMO:0000016,body weighing method,,0.0,,,,,controlled cocoa butter content diet (7.5 null) (for 90 days) and controlled cholesterol content diet (1.25 null) (for 90 days) and alpha-lipoic acid (50 mg/kg) ,110849,controlled cocoa butter content diet (7.5 null) (for 90 days),controlled cholesterol content diet (1.25 null) (for 90 days),alpha-lipoic acid (50 mg/kg) ,,,,,, 3193,"Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706.",body mass,,RS:0004851,GK/Jpe,male,540 days,7,,CMO:0000012,body weight,,,,410.9,g,5.1,13.4933,MMO:0000016,body weighing method,,0.0,,,,,controlled cocoa butter content diet (7.5 null) (for 90 days) and controlled cholesterol content diet (1.25 null) (for 90 days),110861,controlled cocoa butter content diet (7.5 null) (for 90 days),controlled cholesterol content diet (1.25 null) (for 90 days),,,,,,, 3195,"Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x.",body mass,,RS:0001792,BDIX/OrlCrl,male,0 days,3,,CMO:0000012,body weight,,sham surgical group,,205,g,4.0415,7.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,111020,control condition,,,,,,,, 3195,"Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x.",body mass,,RS:0001792,BDIX/OrlCrl,male,0 days,5,,CMO:0000012,body weight,,baseline group A,,201,g,5.8138,13.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,111021,control condition,,,,,,,, 3195,"Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x.",body mass,,RS:0001792,BDIX/OrlCrl,male,0 days,5,,CMO:0000012,body weight,,baseline group B,,196,g,4.4721,10.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,111022,control condition,,,,,,,, 3195,"Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x.",body mass,,RS:0001792,BDIX/OrlCrl,male,0 days,5,,CMO:0000012,body weight,,baseline group C,,205,g,6.7082,15.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,111023,control condition,,,,,,,, 3195,"Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x.",body mass,,RS:0001792,BDIX/OrlCrl,male,0 days,5,,CMO:0000012,body weight,,baseline group 1,,201,g,7.6026,17.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,111024,control condition,,,,,,,, 3195,"Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x.",body mass,,RS:0001792,BDIX/OrlCrl,male,0 days,5,,CMO:0000012,body weight,,baseline group 2,,204,g,7.6026,17.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,111025,control condition,,,,,,,, 3195,"Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x.",body mass,,RS:0001792,BDIX/OrlCrl,male,0 days,5,,CMO:0000012,body weight,,baseline group 3,,195,g,5.8138,13.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,111026,control condition,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,male,-1 days,84,,CMO:0002080,fetal body weight,,,,2.92,g,0.0218,0.2,MMO:0000016,body weighing method,,0.0,,,12,days,control condition,111215,control condition,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,male,-1 days,36,,CMO:0002080,fetal body weight,,,,2.83,g,0.0233,0.14,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (20 mg/kg) ,111216,trypan blue (20 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,male,-1 days,44,,CMO:0002080,fetal body weight,,,,2.63,g,0.0513,0.34,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (30 mg/kg) ,111217,trypan blue (30 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,male,-1 days,18,,CMO:0002080,fetal body weight,,,,2.78,g,0.1603,0.68,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (40 mg/kg) ,111218,trypan blue (40 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,male,-1 days,38,,CMO:0002080,fetal body weight,,,,2.59,g,0.0422,0.26,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (60 mg/kg) ,111219,trypan blue (60 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,male,-1 days,24,,CMO:0002080,fetal body weight,,,,2.43,g,0.1,0.49,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (120 mg/kg) ,111220,trypan blue (120 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004962,BDIX/Nem,male,-1 days,56,,CMO:0002080,fetal body weight,,,,2.97,g,0.0214,0.16,MMO:0000016,body weighing method,,0.0,,,12,days,control condition,111221,control condition,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004962,BDIX/Nem,male,-1 days,49,,CMO:0002080,fetal body weight,,,,2.84,g,0.0271,0.19,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (60 mg/kg) ,111222,trypan blue (60 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004962,BDIX/Nem,male,-1 days,31,,CMO:0002080,fetal body weight,,,,2.69,g,0.0593,0.33,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (120 mg/kg) ,111223,trypan blue (120 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,female,-1 days,57,,CMO:0002080,fetal body weight,,,,2.76,g,0.0278,0.21,MMO:0000016,body weighing method,,0.0,,,12,days,control condition,111224,control condition,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,female,-1 days,40,,CMO:0002080,fetal body weight,,,,2.76,g,0.0158,0.1,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (20 mg/kg) ,111225,trypan blue (20 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,female,-1 days,41,,CMO:0002080,fetal body weight,,,,2.49,g,0.0453,0.29,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (30 mg/kg) ,111226,trypan blue (30 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,female,-1 days,28,,CMO:0002080,fetal body weight,,,,2.55,g,0.1153,0.61,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (40 mg/kg) ,111227,trypan blue (40 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,female,-1 days,36,,CMO:0002080,fetal body weight,,,,2.45,g,0.025,0.15,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (60 mg/kg) ,111228,trypan blue (60 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004961,WM/Nem,female,-1 days,26,,CMO:0002080,fetal body weight,,,,2.32,g,0.0922,0.47,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (120 mg/kg) ,111229,trypan blue (120 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004962,BDIX/Nem,female,-1 days,40,,CMO:0002080,fetal body weight,,,,2.74,g,0.0237,0.15,MMO:0000016,body weighing method,,0.0,,,12,days,control condition,111230,control condition,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004962,BDIX/Nem,female,-1 days,58,,CMO:0002080,fetal body weight,,,,2.66,g,0.0315,0.24,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (60 mg/kg) ,111231,trypan blue (60 mg/kg) ,,,,,,,, 3199,"Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108.",body mass,,RS:0004962,BDIX/Nem,female,-1 days,42,,CMO:0002080,fetal body weight,,,,2.58,g,0.0525,0.34,MMO:0000016,body weighing method,,0.0,,,12,days,trypan blue (120 mg/kg) ,111232,trypan blue (120 mg/kg) ,,,,,,,, 2968,"Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144.",body mass,,RS:0004423,SD-Apoeem1Sage,male,56 days,7,,CMO:0000012,body weight,,,,421.4,g,10.9988,29.1,MMO:0000016,body weighing method,,0.0,,,,,control condition,138265,control condition,,,,,,,, 2968,"Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144.",body mass,,RS:0004423,SD-Apoeem1Sage,male,56 days,7,,CMO:0000012,body weight,,,,410,g,10.9232,28.9,MMO:0000016,body weighing method,,,,,,,removal of maxillary molar crown (for 56 days),138266,removal of maxillary molar crown (for 56 days),,,,,,,, 2947,"Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013.",body mass,,RS:0001827,Crl:LE,male,28 days,N/A,,CMO:0000012,body weight,,,,74.2,g,,2.4,MMO:0000016,body weighing method,,,,,,,control condition,138267,control condition,,,,,,,, 2947,"Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013.",body mass,,RS:0003393,LE-Lrrk2em1Sage-/-,male,28 days,N/A,,CMO:0000012,body weight,,,,86.4,g,,3.0,MMO:0000016,body weighing method,,0.0,,,,,control condition,138271,control condition,,,,,,,, 2801,"Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30.",body mass,,RS:0000785,SR/Hsd,male,61 days to 52 days,N/A,,CMO:0000420,body weight gain,,change from surgery weight (2wks),,59,g,4.0,,MMO:0000016,body weighing method,,0.0,,,,,aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days),138419,aldosterone (22.5 ng/hr) (for 14 days),artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days),,,,,,,